chrom	pos	ref	alt	measureset_type	measureset_id	rcv	allele_id	symbol	hgvs_c	hgvs_p	molecular_consequence	clinical_significance	clinical_significance_ordered	review_status	review_status_ordered	all_submitters	all_traits	all_pmids	inheritance_modes	age_of_onset	prevalence	disease_mechanism	origin	xrefs
1	7869953	C	G	Haplotype	224889	RCV000210468	226735	PER3	NM_001289862.1:c.1243C>G	NP_001276791.1:p.Pro415Ala	NM_001289862.1:c.1243C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Advanced sleep phase syndrome, familial, 3;ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3 (1 family)	26903630		Adolescent			germline	MedGen:C4225169;OMIM:616882;Orphanet:164736
1	7869960	A	G	Haplotype	224889	RCV000210468	226734	PER3	NM_001289862.1:c.1250A>G	NP_001276791.1:p.His417Arg	NM_001289862.1:c.1250A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Advanced sleep phase syndrome, familial, 3;ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3 (1 family)	26903630		Adolescent			germline	MedGen:C4225169;OMIM:616882;Orphanet:164736
1	8045031	G	A	Haplotype	60700	RCV000007484	22107	PARK7	NM_007262.4:c.487G>A	NP_009193.2:p.Glu163Lys	NM_007262.4:c.487G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Parkinson disease 7;PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	16240358,20301402,23279440		Adult	1-5 / 10 000		germline	GeneReviews:NBK1223;Genetic Alliance:Parkinson+disease+7/9090;MedGen:C1853445;OMIM:602533.0001;OMIM:602533.0002;OMIM:602533.0003;OMIM:602533.0004;OMIM:602533.0005;OMIM:602533.0006;OMIM:606324;Orphanet:2828
1	25627552	C	G	Haplotype	202166	RCV000184007	198596	RHD	NM_016124.4:c.602C>G	NP_057208.2:p.Thr201Arg	NM_016124.4:c.602C>G:missense variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363
1	25627552	C	G	Haplotype	208474	RCV000190496	198596	RHD	NM_016124.4:c.602C>G	NP_057208.2:p.Thr201Arg	NM_016124.4:c.602C>G:missense variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363
1	25628043	T	G	Haplotype	202166	RCV000184007	198597	RHD	NM_016124.4:c.667T>G	NP_057208.2:p.Phe223Val	NM_016124.4:c.667T>G:missense variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363
1	25628043	T	G	Haplotype	208474	RCV000190496	198597	RHD	NM_016124.4:c.667T>G	NP_057208.2:p.Phe223Val	NM_016124.4:c.667T>G:missense variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363
1	25628073	G	C	Haplotype	208474	RCV000190496	204995	RHD	NM_016124.4:c.697G>C	NP_057208.2:p.Glu233Gln	NM_016124.4:c.697G>C:missense variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363
1	25628109	G	C	Haplotype	208474	RCV000190496	204996	RHD	NM_016124.4:c.733G>C	NP_057208.2:p.Val245Leu	NM_016124.4:c.733G>C:missense variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363
1	25628120	C	T	Haplotype	202166	RCV000184007	198598	RHD	NM_016124.4:c.744C>T	NP_057208.2:p.Ser248=	NM_016124.4:c.744C>T:synonymous variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363
1	25628120	C	T	Haplotype	208474	RCV000190496	198598	RHD	NM_016124.4:c.744C>T	NP_057208.2:p.Ser248=	NM_016124.4:c.744C>T:synonymous variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363
1	25633104	G	A	Haplotype	202166	RCV000184007	198599	RHD	NM_016124.4:c.957G>A	NP_057208.2:p.Val319=	NM_001127691.2:c.939+3154G>A:intron variant;NM_016124.4:c.957G>A:synonymous variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363
1	25633172	T	C	Haplotype	202166	RCV000184007	198600	RHD	NM_001127691.2:c.939+3222T>C	NP_057208.2:p.Ile342Thr	NM_001127691.2:c.939+3222T>C:intron variant;NM_016124.4:c.1025T>C:missense variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363
1	25633210	G	A	Haplotype	202166	RCV000184007	198601	RHD	NM_001127691.2:c.939+3260G>A	NP_057208.2:p.Gly355Ser	NM_001127691.2:c.939+3260G>A:intron variant;NM_016124.4:c.1063G>A:missense variant	not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363
1	25701876	C	T	Haplotype	208474	RCV000190496	204997	RHD				not provided	not provided	no assertion provided	no assertion provided	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363
1	25747230	G	C	Haplotype	17709	RCV000019283	32748	RHCE	NM_020485.5:c.48G=	NP_065231.3:p.Trp16=	NM_020485.5:c.48G=:synonymous variant	Benign	Benign	no assertion criteria provided	no assertion criteria provided	OMIM	RH C/c POLYMORPHISM;RH C/c POLYMORPHISM	8220426					germline	OMIM:111700.0002
1	53676401	T	G	Haplotype	30118	RCV000023026	39073	CPT2	NM_000098.2:c.1055T>G	NP_000089.1:p.Phe352Cys	NM_000098.2:c.1055T>G:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Encephalopathy, acute, infection-induced, 4, susceptibility to;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	15811315,18306170,20934285,21697855		Childhood			germline	Genetic Alliance:Encephalopathy%2C+acute%2C+infection-induced%2C+4%2C+susceptibility+to/8308;MedGen:C3280160;OMIM:614212;Orphanet:263524
1	53676448	G	A	Haplotype	30118	RCV000023026	39074	CPT2	NM_000098.2:c.1102G>A	NP_000089.1:p.Val368Ile	NM_000098.2:c.1102G>A:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Encephalopathy, acute, infection-induced, 4, susceptibility to;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	15811315,18306170,20934285,21697855		Childhood			germline	Genetic Alliance:Encephalopathy%2C+acute%2C+infection-induced%2C+4%2C+susceptibility+to/8308;MedGen:C3280160;OMIM:614212;Orphanet:263524
1	53676583	CAG	C	Haplotype	60702	RCV000202553	98339	CPT2	NM_000098.2:c.1239_1240delGA	NP_000089.1:p.Lys414Thrfs	NM_000098.2:c.1239_1240delGA:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Carnitine palmitoyltransferase II deficiency;Carnitine palmitoyltransferase II deficiency	10090476,20301431,25173338	Autosomal recessive inheritance				germline	GeneReviews:NBK1253;Genetic Testing Registry (GTR):GTR000530033;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000552216;MedGen:C0342790;Office of Rare Diseases:1121;SNOMED CT:238002005
1	53676688	T	C	Haplotype	60702	RCV000202553	23999	CPT2	NM_000098.2:c.1342T>C	NP_000089.1:p.Phe448Leu	NM_000098.2:c.1342T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Carnitine palmitoyltransferase II deficiency;Carnitine palmitoyltransferase II deficiency	10090476,20301431,25173338	Autosomal recessive inheritance				germline	GeneReviews:NBK1253;Genetic Testing Registry (GTR):GTR000530033;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000552216;MedGen:C0342790;Office of Rare Diseases:1121;SNOMED CT:238002005
1	55331078	C	G	Haplotype	4368	RCV000004616	38433	DHCR24	NM_014762.3:c.918G>C	NP_055577.1:p.Lys306Asn	NM_014762.3:c.918G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Desmosterolosis;DESMOSTEROLOSIS	11519011		Antenatal	<1 / 1 000 000		germline	GeneTests:238860;Genetic Alliance:Desmosterolosis/2221;MedGen:C1865596;OMIM:602398;Office of Rare Diseases:10283;Orphanet:35107
1	55331115	T	G	Haplotype	4368	RCV000004616	19407	DHCR24	NM_014762.3:c.881A>C	NP_055577.1:p.Asn294Thr	NM_014762.3:c.881A>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Desmosterolosis;DESMOSTEROLOSIS	11519011		Antenatal	<1 / 1 000 000		germline	GeneTests:238860;Genetic Alliance:Desmosterolosis/2221;MedGen:C1865596;OMIM:602398;Office of Rare Diseases:10283;Orphanet:35107
1	94467548	C	G	Haplotype	236131	RCV000408516	22923	ABCA4	NM_000350.2:c.6148G>C	NP_000341.2:p.Val2050Leu	NM_000350.2:c.6148G>C:missense variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94471055	C	T	Haplotype	236068	RCV000408532	105317	ABCA4	NM_000350.2:c.6089G>A	NP_000341.2:p.Arg2030Gln	NM_000350.2:c.6089G>A:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94480178	G	T	Haplotype	236131	RCV000408516	105260	ABCA4	NM_000350.2:c.5381C>A	NP_000341.2:p.Ala1794Asp	NM_000350.2:c.5381C>A:missense variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94485181	A	C	Haplotype	236092	RCV000408474	237656	ABCA4	NM_000350.2:c.5153T>G	NP_000341.2:p.Val1718Gly	NM_000350.2:c.5153T>G:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94492973	G	A	Haplotype	225694	RCV000211040	227509	ABCA4	NM_000350.2:c.4539+2028C>T		NM_000350.2:c.4539+2028C>T:intron variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Stargardt disease 1	26527198,28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94508356	T	A	Haplotype	236091	RCV000408579	237681	ABCA4	NM_000350.2:c.3289A>T	NP_000341.2:p.Arg1097Ter	NM_000350.2:c.3289A>T:nonsense	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94508969	G	A	Haplotype	7901	RCV000008358	22933	ABCA4	NM_000350.2:c.3113C>T	NP_000341.2:p.Ala1038Val	NM_000350.2:c.3113C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Stargardt disease 1;STARGARDT DISEASE 1	10958761,10958763,12796258,16103129,28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94508969	G	A	Haplotype	7901	RCV000008359	22933	ABCA4	NM_000350.2:c.3113C>T	NP_000341.2:p.Ala1038Val	NM_000350.2:c.3113C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cone-rod dystrophy 3	10958761,10958763,12796258,16103129,28118664	Autosomal recessive inheritance	Childhood	1-9 / 100 000		germline	Genetic Alliance:Cone-Rod+Dystrophy+3/1769;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1858806;OMIM:604116;Office of Rare Diseases:10653;Orphanet:1872
1	94517254	C	G	Haplotype	236091	RCV000408579	22918	ABCA4	NM_000350.2:c.2588G>C	NP_000341.2:p.Gly863Ala	NM_000350.2:c.2588G>C:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94517254	C	G	Haplotype	236092	RCV000408474	22918	ABCA4	NM_000350.2:c.2588G>C	NP_000341.2:p.Gly863Ala	NM_000350.2:c.2588G>C:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94528806	A	G	Haplotype	7901	RCV000008358	22940	ABCA4	NM_000350.2:c.1622T>C	NP_000341.2:p.Leu541Pro	NM_000350.2:c.1622T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Stargardt disease 1;STARGARDT DISEASE 1	10958761,10958763,12796258,16103129,28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94528806	A	G	Haplotype	7901	RCV000008359	22940	ABCA4	NM_000350.2:c.1622T>C	NP_000341.2:p.Leu541Pro	NM_000350.2:c.1622T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cone-rod dystrophy 3	10958761,10958763,12796258,16103129,28118664	Autosomal recessive inheritance	Childhood	1-9 / 100 000		germline	Genetic Alliance:Cone-Rod+Dystrophy+3/1769;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1858806;OMIM:604116;Office of Rare Diseases:10653;Orphanet:1872
1	94576926	G	A	Haplotype	225694	RCV000211040	227508	ABCA4	NM_000350.2:c.302+68C>T		NM_000350.2:c.302+68C>T:intron variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Stargardt disease 1	26527198,28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	94586601	T	C	Haplotype	236068	RCV000408532	104999	ABCA4	NM_000350.2:c.1A>G	NP_000341.2:p.Met1Val	NM_000350.2:c.1A>G:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664	Autosomal recessive inheritance	Adolescent	1-5 / 10 000		germline	Genetic Alliance:Stargardt+disease+1/9354;Genetic Testing Registry (GTR):GTR000518794;Genetic Testing Registry (GTR):GTR000518797;Genetic Testing Registry (GTR):GTR000518887;Genetic Testing Registry (GTR):GTR000518888;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:stargardt-macular-degeneration;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827
1	116269619	T	C	Haplotype	228471	RCV000217394	44436	CASQ2	NM_001232.3:c.731A>G	NP_001223.2:p.His244Arg	NM_001232.3:c.731A>G:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
1	116269620	G	A	Haplotype	228471	RCV000217394	228262	CASQ2	NM_001232.3:c.730C>T	NP_001223.2:p.His244Tyr	NM_001232.3:c.730C>T:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
1	155204994	C	G	Haplotype	4297	RCV000004533	38385	GBA	NM_001005741.2:c.1497G>C	NP_001005741.1:p.Val499=	NM_001005741.2:c.1497G>C:synonymous variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I	10685993,1437405,1594045,18197057,1899336,1972019,19888064,20301446,7857677,8118460,8929950		All ages	1-9 / 100 000		germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009
1	155204994	C	G	Haplotype	4297	RCV000004534	38385	GBA	NM_001005741.2:c.1497G>C	NP_001005741.1:p.Val499=	NM_001005741.2:c.1497G>C:synonymous variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Acute neuronopathic Gaucher's disease	10685993,1437405,1594045,1899336,1972019,20301446,7857677,8118460,8929950	Autosomal recessive inheritance				germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+2/3003;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008
1	155204994	C	G	Haplotype	4297	RCV000004535	38385	GBA	NM_001005741.2:c.1497G>C	NP_001005741.1:p.Val499=	NM_001005741.2:c.1497G>C:synonymous variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Subacute neuronopathic Gaucher's disease	10685993,1437405,1594045,1899336,1972019,20301446,7857677,8118460,8929950	Autosomal recessive inheritance	All ages			germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+3/3004;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268251;OMIM:231000;OMIM:606463.0001;OMIM:606463.0005;OMIM:606463.0006;OMIM:606463.0007;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;OMIM:606463.0047;Orphanet:355;Orphanet:77261;SNOMED CT:5963005
1	155204994	C	G	Haplotype	4297	RCV000004536	38385	GBA	NM_001005741.2:c.1497G>C	NP_001005741.1:p.Val499=	NM_001005741.2:c.1497G>C:synonymous variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Gaucher disease, perinatal lethal	10685993,1437405,1594045,1899336,1972019,20301446,7857677,8118460,8929950	Autosomal recessive inheritance				germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Perinatal+Lethal/3001;Genetic Testing Registry (GTR):GTR000552033;MedGen:C1842704;OMIM:608013
1	155205008	C	G	Haplotype	4297	RCV000004533	38384	GBA	NM_001005741.2:c.1483G>C	NP_001005741.1:p.Ala495Pro	NM_001005741.2:c.1483G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I	10685993,1437405,1594045,18197057,1899336,1972019,19888064,20301446,7857677,8118460,8929950		All ages	1-9 / 100 000		germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009
1	155205008	C	G	Haplotype	4297	RCV000004534	38384	GBA	NM_001005741.2:c.1483G>C	NP_001005741.1:p.Ala495Pro	NM_001005741.2:c.1483G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Acute neuronopathic Gaucher's disease	10685993,1437405,1594045,1899336,1972019,20301446,7857677,8118460,8929950	Autosomal recessive inheritance				germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+2/3003;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008
1	155205008	C	G	Haplotype	4297	RCV000004535	38384	GBA	NM_001005741.2:c.1483G>C	NP_001005741.1:p.Ala495Pro	NM_001005741.2:c.1483G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Subacute neuronopathic Gaucher's disease	10685993,1437405,1594045,1899336,1972019,20301446,7857677,8118460,8929950	Autosomal recessive inheritance	All ages			germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+3/3004;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268251;OMIM:231000;OMIM:606463.0001;OMIM:606463.0005;OMIM:606463.0006;OMIM:606463.0007;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;OMIM:606463.0047;Orphanet:355;Orphanet:77261;SNOMED CT:5963005
1	155205008	C	G	Haplotype	4297	RCV000004536	38384	GBA	NM_001005741.2:c.1483G>C	NP_001005741.1:p.Ala495Pro	NM_001005741.2:c.1483G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Gaucher disease, perinatal lethal	10685993,1437405,1594045,1899336,1972019,20301446,7857677,8118460,8929950	Autosomal recessive inheritance				germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Perinatal+Lethal/3001;Genetic Testing Registry (GTR):GTR000552033;MedGen:C1842704;OMIM:608013
1	155205043	A	G	Haplotype	4297	RCV000004533	19327	GBA	NM_001005741.2:c.1448T>C	NP_001005741.1:p.Leu483Pro	NM_001005741.2:c.1448T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I	10685993,1437405,1594045,18197057,1899336,1972019,19888064,20301446,7857677,8118460,8929950		All ages	1-9 / 100 000		germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009
1	155205043	A	G	Haplotype	4297	RCV000004534	19327	GBA	NM_001005741.2:c.1448T>C	NP_001005741.1:p.Leu483Pro	NM_001005741.2:c.1448T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Acute neuronopathic Gaucher's disease	10685993,1437405,1594045,1899336,1972019,20301446,7857677,8118460,8929950	Autosomal recessive inheritance				germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+2/3003;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008
1	155205043	A	G	Haplotype	4297	RCV000004535	19327	GBA	NM_001005741.2:c.1448T>C	NP_001005741.1:p.Leu483Pro	NM_001005741.2:c.1448T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Subacute neuronopathic Gaucher's disease	10685993,1437405,1594045,1899336,1972019,20301446,7857677,8118460,8929950	Autosomal recessive inheritance	All ages			germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+3/3004;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268251;OMIM:231000;OMIM:606463.0001;OMIM:606463.0005;OMIM:606463.0006;OMIM:606463.0007;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;OMIM:606463.0047;Orphanet:355;Orphanet:77261;SNOMED CT:5963005
1	155205043	A	G	Haplotype	4297	RCV000004536	19327	GBA	NM_001005741.2:c.1448T>C	NP_001005741.1:p.Leu483Pro	NM_001005741.2:c.1448T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Gaucher disease, perinatal lethal	10685993,1437405,1594045,1899336,1972019,20301446,7857677,8118460,8929950	Autosomal recessive inheritance				germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Perinatal+Lethal/3001;Genetic Testing Registry (GTR):GTR000552033;MedGen:C1842704;OMIM:608013
1	155205518	C	G	Haplotype	4334	RCV000004580	19332	GBA	NM_001005741.2:c.1342G>C	NP_001005741.1:p.Asp448His	NM_001005741.2:c.1342G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Acute neuronopathic Gaucher's disease;GAUCHER DISEASE, TYPE II	15690354,20301446	Autosomal recessive inheritance				germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+2/3003;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008
1	155205518	C	G	Haplotype	4334	RCV000004581	19332	GBA	NM_001005741.2:c.1342G>C	NP_001005741.1:p.Asp448His	NM_001005741.2:c.1342G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Subacute neuronopathic Gaucher's disease	15690354,20301446	Autosomal recessive inheritance	All ages			germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+3/3004;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268251;OMIM:231000;OMIM:606463.0001;OMIM:606463.0005;OMIM:606463.0006;OMIM:606463.0007;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;OMIM:606463.0047;Orphanet:355;Orphanet:77261;SNOMED CT:5963005
1	155206167	C	T	Haplotype	4299	RCV000004538	38432	GBA	NM_001005741.2:c.1093G>A	NP_001005741.1:p.Glu365Lys	NM_001005741.2:c.1093G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I	10079102,11903352,15146461,18197057,1864608,19888064,20301446		All ages	1-9 / 100 000		germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009
1	155207249	A	C	Haplotype	4334	RCV000004580	19373	GBA	NM_001005741.2:c.882T>G	NP_001005741.1:p.His294Gln	NM_001005741.2:c.882T>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Acute neuronopathic Gaucher's disease;GAUCHER DISEASE, TYPE II	15690354,20301446	Autosomal recessive inheritance				germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+2/3003;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008
1	155207249	A	C	Haplotype	4334	RCV000004581	19373	GBA	NM_001005741.2:c.882T>G	NP_001005741.1:p.His294Gln	NM_001005741.2:c.882T>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Subacute neuronopathic Gaucher's disease	15690354,20301446	Autosomal recessive inheritance	All ages			germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+3/3004;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268251;OMIM:231000;OMIM:606463.0001;OMIM:606463.0005;OMIM:606463.0006;OMIM:606463.0007;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;OMIM:606463.0047;Orphanet:355;Orphanet:77261;SNOMED CT:5963005
1	155208361	C	G	Haplotype	4299	RCV000004538	19338	GBA	NM_001005741.2:c.535G>C	NP_001005741.1:p.Asp179His	NM_001005741.2:c.535G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I	10079102,11903352,15146461,18197057,1864608,19888064,20301446		All ages	1-9 / 100 000		germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009
1	156830751	C	T	Haplotype	12304	RCV000030667	27343	NTRK1	NM_002529.3:c.25C>T	NP_002520.2:p.Gln9Ter	NM_001007792.1:c.123-3395C>T:intron variant;NM_001012331.1:c.25C>T:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hereditary insensitivity to pain with anhidrosis;INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	10330344,11159935,20301726		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1769;Genetic Alliance:Insensitivity+to+pain%2C+congenital%2C+with+anhidrosis/3832;MedGen:C0020074;OMIM:256800;Office of Rare Diseases:3006;Orphanet:642;SNOMED CT:62985007
1	156848918	C	T	Haplotype	12304	RCV000030667	38397	NTRK1	NM_002529.3:c.1810C>T	NP_002520.2:p.His604Tyr	NM_001007792.1:c.1702C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hereditary insensitivity to pain with anhidrosis;INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	10330344,11159935,20301726		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1769;Genetic Alliance:Insensitivity+to+pain%2C+congenital%2C+with+anhidrosis/3832;MedGen:C0020074;OMIM:256800;Office of Rare Diseases:3006;Orphanet:642;SNOMED CT:62985007
1	156848946	G	T	Haplotype	12304	RCV000030667	27347	NTRK1	NM_002529.3:c.1838G>T	NP_002520.2:p.Gly613Val	NM_001007792.1:c.1730G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hereditary insensitivity to pain with anhidrosis;INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	10330344,11159935,20301726		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1769;Genetic Alliance:Insensitivity+to+pain%2C+congenital%2C+with+anhidrosis/3832;MedGen:C0020074;OMIM:256800;Office of Rare Diseases:3006;Orphanet:642;SNOMED CT:62985007
1	161276217	G	C	Haplotype	14182	RCV000015246	38403	MPZ	NM_000530.7:c.486C>G	NP_000521.2:p.Ile162Met	NM_000530.7:c.486C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Charcot-Marie-Tooth disease type 2I;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	11835375,20301462,9222756	Autosomal dominant inheritance	Adult			germline	GeneReviews:NBK1285;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+2I/1300;Genetic Testing Registry (GTR):GTR000056721;Genetic Testing Registry (GTR):GTR000231905;Genetic Testing Registry (GTR):GTR000262712;Genetic Testing Registry (GTR):GTR000508897;Genetic Testing Registry (GTR):GTR000509965;Genetic Testing Registry (GTR):GTR000520409;Genetic Testing Registry (GTR):GTR000529452;MedGen:C1843251;OMIM:607677;Office of Rare Diseases:9197;Orphanet:99942
1	161276564	C	T	Haplotype	14180	RCV000015243	38402	MPZ	NM_000530.7:c.382G>A	NP_000521.2:p.Asp128Asn	NM_000530.7:c.382G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Dejerine-sottas syndrome, sporadic;DEJERINE-SOTTAS SYNDROME, SPORADIC	9222756					germline	MedGen:C4016265
1	161276600	T	G	Haplotype	14180	RCV000015243	38401	MPZ	NM_000530.7:c.346A>C	NP_000521.2:p.Asn116His	NM_000530.7:c.346A>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Dejerine-sottas syndrome, sporadic;DEJERINE-SOTTAS SYNDROME, SPORADIC	9222756					germline	MedGen:C4016265
1	161276605	A	G	Haplotype	14180	RCV000015243	29219	MPZ	NM_000530.7:c.341T>C	NP_000521.2:p.Ile114Thr	NM_000530.7:c.341T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Dejerine-sottas syndrome, sporadic;DEJERINE-SOTTAS SYNDROME, SPORADIC	9222756					germline	MedGen:C4016265
1	161276609	C	A	Haplotype	208147	RCV000194363	49442	MPZ	NM_000530.7:c.337G>T	NP_000521.2:p.Val113Phe	NM_000530.7:c.337G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Charcot-Marie-Tooth disease, demyelinating, type 1b;Charcot-Marie-Tooth disease, type IB	19502294,20301384	Autosomal dominant inheritance	Adolescent	DI-CMTB is a rare cause of CMT. Up to 3.4% of CMT is caused by a DNM2 mutation		germline	GeneReviews:NBK1205;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+1B/1285;Genetic Testing Registry (GTR):GTR000056721;Genetic Testing Registry (GTR):GTR000262712;Genetic Testing Registry (GTR):GTR000310902;Genetic Testing Registry (GTR):GTR000508897;Genetic Testing Registry (GTR):GTR000509930;Genetic Testing Registry (GTR):GTR000520409;Genetic Testing Registry (GTR):GTR000521569;Genetic Testing Registry (GTR):GTR000529452;MedGen:C0270912;OMIM:118200;Office of Rare Diseases:1246;Orphanet:101082;SNOMED CT:42986003
1	161276672	C	T	Haplotype	14182	RCV000015246	38404	MPZ	NM_000530.7:c.274G>A	NP_000521.2:p.Val92Met	NM_000530.7:c.274G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Charcot-Marie-Tooth disease type 2I;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	11835375,20301462,9222756	Autosomal dominant inheritance	Adult			germline	GeneReviews:NBK1285;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+2I/1300;Genetic Testing Registry (GTR):GTR000056721;Genetic Testing Registry (GTR):GTR000231905;Genetic Testing Registry (GTR):GTR000262712;Genetic Testing Registry (GTR):GTR000508897;Genetic Testing Registry (GTR):GTR000509965;Genetic Testing Registry (GTR):GTR000520409;Genetic Testing Registry (GTR):GTR000529452;MedGen:C1843251;OMIM:607677;Office of Rare Diseases:9197;Orphanet:99942
1	161276680	A	T	Haplotype	14182	RCV000015246	29221	MPZ	NM_000530.7:c.266T>A	NP_000521.2:p.Ile89Asn	NM_000530.7:c.266T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Charcot-Marie-Tooth disease type 2I;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	11835375,20301462,9222756	Autosomal dominant inheritance	Adult			germline	GeneReviews:NBK1285;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+2I/1300;Genetic Testing Registry (GTR):GTR000056721;Genetic Testing Registry (GTR):GTR000231905;Genetic Testing Registry (GTR):GTR000262712;Genetic Testing Registry (GTR):GTR000508897;Genetic Testing Registry (GTR):GTR000509965;Genetic Testing Registry (GTR):GTR000520409;Genetic Testing Registry (GTR):GTR000529452;MedGen:C1843251;OMIM:607677;Office of Rare Diseases:9197;Orphanet:99942
1	161276705	G	A	Haplotype	208147	RCV000194363	49438	MPZ	NM_000530.7:c.241C>T	NP_000521.2:p.His81Tyr	NM_000530.7:c.241C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Charcot-Marie-Tooth disease, demyelinating, type 1b;Charcot-Marie-Tooth disease, type IB	19502294,20301384	Autosomal dominant inheritance	Adolescent	DI-CMTB is a rare cause of CMT. Up to 3.4% of CMT is caused by a DNM2 mutation		germline	GeneReviews:NBK1205;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+1B/1285;Genetic Testing Registry (GTR):GTR000056721;Genetic Testing Registry (GTR):GTR000262712;Genetic Testing Registry (GTR):GTR000310902;Genetic Testing Registry (GTR):GTR000508897;Genetic Testing Registry (GTR):GTR000509930;Genetic Testing Registry (GTR):GTR000520409;Genetic Testing Registry (GTR):GTR000521569;Genetic Testing Registry (GTR):GTR000529452;MedGen:C0270912;OMIM:118200;Office of Rare Diseases:1246;Orphanet:101082;SNOMED CT:42986003
1	161599693	T	C	Haplotype	36924	RCV000030607	45587	FCGR3B	NM_000570.4:c.194A>G	NP_000561.3:p.Asn65Ser	NM_000570.4:c.194A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Neutrophil-specific antigens na1/na2;NEUTROPHIL-SPECIFIC ANTIGENS NA1/NA2	2478590					germline	MedGen:C4017227
1	171076966	G	A	Haplotype	16318	RCV000017711	38476	FMO3	NM_006894.5:c.472G>A	NP_008825.4:p.Glu158Lys	NM_001002294.2:c.472G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Trimethylaminuria, mild;TRIMETHYLAMINURIA, MILD	10485731					germline	MedGen:C4016101
1	171076966	G	A	Haplotype	16318	RCV000201276	38476	FMO3	NM_006894.5:c.472G>A	NP_008825.4:p.Glu158Lys	NM_001002294.2:c.472G>A:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Trimethylaminuria	10485731,10896299,11809920,20301282,22126753	Autosomal recessive inheritance			loss of function	germline	GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005
1	171076966	G	A	Haplotype	217371	RCV000201278	38476	FMO3	NM_006894.5:c.472G>A	NP_008825.4:p.Glu158Lys	NM_001002294.2:c.472G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Trimethylaminuria	19321370,20301282,22126753	Autosomal recessive inheritance			loss of function	germline	GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005
1	171077295	T	C	Haplotype	217371	RCV000201278	214011	FMO3	NM_006894.5:c.560T>C	NP_008825.4:p.Val187Ala	NM_001002294.2:c.560T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Trimethylaminuria	19321370,20301282,22126753	Autosomal recessive inheritance			loss of function	germline	GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005
1	171083242	A	G	Haplotype	16318	RCV000017711	31357	FMO3	NM_006894.5:c.923A>G	NP_008825.4:p.Glu308Gly	NM_001002294.2:c.923A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Trimethylaminuria, mild;TRIMETHYLAMINURIA, MILD	10485731					germline	MedGen:C4016101
1	171083242	A	G	Haplotype	16318	RCV000201276	31357	FMO3	NM_006894.5:c.923A>G	NP_008825.4:p.Glu308Gly	NM_001002294.2:c.923A>G:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Trimethylaminuria	10485731,10896299,11809920,20301282,22126753	Autosomal recessive inheritance			loss of function	germline	GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005
1	179545050	C	A	Haplotype	225143	RCV000210779	227036	NPHS2	NM_014625.3:c.-51G>T		NM_014625.3:c.-51G>T:5 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Human Genetics Disease in Children – Taif University,Taif University	Nephrotic syndrome, idiopathic, steroid-resistant		Autosomal recessive inheritance	All ages			unknown	Genetic Alliance:Nephrotic+syndrome%2C+idiopathic%2C+steroid-resistant/5149;Genetic Testing Registry (GTR):GTR000552033;MedGen:C1868672;OMIM:600995;Office of Rare Diseases:3946;Orphanet:656
1	179545051	G	C	Haplotype	225143	RCV000210779	227037	NPHS2	NM_014625.3:c.-52C>G		NM_014625.3:c.-52C>G:5 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Human Genetics Disease in Children – Taif University,Taif University	Nephrotic syndrome, idiopathic, steroid-resistant		Autosomal recessive inheritance	All ages			unknown	Genetic Alliance:Nephrotic+syndrome%2C+idiopathic%2C+steroid-resistant/5149;Genetic Testing Registry (GTR):GTR000552033;MedGen:C1868672;OMIM:600995;Office of Rare Diseases:3946;Orphanet:656
1	183543642	T	C	Haplotype	2240	RCV000002328	38423	NCF2	NM_000433.3:c.481A>G	NP_000424.2:p.Lys161Glu	NM_000433.3:c.481A>G:missense variant;NM_001190789.1:c.366+3092A>G:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2;GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	22876374,9070911		Adolescent	1-9 / 1 000 000		germline	GeneReviews:NBK99496;Genetic Alliance:Chronic+granulomatous+disease%2C+autosomal+recessive+cytochrome+b-positive%2C+type+II/7977;MedGen:C1856245;OMIM:233710;Orphanet:379
1	183543644	T	A	Haplotype	2240	RCV000002328	17279	NCF2	NM_000433.3:c.479A>T	NP_000424.2:p.Asp160Val	NM_000433.3:c.479A>T:missense variant;NM_001190789.1:c.366+3090A>T:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2;GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	22876374,9070911		Adolescent	1-9 / 1 000 000		germline	GeneReviews:NBK99496;Genetic Alliance:Chronic+granulomatous+disease%2C+autosomal+recessive+cytochrome+b-positive%2C+type+II/7977;MedGen:C1856245;OMIM:233710;Orphanet:379
1	209880216	C	CA	Haplotype	8911	RCV000009466	23950	HSD11B1	NM_181755.2:c.331+53_331+54insA		NM_181755.2:c.331+53_331+54insA:intron variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	OMIM	Cortisone reductase deficiency 2;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	12858176,15827106,16091483,16817821,17062770			<1 / 1 000 000		germline	Genetic Alliance:CORTISONE+REDUCTASE+DEFICIENCY+2/8103;MedGen:C3553382;OMIM:614662;Orphanet:168588
1	209880259	T	G	Haplotype	8911	RCV000009466	76328	HSD11B1	NM_181755.2:c.332-29T>G		NM_181755.2:c.332-29T>G:intron variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	OMIM	Cortisone reductase deficiency 2;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	12858176,15827106,16091483,16817821,17062770			<1 / 1 000 000		germline	Genetic Alliance:CORTISONE+REDUCTASE+DEFICIENCY+2/8103;MedGen:C3553382;OMIM:614662;Orphanet:168588
1	211093297	C	G	Haplotype	203434	RCV000185594	181518	KCNH1	NM_172362.2:c.1147G>C	NP_758872.1:p.Val383Leu	NM_172362.2:c.1147G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Zimmermann-Laband syndrome 1;ZIMMERMANN-LABAND SYNDROME 1	18541964,25915598		Infancy	<1 / 1 000 000		germline	Gene:353173;Genetic Alliance:Laband+syndrome/4062;MedGen:CN032818;OMIM:135500;Orphanet:3473
1	211093389	G	T	Haplotype	203434	RCV000185594	181521	KCNH1	NM_002238.3:c.974C>A	NP_758872.1:p.Ser352Tyr	NM_172362.2:c.1055C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Zimmermann-Laband syndrome 1;ZIMMERMANN-LABAND SYNDROME 1	18541964,25915598		Infancy	<1 / 1 000 000		germline	Gene:353173;Genetic Alliance:Laband+syndrome/4062;MedGen:CN032818;OMIM:135500;Orphanet:3473
1	227170697	C	T	Haplotype	217876	RCV000201953	214530	COQ8A	NM_020247.4:c.1042C>T	NP_064632.2:p.Arg348Ter	NM_020247.4:c.1042C>T:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Coenzyme Q10 deficiency, primary, 4	18319072,20580948,28125198		Childhood	<1 / 1 000 000		germline	GeneReviews:NBK410087;Genetic Alliance:Spinocerebellar+ataxia%2C+autosomal+recessive+9/9342;MedGen:C2677589;OMIM:612016;Orphanet:139485
1	227173033	G	A	Haplotype	217876	RCV000201953	18675	COQ8A	NM_020247.4:c.1651G>A	NP_064632.2:p.Glu551Lys	NM_020247.4:c.1651G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Coenzyme Q10 deficiency, primary, 4	18319072,20580948,28125198		Childhood	<1 / 1 000 000		germline	GeneReviews:NBK410087;Genetic Alliance:Spinocerebellar+ataxia%2C+autosomal+recessive+9/9342;MedGen:C2677589;OMIM:612016;Orphanet:139485
1	229568534	G	A	Haplotype	18293	RCV000019955	38498	ACTA1	NM_001100.3:c.223C>T	NP_001091.1:p.His75Tyr	NM_001100.3:c.223C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Nemaline myopathy 3;NEMALINE MYOPATHY 3	19553116,20301465,22510848	Autosomal recessive inheritance				germline	GeneReviews:NBK1288;Genetic Alliance:Nemaline+myopathy+3/5125;Genetic Testing Registry (GTR):GTR000502403;Genetic Testing Registry (GTR):GTR000502456;Genetic Testing Registry (GTR):GTR000506311;Genetic Testing Registry (GTR):GTR000506312;Genetic Testing Registry (GTR):GTR000519025;Genetic Testing Registry (GTR):GTR000522325;Genetic Testing Registry (GTR):GTR000552030;MedGen:C1834336;OMIM:161800;Office of Rare Diseases:10111
1	229568535	C	A	Haplotype	18293	RCV000019955	33332	ACTA1	NM_001100.3:c.222G>T	NP_001091.1:p.Glu74Asp	NM_001100.3:c.222G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Nemaline myopathy 3;NEMALINE MYOPATHY 3	19553116,20301465,22510848	Autosomal recessive inheritance				germline	GeneReviews:NBK1288;Genetic Alliance:Nemaline+myopathy+3/5125;Genetic Testing Registry (GTR):GTR000502403;Genetic Testing Registry (GTR):GTR000502456;Genetic Testing Registry (GTR):GTR000506311;Genetic Testing Registry (GTR):GTR000506312;Genetic Testing Registry (GTR):GTR000519025;Genetic Testing Registry (GTR):GTR000522325;Genetic Testing Registry (GTR):GTR000552030;MedGen:C1834336;OMIM:161800;Office of Rare Diseases:10111
2	47273468	A	G	Haplotype	190388	RCV000170526	188215	TTC7A	NM_020458.3:c.1817A>G	NP_065191.2:p.Lys606Arg	NM_001288953.1:c.1715A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Multiple gastrointestinal atresias;GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME	23830146		Neonatal			germline	MedGen:C0220744;OMIM:243150;OMIM:609332.0001;OMIM:609332.0002;OMIM:609332.0003;OMIM:609332.0004;OMIM:609332.0005;OMIM:609332.0006;OMIM:609332.0007;OMIM:609332.0008;OMIM:609332.0009;OMIM:609332.0010;OMIM:609332.0011;OMIM:609332.0012;OMIM:609332.0013;OMIM:609332.0014;OMIM:609332.0015;Office of Rare Diseases:3013;Orphanet:2300;SNOMED CT:95472001
2	47277182	T	C	Haplotype	190388	RCV000170526	188216	TTC7A	NM_020458.3:c.2014T>C	NP_065191.2:p.Ser672Pro	NM_001288953.1:c.1912T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Multiple gastrointestinal atresias;GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME	23830146		Neonatal			germline	MedGen:C0220744;OMIM:243150;OMIM:609332.0001;OMIM:609332.0002;OMIM:609332.0003;OMIM:609332.0004;OMIM:609332.0005;OMIM:609332.0006;OMIM:609332.0007;OMIM:609332.0008;OMIM:609332.0009;OMIM:609332.0010;OMIM:609332.0011;OMIM:609332.0012;OMIM:609332.0013;OMIM:609332.0014;OMIM:609332.0015;Office of Rare Diseases:3013;Orphanet:2300;SNOMED CT:95472001
2	86444224	T	C	Distinct chromosomes	157528	RCV000144873	167389	REEP1	NM_001164730.1:c.626A>G	NP_001158202.1:p.Ter209Trp	NM_001164730.1:c.626A>G:stop lost;NM_001164732.1:c.370A>G:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type|spasticity;Charcot-Marie-Tooth disease	20301532,25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001
2	128412067	G	A	Haplotype	222901	RCV000208555	224616	LIMS2	NM_001161404.1:c.275C>T	NP_001154876.1:p.Pro92Leu	NM_001161404.1:c.275C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Muscular dystrophy, limb-girdle, type 2W;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W (1 family)	25589244					germline	MedGen:C4225192;OMIM:616827
2	128412081	G	C	Haplotype	222901	RCV000208555	224615	LIMS2	NM_001136037.2:c.342C>G	NP_001154876.1:p.Asn87Lys	NM_001161404.1:c.261C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Muscular dystrophy, limb-girdle, type 2W;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W (1 family)	25589244					germline	MedGen:C4225192;OMIM:616827
2	167129256	C	A	Haplotype	30359	RCV000023304	39316	SCN9A	NM_002977.3:c.2971G>T	NP_002968.1:p.Val991Leu	NM_002977.3:c.2971G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Small fiber neuropathy;NEUROPATHY, SMALL FIBER	21698661					germline	GeneTests:320010;Genetics Home Reference:small-fiber-neuropathy;MedGen:C3276709;OMIM:133020
2	167133540	T	G	Haplotype	30359	RCV000023304	39315	SCN9A	NM_002977.3:c.2794A>C	NP_002968.1:p.Met932Leu	NM_002977.3:c.2794A>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Small fiber neuropathy;NEUROPATHY, SMALL FIBER	21698661					germline	GeneTests:320010;Genetics Home Reference:small-fiber-neuropathy;MedGen:C3276709;OMIM:133020
2	179395322	AC	A	Haplotype	178839	RCV000155611	172806	TTN-AS1	NM_133378.4:c.98315delG	NP_001254479.2:p.Gly35340Valfs	NM_001267550.2:c.106019delG:frameshift variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Autosomal recessive centronuclear myopathy	22617344,23975875,24033266	Autosomal recessive inheritance	Childhood			germline	Genetic Alliance:Autosomal+recessive+centronuclear+myopathy/7787;Genetic Testing Registry (GTR):GTR000324320;Genetic Testing Registry (GTR):GTR000500129;Genetic Testing Registry (GTR):GTR000506311;Genetic Testing Registry (GTR):GTR000506312;Genetic Testing Registry (GTR):GTR000509767;Genetic Testing Registry (GTR):GTR000553005;Genetics Home Reference:centronuclear-myopathy;MedGen:C0410204;OMIM:255200;Orphanet:169186;Orphanet:ORPHA169186;SNOMED CT:240081004
2	179434462	ATGTT	A	Haplotype	178839	RCV000155611	172708	TTN-AS1	NM_001267550.2:c.76393_76396delAACA	NP_001254479.2:p.Asn25465Terfs	NM_001267550.2:c.76393_76396delAACA:frameshift variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Autosomal recessive centronuclear myopathy	22617344,23975875,24033266	Autosomal recessive inheritance	Childhood			germline	Genetic Alliance:Autosomal+recessive+centronuclear+myopathy/7787;Genetic Testing Registry (GTR):GTR000324320;Genetic Testing Registry (GTR):GTR000500129;Genetic Testing Registry (GTR):GTR000506311;Genetic Testing Registry (GTR):GTR000506312;Genetic Testing Registry (GTR):GTR000509767;Genetic Testing Registry (GTR):GTR000553005;Genetics Home Reference:centronuclear-myopathy;MedGen:C0410204;OMIM:255200;Orphanet:169186;Orphanet:ORPHA169186;SNOMED CT:240081004
2	179472292	T	A	Haplotype	179465	RCV000156254	56237	TTN-AS1	NM_001267550.2:c.53123A>T	NP_597676.3:p.Lys8768Ile	NM_001267550.2:c.53123A>T:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
2	179472293	T	C	Haplotype	179465	RCV000156254	173874	TTN-AS1	NM_001267550.2:c.53122A>G	NP_001254479.2:p.Lys17708Glu	NM_001267550.2:c.53122A>G:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
2	189861915	C	T	Haplotype	101229	RCV000087466	106974	COL3A1	NM_000090.3:c.1786C>T	NP_000081.1:p.Arg596Ter	NM_000090.3:c.1786C>T:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Collagen Diagnostic Laboratory	Ehlers-Danlos syndrome, type 4;Ehlers-Danlos syndrome, type 4	20301667,23788249,24882528,25173340,25355838,25356965,27854360	Autosomal dominant inheritance	Infancy	1-9 / 100 000		germline	GeneReviews:NBK1494;Genetic Alliance:Ehlers-Danlos+Syndrome+Vascular+Type/2491;Genetic Testing Registry (GTR):GTR000500400;Genetic Testing Registry (GTR):GTR000500403;Genetic Testing Registry (GTR):GTR000501094;Genetic Testing Registry (GTR):GTR000510815;Genetic Testing Registry (GTR):GTR000510818;Genetic Testing Registry (GTR):GTR000519266;Genetic Testing Registry (GTR):GTR000519381;Genetic Testing Registry (GTR):GTR000521913;Genetic Testing Registry (GTR):GTR000525815;Genetic Testing Registry (GTR):GTR000525816;Genetic Testing Registry (GTR):GTR000525817;Genetic Testing Registry (GTR):GTR000525925;Genetic Testing Registry (GTR):GTR000528496;Genetic Testing Registry (GTR):GTR000552603;MedGen:C0268338;OMIM:130050;Orphanet:286;SNOMED CT:17025000
2	189874931	G	A	Haplotype	101229	RCV000087466	106975	COL3A1	NM_000090.3:c.3851G>A	NP_000081.1:p.Gly1284Glu	NM_000090.3:c.3851G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Collagen Diagnostic Laboratory	Ehlers-Danlos syndrome, type 4;Ehlers-Danlos syndrome, type 4	20301667,23788249,24882528,25173340,25355838,25356965,27854360	Autosomal dominant inheritance	Infancy	1-9 / 100 000		germline	GeneReviews:NBK1494;Genetic Alliance:Ehlers-Danlos+Syndrome+Vascular+Type/2491;Genetic Testing Registry (GTR):GTR000500400;Genetic Testing Registry (GTR):GTR000500403;Genetic Testing Registry (GTR):GTR000501094;Genetic Testing Registry (GTR):GTR000510815;Genetic Testing Registry (GTR):GTR000510818;Genetic Testing Registry (GTR):GTR000519266;Genetic Testing Registry (GTR):GTR000519381;Genetic Testing Registry (GTR):GTR000521913;Genetic Testing Registry (GTR):GTR000525815;Genetic Testing Registry (GTR):GTR000525816;Genetic Testing Registry (GTR):GTR000525817;Genetic Testing Registry (GTR):GTR000525925;Genetic Testing Registry (GTR):GTR000528496;Genetic Testing Registry (GTR):GTR000552603;MedGen:C0268338;OMIM:130050;Orphanet:286;SNOMED CT:17025000
2	201436518	CAG	C	Haplotype	375673	RCV000417144	362513	SGO2	NM_152524.5:c.1453_1454delGA	NP_689737.4:p.Glu485Lysfs	NM_152524.5:c.1453_1454delGA:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Laboratory of Molecular Genetics,National Institutes of Health	Perrault Syndrome;Deafness;Primary ovarian insufficiency;Perrault Syndrome						germline	Illumina Clinical Services Laboratory,Illumina:37522;MedGen:CN239459
2	202574623	G	A	Haplotype	217879	RCV000201952	214531	ALS2	NM_020919.3:c.4261C>T	NP_065970.2:p.Arg1421Ter	NM_020919.3:c.4261C>T:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Infantile-onset ascending hereditary spastic paralysis	12919135,18394004,20301421	Autosomal recessive inheritance	Infancy	<1 / 1 000 000	loss of function	germline	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168
2	202588048	C	G	CompoundHeterozygote	42162	RCV000034989	205072	ALS2	NM_020919.3:c.3624+5G>C		NM_020919.3:c.3624+5G>C:intron variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Amyotrophic lateral sclerosis type 2;ALS2-Related Disorders	20018642,20301421,20301623		Childhood	<1 / 1 000 000		not provided	GeneReviews:NBK1243;Genetic Alliance:Amyotrophic+Lateral+Sclerosis+Type+2/404;MedGen:C1859807;OMIM:205100;OMIM:606352.0001;OMIM:606352.0011;OMIM:606352.0016;OMIM:606352.0017;Office of Rare Diseases:9470;Orphanet:300605
2	202588111	AC	A	CompoundHeterozygote	42162	RCV000034989	51328	ALS2	NM_020919.3:c.3565delG	NP_065970.2:p.Val1189Trpfs	NM_020919.3:c.3565delG:frameshift variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Amyotrophic lateral sclerosis type 2;ALS2-Related Disorders	20018642,20301421,20301623		Childhood	<1 / 1 000 000		not provided	GeneReviews:NBK1243;Genetic Alliance:Amyotrophic+Lateral+Sclerosis+Type+2/404;MedGen:C1859807;OMIM:205100;OMIM:606352.0001;OMIM:606352.0011;OMIM:606352.0016;OMIM:606352.0017;Office of Rare Diseases:9470;Orphanet:300605
2	202588148	C	A	CompoundHeterozygote	42138	RCV000034965	205071	ALS2	NM_020919.3:c.3529G>T	NP_065970.2:p.Gly1177Ter	NM_020919.3:c.3529G>T:nonsense	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Infantile-onset ascending hereditary spastic paralysis;ALS2-Related Disorders	18394004,20301421	Autosomal recessive inheritance	Infancy	<1 / 1 000 000	loss of function	not provided	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168
2	202611376	G	T	Haplotype	217879	RCV000201952	214532	ALS2	NM_020919.3:c.1911C>A	NP_065970.2:p.Tyr637Ter	NM_020919.3:c.1911C>A:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Infantile-onset ascending hereditary spastic paralysis	12919135,18394004,20301421	Autosomal recessive inheritance	Infancy	<1 / 1 000 000	loss of function	germline	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168
2	202611461	T	TCACTG	CompoundHeterozygote	42138	RCV000034965	51304	ALS2	NM_020919.3:c.1821_1825dupCAGTG	NP_065970.2:p.Glu609Alafs	NM_020919.3:c.1821_1825dupCAGTG:frameshift variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Infantile-onset ascending hereditary spastic paralysis;ALS2-Related Disorders	18394004,20301421	Autosomal recessive inheritance	Infancy	<1 / 1 000 000	loss of function	not provided	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168
2	228137806	G	A	Haplotype	397582	RCV000449541	384474	COL4A3	NM_000091.4:c.1900G>A	NP_000082.2:p.Gly634Arg	NM_000091.4:c.1900G>A:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Alport syndrome, autosomal recessive	20301386,22166944		Childhood	1-9 / 100 000		germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome+Recessive+Type/337;MedGen:C1567744;OMIM:203780;Orphanet:63;Orphanet:88919
2	228137833	G	A	Haplotype	397582	RCV000449541	285718	COL4A3	NM_000091.4:c.1927G>A	NP_000082.2:p.Gly643Ser	NM_000091.4:c.1927G>A:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Alport syndrome, autosomal recessive	20301386,22166944		Childhood	1-9 / 100 000		germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome+Recessive+Type/337;MedGen:C1567744;OMIM:203780;Orphanet:63;Orphanet:88919
2	233348866	G	A	Haplotype	235817	RCV000224367	48091	ECEL1	NM_004826.3:c.1252C>T	NP_004817.2:p.Arg418Cys	NM_004826.3:c.1252C>T:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301		Infancy	<1 / 1 000 000		inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457
2	233348866	G	T	Haplotype	235818	RCV000224716	48089	ECEL1	NM_004826.3:c.1252C>A	NP_004817.2:p.Arg418Ser	NM_004826.3:c.1252C>A:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301		Infancy	<1 / 1 000 000		inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457
2	233349179	T	A	Haplotype	235818	RCV000224716	48090	ECEL1	NM_004826.3:c.1184+3A>T		NM_004826.3:c.1184+3A>T:intron variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301		Infancy	<1 / 1 000 000		inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457
2	233349788	T	C	Haplotype	235820	RCV000224404	237475	ECEL1	NM_004826.3:c.869A>G	NP_004817.2:p.Tyr290Cys	NM_004826.3:c.869A>G:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301		Infancy	<1 / 1 000 000		inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457
2	233349963	CCCAT	AGC	Haplotype	235820	RCV000224404	237476	ECEL1	NM_004826.3:c.797_801delATGGGinsGCT	NP_004817.2:p.Asp266Glyfs	NM_004826.3:c.797_801delATGGGinsGCT:frameshift variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301		Infancy	<1 / 1 000 000		inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457
2	233350647	G	GT	Haplotype	235821	RCV000224209	48087	ECEL1	NM_004826.3:c.716dupA	NP_004817.2:p.Tyr239Terfs	NM_004826.3:c.716dupA:frameshift variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301		Infancy	<1 / 1 000 000		inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457
2	233350774	C	T	Haplotype	235817	RCV000224367	48092	ECEL1	NM_004826.3:c.590G>A	NP_004817.2:p.Gly197Asp	NM_004826.3:c.590G>A:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301		Infancy	<1 / 1 000 000		inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457
2	233351008	CTGGCGTCCAGGT	C	Haplotype	235821	RCV000224209	48088	ECEL1	NM_004826.3:c.344_355delACCTGGACGCCA	NP_004817.2:p.Asn115_Ala118del	NM_004826.3:c.344_355delACCTGGACGCCA:inframe_variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301		Infancy	<1 / 1 000 000		inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457
2	241808719	T	TTCCTGGTTG	Haplotype	204181	RCV000186388	200465	AGXT	NM_000030.2:c.299_307dupTCCTGGTTG	NP_000021.1:p.Val102_Gly103insValLeuVal	NM_000030.2:c.299_307dupTCCTGGTTG:inframe_variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	17460142,20301460,22547750	Autosomal recessive inheritance	All ages	1 per million;<1 / 1 000 000	loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001
2	241808729	G	A	Haplotype	204181	RCV000186388	200466	AGXT	NM_000030.2:c.308G>A	NP_000021.1:p.Gly103Glu	NM_000030.2:c.308G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	17460142,20301460,22547750	Autosomal recessive inheritance	All ages	1 per million;<1 / 1 000 000	loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001
2	241815403	G	GA	Haplotype	204202	RCV000186409	200559	AGXT	NM_000030.2:c.829_830insA	NP_000021.1:p.Ala277Aspfs	NM_000030.2:c.829_830insA:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	20301460,22547750	Autosomal recessive inheritance	All ages	1 per million;<1 / 1 000 000	loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001
2	241815405	C	A	Haplotype	204202	RCV000186409	200560	AGXT	NM_000030.2:c.830C>A	NP_000021.1:p.Ala277Asp	NM_000030.2:c.830C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	20301460,22547750	Autosomal recessive inheritance	All ages	1 per million;<1 / 1 000 000	loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001
3	15676984	GCGGCTG	TCC	Haplotype	38562	RCV000021886	16934	BTD	NM_000060.4:c.98_104delGCGGCTGinsTCC	NP_000051.1:p.Cys33Phefs	NM_000060.4:c.98_104delGCGGCTGinsTCC:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	14707518,15776412,20301497,22378278,22475884,9396567	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677019	G	A	Haplotype	24975	RCV000021890	36313	BTD	NM_000060.4:c.133G>A	NP_000051.1:p.Gly45Arg	NM_000060.4:c.133G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15060693,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677019	G	A	Haplotype	38563	RCV000021889	36313	BTD	NM_000060.4:c.133G>A	NP_000051.1:p.Gly45Arg	NM_000060.4:c.133G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15060693,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677045	C	A	Haplotype	24977	RCV000021892	36316	BTD	NM_000060.4:c.159C>A	NP_000051.1:p.His53Gln	NM_000060.4:c.159C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677046	G	T	Haplotype	24977	RCV000021892	36317	BTD	NM_000060.4:c.160G>T	NP_000051.1:p.Glu54Ter	NM_000060.4:c.160G>T:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677098	T	C	Haplotype	38562	RCV000021886	47043	BTD	NM_000060.4:c.212T>C	NP_000051.1:p.Leu71Pro	NM_000060.4:c.212T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	14707518,15776412,20301497,22378278,22475884,9396567	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677098	T	C	Haplotype	38564	RCV000021901	47043	BTD	NM_000060.4:c.212T>C	NP_000051.1:p.Leu71Pro	NM_000060.4:c.212T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	14707518,15060693,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677121	C	T	Haplotype	38565	RCV000021903	16944	BTD	NM_000060.4:c.235C>T	NP_000051.1:p.Arg79Cys	NM_000060.4:c.235C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10801053,15776412,16435182,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677121	C	T	Haplotype	38566	RCV000032009	16944	BTD	NM_000060.4:c.235C>T	NP_000051.1:p.Arg79Cys	NM_000060.4:c.235C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,10801053,15776412,16435182,20301497,22378278,22475884,9396567	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677122	G	A	Haplotype	38564	RCV000021901	46851	BTD	NM_000060.4:c.236G>A	NP_000051.1:p.Arg79His	NM_000060.4:c.236G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	14707518,15060693,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15677169	C	T	Haplotype	24994	RCV000021912	36332	BTD	NM_000060.4:c.283C>T	NP_000051.1:p.Gln95Ter	NM_000060.4:c.283C>T:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15685833	G	A	Haplotype	38566	RCV000032009	46845	BTD	NM_000060.4:c.470G>A	NP_000051.1:p.Arg157His	NM_000060.4:c.470G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,10801053,15776412,16435182,20301497,22378278,22475884,9396567	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15685833	G	A	Haplotype	38568	RCV000021933	46845	BTD	NM_000060.4:c.470G>A	NP_000051.1:p.Arg157His	NM_000060.4:c.470G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15776412,16435182,20301497,22378278,22475884,9396567	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15685874	G	A	Haplotype	25016	RCV000021936	36353	BTD	NM_000060.4:c.511G>A	NP_000051.1:p.Ala171Thr	NM_000060.4:c.511G>A:missense variant	Pathogenic	Pathogenic;Pathogenic	no assertion criteria provided	no assertion criteria provided;no assertion criteria provided	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY;Biotinidase deficiency	10400129,15776412,20301497,21228398,22378278,22475884,7509806,9375914,9654207	Autosomal recessive inheritance	Infancy	1-9 / 100 000		germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686004	A	G	Haplotype	25030	RCV000021952	36367	BTD	NM_000060.4:c.641A>G	NP_000051.1:p.Asn214Ser	NM_000060.4:c.641A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686157	A	T	Haplotype	25042	RCV000021964	36378	BTD	NM_000060.4:c.794A>T	NP_000051.1:p.His265Leu	NM_000060.4:c.794A>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	12359137,20083419,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686228	G	C	Haplotype	38563	RCV000021889	46848	BTD	NM_000060.4:c.865G>C	NP_000051.1:p.Ala289Pro	NM_000060.4:c.865G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15060693,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686296	T	G	Haplotype	25042	RCV000021964	36379	BTD	NM_000060.4:c.933T>G	NP_000051.1:p.Ser311Arg	NM_000060.4:c.933T>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	12359137,20083419,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686534	C	T	Haplotype	38571	RCV000021985	46849	BTD	NM_000060.4:c.1171C>T	NP_000051.1:p.Pro391Ser	NM_000060.4:c.1171C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	11668630,15776412,20301497,22378278,22475884,9396567	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686570	T	G	Haplotype	1904	RCV000001981	16943	BTD	NM_000060.4:c.1207T>G	NP_000051.1:p.Phe403Val	NM_000060.4:c.1207T>G:missense variant	Pathogenic	Pathogenic;Pathogenic	no assertion criteria provided	no assertion criteria provided;no assertion criteria provided	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY;Biotinidase deficiency	10400129,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686634	G	C	Haplotype	24975	RCV000021890	36314	BTD	NM_000060.4:c.1271G>C	NP_000051.1:p.Cys424Ser	NM_000060.4:c.1271G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15060693,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686693	G	C	Haplotype	1904	RCV000001981	16939	BTD	NM_000060.4:c.1330G>C	NP_000051.1:p.Asp444His	NM_000060.4:c.1330G>C:missense variant	Pathogenic	Pathogenic;Pathogenic	no assertion criteria provided	no assertion criteria provided;no assertion criteria provided	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY;Biotinidase deficiency	10400129,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686693	G	C	Haplotype	24994	RCV000021912	16939	BTD	NM_000060.4:c.1330G>C	NP_000051.1:p.Asp444His	NM_000060.4:c.1330G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686693	G	C	Haplotype	25016	RCV000021936	16939	BTD	NM_000060.4:c.1330G>C	NP_000051.1:p.Asp444His	NM_000060.4:c.1330G>C:missense variant	Pathogenic	Pathogenic;Pathogenic	no assertion criteria provided	no assertion criteria provided;no assertion criteria provided	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY;Biotinidase deficiency	10400129,15776412,20301497,21228398,22378278,22475884,7509806,9375914,9654207	Autosomal recessive inheritance	Infancy	1-9 / 100 000		germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686693	G	C	Haplotype	25030	RCV000021952	16939	BTD	NM_000060.4:c.1330G>C	NP_000051.1:p.Asp444His	NM_000060.4:c.1330G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15776412,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686693	G	C	Haplotype	38568	RCV000021933	16939	BTD	NM_000060.4:c.1330G>C	NP_000051.1:p.Asp444His	NM_000060.4:c.1330G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129,15776412,16435182,20301497,22378278,22475884,9396567	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686697	G	T	Haplotype	38571	RCV000021985	36396	BTD	NM_000060.4:c.1334G>T	NP_000051.1:p.Gly445Val	NM_000060.4:c.1334G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	11668630,15776412,20301497,22378278,22475884,9396567	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	15686724	A	C	Haplotype	38565	RCV000021903	36326	BTD	NM_000060.4:c.1361A>C	NP_000051.1:p.Tyr454Ser	NM_000060.4:c.1361A>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10801053,15776412,16435182,20301497,22378278,22475884	Autosomal recessive inheritance	Infancy	1-9 / 100 000		not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;Genetic Testing Registry (GTR):GTR000332508;Genetic Testing Registry (GTR):GTR000502884;Genetic Testing Registry (GTR):GTR000503007;Genetic Testing Registry (GTR):GTR000503010;Genetic Testing Registry (GTR):GTR000503025;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000506389;Genetic Testing Registry (GTR):GTR000512248;Genetic Testing Registry (GTR):GTR000521225;Genetic Testing Registry (GTR):GTR000521376;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000529377;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004
3	33060002	G	A	Haplotype	208495	RCV000190508	205010	GLB1	NM_000404.3:c.1285C>T	NP_000395.2:p.Pro429Ser	NM_000404.3:c.1285C>T:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Mucopolysaccharidosis, MPS-IV-B	24156116		Childhood	<1 / 1 000 000		germline	GeneReviews:NBK164500;Genetic Alliance:Morquio+syndrome+B/4877;MedGen:C0086652;OMIM:253010;Orphanet:582;SNOMED CT:238044004
3	33065789	G	T	Haplotype	208495	RCV000190508	205011	GLB1	NM_000404.3:c.1097C>A	NP_000395.2:p.Pro366His	NM_000404.3:c.1097C>A:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Mucopolysaccharidosis, MPS-IV-B	24156116		Childhood	<1 / 1 000 000		germline	GeneReviews:NBK164500;Genetic Alliance:Morquio+syndrome+B/4877;MedGen:C0086652;OMIM:253010;Orphanet:582;SNOMED CT:238044004
3	38593004	G	A	Haplotype	9371	RCV000009965	38446	SCN5A	NM_198056.2:c.4859C>T	NP_932173.1:p.Thr1620Met	NM_000335.4:c.4856C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10618304,19251209,20129283,20301690,21321465,21810866,23788249,25356965,27854360,9521325	Autosomal dominant inheritance	Adult	1-5 / 10 000		germline	GeneReviews:NBK1517;Genetic Testing Registry (GTR):GTR000316547;Genetic Testing Registry (GTR):GTR000329728;Genetic Testing Registry (GTR):GTR000500447;Genetic Testing Registry (GTR):GTR000502993;Genetic Testing Registry (GTR):GTR000508959;Genetic Testing Registry (GTR):GTR000508974;Genetic Testing Registry (GTR):GTR000511301;Genetic Testing Registry (GTR):GTR000512866;Genetic Testing Registry (GTR):GTR000519387;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000523351;Genetic Testing Registry (GTR):GTR000523361;Genetic Testing Registry (GTR):GTR000525923;Genetic Testing Registry (GTR):GTR000528443;Genetic Testing Registry (GTR):GTR000528497;Genetic Testing Registry (GTR):GTR000528500;MedGen:CN029323;OMIM:601144;Orphanet:130
3	38603947	G	A	Haplotype	9407	RCV000010010	38448	SCN5A	NM_198056.2:c.3922C>T	NP_932173.1:p.Leu1308Phe	NM_000335.4:c.3919C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10532948,15851227,18599870,19841300,20129283,20301690,21810866,23788249,25356965,27854360	Autosomal dominant inheritance	Adult	1-5 / 10 000		germline	GeneReviews:NBK1517;Genetic Testing Registry (GTR):GTR000316547;Genetic Testing Registry (GTR):GTR000329728;Genetic Testing Registry (GTR):GTR000500447;Genetic Testing Registry (GTR):GTR000502993;Genetic Testing Registry (GTR):GTR000508959;Genetic Testing Registry (GTR):GTR000508974;Genetic Testing Registry (GTR):GTR000511301;Genetic Testing Registry (GTR):GTR000512866;Genetic Testing Registry (GTR):GTR000519387;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000523351;Genetic Testing Registry (GTR):GTR000523361;Genetic Testing Registry (GTR):GTR000525923;Genetic Testing Registry (GTR):GTR000528443;Genetic Testing Registry (GTR):GTR000528497;Genetic Testing Registry (GTR):GTR000528500;MedGen:CN029323;OMIM:601144;Orphanet:130
3	38608046	G	A	Haplotype	9371	RCV000009965	24410	SCN5A	NM_198056.2:c.3694C>T	NP_932173.1:p.Arg1232Trp	NM_000335.4:c.3691C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10618304,19251209,20129283,20301690,21321465,21810866,23788249,25356965,27854360,9521325	Autosomal dominant inheritance	Adult	1-5 / 10 000		germline	GeneReviews:NBK1517;Genetic Testing Registry (GTR):GTR000316547;Genetic Testing Registry (GTR):GTR000329728;Genetic Testing Registry (GTR):GTR000500447;Genetic Testing Registry (GTR):GTR000502993;Genetic Testing Registry (GTR):GTR000508959;Genetic Testing Registry (GTR):GTR000508974;Genetic Testing Registry (GTR):GTR000511301;Genetic Testing Registry (GTR):GTR000512866;Genetic Testing Registry (GTR):GTR000519387;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000523351;Genetic Testing Registry (GTR):GTR000523361;Genetic Testing Registry (GTR):GTR000525923;Genetic Testing Registry (GTR):GTR000528443;Genetic Testing Registry (GTR):GTR000528497;Genetic Testing Registry (GTR):GTR000528500;MedGen:CN029323;OMIM:601144;Orphanet:130
3	38645420	T	C	Haplotype	9398	RCV000010000	38447	SCN5A	NM_198056.2:c.1673A>G	NP_932173.1:p.His558Arg	NM_000335.4:c.1673A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Progressive familial heart block type 1A;PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	10807545,11463728,11997281,12569159,12639704,14760,18378609,23788249,23994779,27854360	Autosomal dominant inheritance	Adult			germline	Genetic Alliance:Progressive+familial+heart+block+type+1A/5978;Genetic Testing Registry (GTR):GTR000500447;Genetic Testing Registry (GTR):GTR000519267;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519405;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000523351;Genetic Testing Registry (GTR):GTR000523361;Genetic Testing Registry (GTR):GTR000528443;Genetics Home Reference:progressive-familial-heart-block;MedGen:C1879286;OMIM:113900;OMIM:600163.0009;OMIM:600163.0017;OMIM:600163.0018;OMIM:600163.0031;Office of Rare Diseases:1093;Orphanet:871
3	38645558	G	A	Haplotype	9398	RCV000010000	24437	SCN5A	NM_198056.2:c.1535C>T	NP_932173.1:p.Thr512Ile	NM_198056.2:c.1535C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Progressive familial heart block type 1A;PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	10807545,11463728,11997281,12569159,12639704,14760,18378609,23788249,23994779,27854360	Autosomal dominant inheritance	Adult			germline	Genetic Alliance:Progressive+familial+heart+block+type+1A/5978;Genetic Testing Registry (GTR):GTR000500447;Genetic Testing Registry (GTR):GTR000519267;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519405;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000523351;Genetic Testing Registry (GTR):GTR000523361;Genetic Testing Registry (GTR):GTR000528443;Genetics Home Reference:progressive-familial-heart-block;MedGen:C1879286;OMIM:113900;OMIM:600163.0009;OMIM:600163.0017;OMIM:600163.0018;OMIM:600163.0031;Office of Rare Diseases:1093;Orphanet:871
3	38655243	C	T	Haplotype	9407	RCV000010010	24446	SCN5A	NM_001099404.1:c.703+223G>A	NP_932173.1:p.Val232Ile	NM_000335.4:c.694G>A:missense variant;NM_001099404.1:c.703+223G>A:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10532948,15851227,18599870,19841300,20129283,20301690,21810866,23788249,25356965,27854360	Autosomal dominant inheritance	Adult	1-5 / 10 000		germline	GeneReviews:NBK1517;Genetic Testing Registry (GTR):GTR000316547;Genetic Testing Registry (GTR):GTR000329728;Genetic Testing Registry (GTR):GTR000500447;Genetic Testing Registry (GTR):GTR000502993;Genetic Testing Registry (GTR):GTR000508959;Genetic Testing Registry (GTR):GTR000508974;Genetic Testing Registry (GTR):GTR000511301;Genetic Testing Registry (GTR):GTR000512866;Genetic Testing Registry (GTR):GTR000519387;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000523351;Genetic Testing Registry (GTR):GTR000523361;Genetic Testing Registry (GTR):GTR000525923;Genetic Testing Registry (GTR):GTR000528443;Genetic Testing Registry (GTR):GTR000528497;Genetic Testing Registry (GTR):GTR000528500;MedGen:CN029323;OMIM:601144;Orphanet:130
3	39307162	G	A	Haplotype	8152	RCV000008629	36774	CX3CR1	NM_001171174.1:c.935C>T	NP_001164645.1:p.Thr312Met	NM_001171174.1:c.935C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Human immunodeficiency virus type 1, rapid progression to AIDS;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS	10731151,11264153,12697743,15208270,17909628,23716478					germline	MedGen:C4016733
3	39307162	G	A	Haplotype	8152	RCV000008630	36774	CX3CR1	NM_001171174.1:c.935C>T	NP_001164645.1:p.Thr312Met	NM_001171174.1:c.935C>T:missense variant	protective	protective	no assertion criteria provided	no assertion criteria provided	OMIM	Coronary artery disease, resistance to	10731151,11264153,12697743,15208270,17909628,23716478					germline	MedGen:C1832288
3	39307162	G	A	Haplotype	8152	RCV000022393	36774	CX3CR1	NM_001171174.1:c.935C>T	NP_001164645.1:p.Thr312Met	NM_001171174.1:c.935C>T:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	NCBI curation	Age-related macular degeneration 12;Age-related macular degeneration 12	15208270,17909628					germline	Genetic Alliance:Age-related+macular+degeneration+12/7651;Genetics Home Reference:age-related-macular-degeneration;MedGen:C3151079;OMIM:613784
3	39307162	G	A	Haplotype	8152	RCV000023109	36774	CX3CR1	NM_001171174.1:c.935C>T	NP_001164645.1:p.Thr312Met	NM_001171174.1:c.935C>T:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO	10731151,11264153,12697743,15208270,17909628,23716478					germline	OMIM:601470.0001
3	39307256	C	T	Haplotype	8152	RCV000008629	23191	CX3CR1	NM_001171174.1:c.841G>A	NP_001164645.1:p.Val281Ile	NM_001171174.1:c.841G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Human immunodeficiency virus type 1, rapid progression to AIDS;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS	10731151,11264153,12697743,15208270,17909628,23716478					germline	MedGen:C4016733
3	39307256	C	T	Haplotype	8152	RCV000008630	23191	CX3CR1	NM_001171174.1:c.841G>A	NP_001164645.1:p.Val281Ile	NM_001171174.1:c.841G>A:missense variant	protective	protective	no assertion criteria provided	no assertion criteria provided	OMIM	Coronary artery disease, resistance to	10731151,11264153,12697743,15208270,17909628,23716478					germline	MedGen:C1832288
3	39307256	C	T	Haplotype	8152	RCV000022393	23191	CX3CR1	NM_001171174.1:c.841G>A	NP_001164645.1:p.Val281Ile	NM_001171174.1:c.841G>A:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	NCBI curation	Age-related macular degeneration 12;Age-related macular degeneration 12	15208270,17909628					germline	Genetic Alliance:Age-related+macular+degeneration+12/7651;Genetics Home Reference:age-related-macular-degeneration;MedGen:C3151079;OMIM:613784
3	39307256	C	T	Haplotype	8152	RCV000023109	23191	CX3CR1	NM_001171174.1:c.841G>A	NP_001164645.1:p.Val281Ile	NM_001171174.1:c.841G>A:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO	10731151,11264153,12697743,15208270,17909628,23716478					germline	OMIM:601470.0001
3	42733468	T	C	Haplotype	228777	RCV000213109	229063	KLHL40	NM_152393.3:c.1849T>C	NP_689606.2:p.Cys617Arg	NM_152393.3:c.1849T>C:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
3	42733469	G	A	Haplotype	228777	RCV000213109	229064	KLHL40	NM_152393.3:c.1850G>A	NP_689606.2:p.Cys617Tyr	NM_152393.3:c.1850G>A:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
3	49160612	G	A	Haplotype	14535	RCV000015634	38466	LAMB2	NM_002292.3:c.4177C>T	NP_002283.3:p.Leu1393Phe	NM_002292.3:c.4177C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Nephrotic syndrome, type 5, with or without ocular abnormalities;NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	16912710		Infancy	<1 / 1 000 000		germline	Genetic Alliance:Nephrotic+syndrome%2C+type+5%2C+with+or+without+ocular+abnormalities/8989;MedGen:C3280113;OMIM:150325.0006;OMIM:150325.0007;OMIM:150325.0008;OMIM:150325.0009;OMIM:150325.0010;OMIM:150325.0011;OMIM:614199;Orphanet:306507
3	49160649	G	T	Haplotype	14535	RCV000015634	29574	LAMB2	NM_002292.3:c.4140C>A	NP_002283.3:p.Asn1380Lys	NM_002292.3:c.4140C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Nephrotic syndrome, type 5, with or without ocular abnormalities;NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	16912710		Infancy	<1 / 1 000 000		germline	Genetic Alliance:Nephrotic+syndrome%2C+type+5%2C+with+or+without+ocular+abnormalities/8989;MedGen:C3280113;OMIM:150325.0006;OMIM:150325.0007;OMIM:150325.0008;OMIM:150325.0009;OMIM:150325.0010;OMIM:150325.0011;OMIM:614199;Orphanet:306507
3	64142981	C	T	Haplotype	30731	RCV000023709	39689	PRICKLE2	NM_198859.3:c.457G>A	NP_942559.1:p.Val153Ile	NM_198859.3:c.457G>A:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	OMIM	Epilepsy, progressive myoclonic 5;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	21276947,26942291,26942292,632821		Adolescent	<1 / 1 000 000		germline	Genetic Alliance:Epilepsy%2C+progressive+myoclonic+5/8335;MedGen:CN226157;OMIM:613832;Orphanet:402082
3	64142995	C	T	Haplotype	30731	RCV000023709	39688	PRICKLE2	NM_198859.3:c.443G>A	NP_942559.1:p.Arg148His	NM_198859.3:c.443G>A:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	OMIM	Epilepsy, progressive myoclonic 5;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	21276947,26942291,26942292,632821		Adolescent	<1 / 1 000 000		germline	Genetic Alliance:Epilepsy%2C+progressive+myoclonic+5/8335;MedGen:CN226157;OMIM:613832;Orphanet:402082
3	114057857	C	T	Haplotype	253111	RCV000239523	247522	ZBTB20	NM_001164342.2:c.2221G>A	NP_001157814.1:p.Gly741Arg	NM_001164342.2:c.2221G>A:missense variant;NR_121662.1:n.883G>A:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Primrose syndrome;PRIMROSE SYNDROME	27061120					germline	Genetic Alliance:Primrose+syndrome/5964;MedGen:C0796121;OMIM:259050;Office of Rare Diseases:4488
3	114058231	G	A	Haplotype	253111	RCV000239523	247523	ZBTB20	NM_001164342.2:c.1847C>T	NP_001157814.1:p.Ser616Phe	NM_001164342.2:c.1847C>T:missense variant;NR_121662.1:n.509C>T:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Primrose syndrome;PRIMROSE SYNDROME	27061120					germline	Genetic Alliance:Primrose+syndrome/5964;MedGen:C0796121;OMIM:259050;Office of Rare Diseases:4488
3	124454069	A	G	Haplotype	11906	RCV000012681	26945	UMPS	NM_000373.3:c.286A>G	NP_000364.1:p.Arg96Gly	NM_000373.3:c.286A>G:missense variant;NR_033434.1:n.263-2346A>G:intron variant;NR_033437.1:n.491A>G:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Orotic aciduria;OROTIC ACIDURIA	9042911		Infancy	<1 / 1 000 000		germline	Genetic Alliance:Orotic+aciduria+hereditary/5431;MedGen:C0268128;OMIM:258900;OMIM:258920;Orphanet:30;SNOMED CT:47641009;SNOMED CT:90093009
3	124462773	G	C	Haplotype	11906	RCV000012681	38455	UMPS	NM_000373.3:c.1285G>C	NP_000364.1:p.Gly429Arg	NM_000373.3:c.1285G>C:missense variant;NR_033434.1:n.1237G>C:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Orotic aciduria;OROTIC ACIDURIA	9042911		Infancy	<1 / 1 000 000		germline	Genetic Alliance:Orotic+aciduria+hereditary/5431;MedGen:C0268128;OMIM:258900;OMIM:258920;Orphanet:30;SNOMED CT:47641009;SNOMED CT:90093009
3	193355102	T	C	Haplotype	5089	RCV000005394	101627	OPA1	NM_015560.2:c.870+32T>C		NM_015560.2:c.870+32T>C:intron variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Glaucoma, normal tension, susceptibility to;GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	11810296,12073024,17188046,19581274					germline	Genetic Alliance:Glaucoma%2C+normal+tension%2C+susceptibility+to/8467;MedGen:C1847730;OMIM:606657
4	996555	G	C	Haplotype	11911	RCV000012686	26950	IDUA	NM_000203.4:c.1225G>C	NP_000194.2:p.Gly409Arg	NM_000203.4:c.1225G>C:missense variant;NR_110313.1:n.1313G>C:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hurler syndrome;HURLER SYNDROME	20301341,8328452	Autosomal recessive inheritance				germline	GeneReviews:NBK1162;Genetic Alliance:Mucopolysaccharidosis+type+I/4912;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0086795;OMIM:607014
4	998181	A	T	Haplotype	11911	RCV000012686	38456	IDUA	NM_000203.4:c.1962A>T	NP_000194.2:p.Ter654Cys	NM_000203.4:c.1962A>T:stop lost;NR_110313.1:n.2054A>T:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hurler syndrome;HURLER SYNDROME	20301341,8328452	Autosomal recessive inheritance				germline	GeneReviews:NBK1162;Genetic Alliance:Mucopolysaccharidosis+type+I/4912;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0086795;OMIM:607014
4	1806111	T	G	Haplotype	16353	RCV000017763	38477	FGFR3	NM_022965.3:c.931-440T>G	NP_001156685.1:p.Leu379Arg	NM_000142.4:c.1130T>G:missense variant;NM_022965.3:c.931-440T>G:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Achondroplasia;ACHONDROPLASIA	16411219,20301331,2783977	Autosomal dominant inheritance	Neonatal	1-9 / 100 000;1.3 per 100,000	gain of function	germline	GeneReviews:NBK1152;GeneTests:2789;Genetic Alliance:Achondroplasia/113;Genetic Testing Registry (GTR):GTR000017792;Genetic Testing Registry (GTR):GTR000193973;Genetic Testing Registry (GTR):GTR000226127;Genetic Testing Registry (GTR):GTR000319775;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000325183;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000332463;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000500431;Genetic Testing Registry (GTR):GTR000501373;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508972;Genetic Testing Registry (GTR):GTR000510685;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000523319;Genetic Testing Registry (GTR):GTR000529586;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552209;Genetic Testing Registry (GTR):GTR000552289;MedGen:C0001080;OMIM:100800;Office of Rare Diseases:8173;Orphanet:15;SNOMED CT:86268005
4	1806119	G	A	Haplotype	16353	RCV000017763	31366	FGFR3	NM_022965.3:c.931-432G>A	NP_001156685.1:p.Gly382Arg	NM_000142.4:c.1138G>A:missense variant;NM_022965.3:c.931-432G>A:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Achondroplasia;ACHONDROPLASIA	16411219,20301331,2783977	Autosomal dominant inheritance	Neonatal	1-9 / 100 000;1.3 per 100,000	gain of function	germline	GeneReviews:NBK1152;GeneTests:2789;Genetic Alliance:Achondroplasia/113;Genetic Testing Registry (GTR):GTR000017792;Genetic Testing Registry (GTR):GTR000193973;Genetic Testing Registry (GTR):GTR000226127;Genetic Testing Registry (GTR):GTR000319775;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000325183;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000332463;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000500431;Genetic Testing Registry (GTR):GTR000501373;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508972;Genetic Testing Registry (GTR):GTR000510685;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000523319;Genetic Testing Registry (GTR):GTR000529586;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552209;Genetic Testing Registry (GTR):GTR000552289;MedGen:C0001080;OMIM:100800;Office of Rare Diseases:8173;Orphanet:15;SNOMED CT:86268005
4	1807123	A	G	Haplotype	16360	RCV000017771	38478	FGFR3	NM_001163213.1:c.1460A>G	NP_001156685.1:p.Gln487Arg	NM_000142.4:c.1454A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Thanatophoric dysplasia type 1;THANATOPHORIC DYSPLASIA, TYPE I	19449430,20301540	Autosomal dominant inheritance	Antenatal	1-9 / 100 000	gain of function	germline	GeneReviews:NBK1366;Genetic Alliance:Thanatophoric+dysplasia+type+1/7051;Genetic Testing Registry (GTR):GTR000226129;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000327813;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508990;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000530324;Genetic Testing Registry (GTR):GTR000552289;MedGen:C1868678;OMIM:187600;Office of Rare Diseases:9295;Orphanet:1860;Orphanet:2655
4	1807371	C	A	Haplotype	16360	RCV000017771	31376	FGFR3	NM_001163213.1:c.1626C>A	NP_001156685.1:p.Asn542Lys	NM_000142.4:c.1620C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Thanatophoric dysplasia type 1;THANATOPHORIC DYSPLASIA, TYPE I	19449430,20301540	Autosomal dominant inheritance	Antenatal	1-9 / 100 000	gain of function	germline	GeneReviews:NBK1366;Genetic Alliance:Thanatophoric+dysplasia+type+1/7051;Genetic Testing Registry (GTR):GTR000226129;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000327813;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508990;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000530324;Genetic Testing Registry (GTR):GTR000552289;MedGen:C1868678;OMIM:187600;Office of Rare Diseases:9295;Orphanet:1860;Orphanet:2655
4	70898903	G	A	Haplotype	14913	RCV000016048	38467	HTN3	NM_000200.2:c.122G>A	NP_000191.1:p.Arg41Gln	NM_000200.2:c.122G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	HIS2*1/HIS2*2 POLYMORPHISM;HIS2*1/HIS2*2 POLYMORPHISM	7951254					germline	OMIM:142702.0001
4	70898922	T	A	Haplotype	14913	RCV000016048	29952	HTN3	NM_000200.2:c.141T>A	NP_000191.1:p.Tyr47Ter	NM_000200.2:c.141T>A:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	HIS2*1/HIS2*2 POLYMORPHISM;HIS2*1/HIS2*2 POLYMORPHISM	7951254					germline	OMIM:142702.0001
4	103189073	C	G	Haplotype	218898	RCV000203237	215658	SLC39A8	NM_022154.5:c.1004G>C	NP_071437.3:p.Ser335Thr	NM_022154.5:c.1004G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn	26637979					germline	MedGen:C4225234;OMIM:608732.0001;OMIM:608732.0002;OMIM:608732.0003;OMIM:608732.0004;OMIM:616721
4	103265723	C	T	Haplotype	218898	RCV000203237	215659	SLC39A8	NM_022154.5:c.97G>A	NP_071437.3:p.Val33Met	NM_022154.5:c.97G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn	26637979					germline	MedGen:C4225234;OMIM:608732.0001;OMIM:608732.0002;OMIM:608732.0003;OMIM:608732.0004;OMIM:616721
4	109088743	A	G	Haplotype	14382	RCV000015459	38464	LEF1-AS1	NM_016269.4:c.181T>C	NP_057353.1:p.Ser61Pro	NM_001166119.1:c.-1307T>C:2KB upstream variant;NM_016269.4:c.181T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Sebaceous tumors, somatic;SEBACEOUS TUMORS, SOMATIC	16565724					somatic	MedGen:C1835244
4	109088791	C	T	Haplotype	14382	RCV000015459	29421	LEF1-AS1	NM_016269.4:c.133G>A	NP_057353.1:p.Glu45Lys	NM_001166119.1:c.-1355G>A:2KB upstream variant;NM_016269.4:c.133G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Sebaceous tumors, somatic;SEBACEOUS TUMORS, SOMATIC	16565724					somatic	MedGen:C1835244
5	225549	G	C	Haplotype	190221	RCV000170440	188048	SDHA	NM_004168.3:c.328G>C	NP_004159.2:p.Ala110Pro	NM_001294332.1:c.313-449G>C:intron variant;NM_004168.3:c.328G>C:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Mitochondrial complex II deficiency;Mitochondrial complex II deficiency	10746566,22972948			<1 / 1 000 000		germline	Genetic Alliance:Mitochondrial+complex+II+deficiency/4824;MedGen:C1855008;OMIM:252011;Office of Rare Diseases:5053;Orphanet:3208
5	240589	A	G	Haplotype	190221	RCV000170440	188049	SDHA	NM_004168.3:c.1549A>G	NP_004159.2:p.Lys517Glu	NM_004168.3:c.1549A>G:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Mitochondrial complex II deficiency;Mitochondrial complex II deficiency	10746566,22972948			<1 / 1 000 000		germline	Genetic Alliance:Mitochondrial+complex+II+deficiency/4824;MedGen:C1855008;OMIM:252011;Office of Rare Diseases:5053;Orphanet:3208
5	1266634	C	T	Haplotype	36946	RCV000030627	45604	TERT	NM_198253.2:c.2599G>A	NP_937983.2:p.Val867Met	NM_198253.2:c.2599G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1;PULMONARY FIBROSIS, TELOMERE-RELATED, 1	21483807		Adult	1-9 / 1 000 000		germline	MedGen:C3553617;OMIM:187270.0001;OMIM:187270.0002;OMIM:187270.0003;OMIM:187270.0004;OMIM:187270.0005;OMIM:187270.0008;OMIM:187270.0009;OMIM:187270.0010;OMIM:187270.0015;OMIM:187270.0016;OMIM:187270.0017;OMIM:614742;Orphanet:88
5	1272311	C	T	Haplotype	36946	RCV000030627	45603	TERT	NM_198253.2:c.2371G>A	NP_937983.2:p.Val791Ile	NM_198253.2:c.2371G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1;PULMONARY FIBROSIS, TELOMERE-RELATED, 1	21483807		Adult	1-9 / 1 000 000		germline	MedGen:C3553617;OMIM:187270.0001;OMIM:187270.0002;OMIM:187270.0003;OMIM:187270.0004;OMIM:187270.0005;OMIM:187270.0008;OMIM:187270.0009;OMIM:187270.0010;OMIM:187270.0015;OMIM:187270.0016;OMIM:187270.0017;OMIM:614742;Orphanet:88
5	41853537	A	T	Haplotype	8165	RCV000008643	38389	OXCT1	NM_000436.3:c.398T>A	NP_000427.1:p.Val133Glu	NM_000436.3:c.398T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Succinyl-CoA acetoacetate transferase deficiency;SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY	9671268		Infancy	<1 / 1 000 000		germline	Genetic Alliance:Succinyl-CoA+acetoacetate+transferase+deficiency/6918;MedGen:C0342792;OMIM:245050;Office of Rare Diseases:5057;Orphanet:832;SNOMED CT:238004006
5	41862758	G	A	Haplotype	8165	RCV000008643	23204	OXCT1	NM_000436.3:c.173C>T	NP_000427.1:p.Thr58Met	NM_000436.3:c.173C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Succinyl-CoA acetoacetate transferase deficiency;SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY	9671268		Infancy	<1 / 1 000 000		germline	Genetic Alliance:Succinyl-CoA+acetoacetate+transferase+deficiency/6918;MedGen:C0342792;OMIM:245050;Office of Rare Diseases:5057;Orphanet:832;SNOMED CT:238004006
5	112043220	A	C	Haplotype	243004	RCV000234986	244097	APC	NM_001127511.2:c.-195A>C		NM_001127511.2:c.-195A>C:5 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial adenomatous polyposis 1;FAMILIAL ADENOMATOUS POLYPOSIS 1 OF PROXIMAL STOMACH	11598466,15604628,20301519,21368914,21813476,23788249,24310308,25356965,25452455,25645574,27087319,27854360	Autosomal dominant inheritance		2.29 to 3.2 per 100,000 individuals	loss of function	germline	GeneReviews:NBK1345;Genetic Testing Registry (GTR):GTR000017525;Genetic Testing Registry (GTR):GTR000172265;Genetic Testing Registry (GTR):GTR000321103;Genetic Testing Registry (GTR):GTR000323395;Genetic Testing Registry (GTR):GTR000326160;Genetic Testing Registry (GTR):GTR000330056;Genetic Testing Registry (GTR):GTR000500012;Genetic Testing Registry (GTR):GTR000500363;Genetic Testing Registry (GTR):GTR000500599;Genetic Testing Registry (GTR):GTR000500894;Genetic Testing Registry (GTR):GTR000501393;Genetic Testing Registry (GTR):GTR000501394;Genetic Testing Registry (GTR):GTR000501794;Genetic Testing Registry (GTR):GTR000508954;Genetic Testing Registry (GTR):GTR000512300;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000515534;Genetic Testing Registry (GTR):GTR000515885;Genetic Testing Registry (GTR):GTR000515899;Genetic Testing Registry (GTR):GTR000520026;Genetic Testing Registry (GTR):GTR000520047;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520077;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520868;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521915;Genetic Testing Registry (GTR):GTR000522559;Genetic Testing Registry (GTR):GTR000527982;Genetic Testing Registry (GTR):GTR000527984;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000529017;Genetic Testing Registry (GTR):GTR000530028;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552290;Genetic Testing Registry (GTR):GTR000552303;MedGen:C2713442;OMIM:175100;OMIM:611731.0021;OMIM:611731.0028;OMIM:611731.0034;OMIM:611731.0035;OMIM:611731.0036;OMIM:611731.0038;OMIM:611731.0042;OMIM:611731.0043;OMIM:611731.0049
5	112043289	GA	G	Haplotype	243004	RCV000234986	244084	APC	NM_001127511.2:c.-125delA		NM_001127511.2:c.-125delA:5 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial adenomatous polyposis 1;FAMILIAL ADENOMATOUS POLYPOSIS 1 OF PROXIMAL STOMACH	11598466,15604628,20301519,21368914,21813476,23788249,24310308,25356965,25452455,25645574,27087319,27854360	Autosomal dominant inheritance		2.29 to 3.2 per 100,000 individuals	loss of function	germline	GeneReviews:NBK1345;Genetic Testing Registry (GTR):GTR000017525;Genetic Testing Registry (GTR):GTR000172265;Genetic Testing Registry (GTR):GTR000321103;Genetic Testing Registry (GTR):GTR000323395;Genetic Testing Registry (GTR):GTR000326160;Genetic Testing Registry (GTR):GTR000330056;Genetic Testing Registry (GTR):GTR000500012;Genetic Testing Registry (GTR):GTR000500363;Genetic Testing Registry (GTR):GTR000500599;Genetic Testing Registry (GTR):GTR000500894;Genetic Testing Registry (GTR):GTR000501393;Genetic Testing Registry (GTR):GTR000501394;Genetic Testing Registry (GTR):GTR000501794;Genetic Testing Registry (GTR):GTR000508954;Genetic Testing Registry (GTR):GTR000512300;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000515534;Genetic Testing Registry (GTR):GTR000515885;Genetic Testing Registry (GTR):GTR000515899;Genetic Testing Registry (GTR):GTR000520026;Genetic Testing Registry (GTR):GTR000520047;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520077;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520868;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521915;Genetic Testing Registry (GTR):GTR000522559;Genetic Testing Registry (GTR):GTR000527982;Genetic Testing Registry (GTR):GTR000527984;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000529017;Genetic Testing Registry (GTR):GTR000530028;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552290;Genetic Testing Registry (GTR):GTR000552303;MedGen:C2713442;OMIM:175100;OMIM:611731.0021;OMIM:611731.0028;OMIM:611731.0034;OMIM:611731.0035;OMIM:611731.0036;OMIM:611731.0038;OMIM:611731.0042;OMIM:611731.0043;OMIM:611731.0049
5	135392443	C	A	Haplotype	7874	RCV000008323	22913	TGFBI	NM_000358.2:c.1637C>A	NP_000349.1:p.Ala546Asp	NM_000358.2:c.1637C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Lattice corneal dystrophy Type I;CORNEAL DYSTROPHY, LATTICE TYPE I	15111592,15531312		All ages			germline	Genetic Alliance:Lattice+corneal+dystrophy+type+1/4117;Genetics Home Reference:lattice-corneal-dystrophy-type-i;MedGen:C1690006;OMIM:122200;Office of Rare Diseases:9678;Orphanet:98964;SNOMED CT:419197009
5	135392458	C	A	Haplotype	7874	RCV000008323	38388	TGFBI	NM_000358.2:c.1652C>A	NP_000349.1:p.Pro551Gln	NM_000358.2:c.1652C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Lattice corneal dystrophy Type I;CORNEAL DYSTROPHY, LATTICE TYPE I	15111592,15531312		All ages			germline	Genetic Alliance:Lattice+corneal+dystrophy+type+1/4117;Genetics Home Reference:lattice-corneal-dystrophy-type-i;MedGen:C1690006;OMIM:122200;Office of Rare Diseases:9678;Orphanet:98964;SNOMED CT:419197009
5	176942003	G	T	Haplotype	403734	RCV000465916	390711	DDX41	NM_016222.3:c.712C>A	NP_057306.2:p.Pro238Thr	NM_016222.3:c.712C>A:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Acute myeloid leukemia;Myelodysplasia	20963938,22138009,23970018,26944477	Autosomal dominant inheritance;Somatic mutation	All ages	1-9 / 100 000		germline	GeneReviews:NBK47457;Genetic Testing Registry (GTR):GTR000500636;Genetic Testing Registry (GTR):GTR000520187;Genetic Testing Registry (GTR):GTR000520395;Genetic Testing Registry (GTR):GTR000520877;Genetic Testing Registry (GTR):GTR000520933;Genetic Testing Registry (GTR):GTR000520934;Genetic Testing Registry (GTR):GTR000521208;Genetic Testing Registry (GTR):GTR000521209;Genetic Testing Registry (GTR):GTR000521632;Genetic Testing Registry (GTR):GTR000521830;Genetic Testing Registry (GTR):GTR000525845;Genetic Testing Registry (GTR):GTR000525849;Genetic Testing Registry (GTR):GTR000525864;Genetic Testing Registry (GTR):GTR000525878;Genetic Testing Registry (GTR):GTR000525897;Genetic Testing Registry (GTR):GTR000525899;Genetic Testing Registry (GTR):GTR000525908;Genetic Testing Registry (GTR):GTR000527980;Genetic Testing Registry (GTR):GTR000528909;Genetic Testing Registry (GTR):GTR000528987;Genetic Testing Registry (GTR):GTR000529054;Genetic Testing Registry (GTR):GTR000529137;Genetic Testing Registry (GTR):GTR000530327;Genetic Testing Registry (GTR):GTR000530420;Genetic Testing Registry (GTR):GTR000530631;Genetic Testing Registry (GTR):GTR000531723;Genetic Testing Registry (GTR):GTR000531726;Genetic Testing Registry (GTR):GTR000551316;Genetic Testing Registry (GTR):GTR000552464;Human Phenotype Ontology:HP:0002863;Human Phenotype Ontology:HP:0004832;Human Phenotype Ontology:HP:0006730;MeSH:D015470;MedGen:C0023467;MedGen:C1851971;OMIM:601626;Orphanet:519;SNOMED CT:17788007
5	176942004	C	A	Haplotype	403734	RCV000465916	390712	DDX41	NM_016222.3:c.711G>T	NP_057306.2:p.Leu237Phe	NM_016222.3:c.711G>T:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Acute myeloid leukemia;Myelodysplasia	20963938,22138009,23970018,26944477	Autosomal dominant inheritance;Somatic mutation	All ages	1-9 / 100 000		germline	GeneReviews:NBK47457;Genetic Testing Registry (GTR):GTR000500636;Genetic Testing Registry (GTR):GTR000520187;Genetic Testing Registry (GTR):GTR000520395;Genetic Testing Registry (GTR):GTR000520877;Genetic Testing Registry (GTR):GTR000520933;Genetic Testing Registry (GTR):GTR000520934;Genetic Testing Registry (GTR):GTR000521208;Genetic Testing Registry (GTR):GTR000521209;Genetic Testing Registry (GTR):GTR000521632;Genetic Testing Registry (GTR):GTR000521830;Genetic Testing Registry (GTR):GTR000525845;Genetic Testing Registry (GTR):GTR000525849;Genetic Testing Registry (GTR):GTR000525864;Genetic Testing Registry (GTR):GTR000525878;Genetic Testing Registry (GTR):GTR000525897;Genetic Testing Registry (GTR):GTR000525899;Genetic Testing Registry (GTR):GTR000525908;Genetic Testing Registry (GTR):GTR000527980;Genetic Testing Registry (GTR):GTR000528909;Genetic Testing Registry (GTR):GTR000528987;Genetic Testing Registry (GTR):GTR000529054;Genetic Testing Registry (GTR):GTR000529137;Genetic Testing Registry (GTR):GTR000530327;Genetic Testing Registry (GTR):GTR000530420;Genetic Testing Registry (GTR):GTR000530631;Genetic Testing Registry (GTR):GTR000531723;Genetic Testing Registry (GTR):GTR000531726;Genetic Testing Registry (GTR):GTR000551316;Genetic Testing Registry (GTR):GTR000552464;Human Phenotype Ontology:HP:0002863;Human Phenotype Ontology:HP:0004832;Human Phenotype Ontology:HP:0006730;MeSH:D015470;MedGen:C0023467;MedGen:C1851971;OMIM:601626;Orphanet:519;SNOMED CT:17788007
6	10874613	A	T	Haplotype	375590	RCV000417072	362401	GCM2	NM_004752.3:c.1136T>A	NP_004743.1:p.Leu379Gln	NM_004752.3:c.1136T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hyperparathyroidism 4;HYPERPARATHYROIDISM 4	27745835					germline	MedGen:CN240514;OMIM:617343
6	10874998	G	C	Haplotype	375590	RCV000417072	362400	GCM2	NM_004752.3:c.751C>G	NP_004743.1:p.Gln251Glu	NM_004752.3:c.751C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hyperparathyroidism 4;HYPERPARATHYROIDISM 4	27745835					germline	MedGen:CN240514;OMIM:617343
6	18130918	T	C	Haplotype	12722	RCV000013559	27764	TPMT	NM_000367.4:c.719A>G	NP_000358.1:p.Tyr240Cys	NM_000367.4:c.719A>G:missense variant	drug response	drug response	no assertion criteria provided	no assertion criteria provided	OMIM	Thiopurine methyltransferase deficiency;THIOPURINES, POOR METABOLISM OF, 1	10208641,12880540,15819814,15967990,8561894,8644731,9177237,9336428,9931345,9931346				loss of function	germline	Genetic Alliance:Thiopurine+S+methyltranferase+deficiency/54;Genetic Testing Registry (GTR):GTR000299976;Genetic Testing Registry (GTR):GTR000502252;Genetic Testing Registry (GTR):GTR000509706;Genetic Testing Registry (GTR):GTR000520079;Genetic Testing Registry (GTR):GTR000522313;Genetic Testing Registry (GTR):GTR000522314;Genetic Testing Registry (GTR):GTR000525921;Genetic Testing Registry (GTR):GTR000553222;MedGen:C0342801;OMIM:187680.0001;OMIM:187680.0002;OMIM:187680.0003;OMIM:187680.0004;OMIM:187680.0005;OMIM:187680.0006;OMIM:187680.0007;OMIM:610460;Office of Rare Diseases:5173;Office of Rare Diseases:9153;PharmGKB:PA356;SNOMED CT:238012003
6	18139228	C	T	Haplotype	12722	RCV000013559	27761	TPMT	NM_000367.4:c.460G>A	NP_000358.1:p.Ala154Thr	NM_000367.4:c.460G>A:missense variant	drug response	drug response	no assertion criteria provided	no assertion criteria provided	OMIM	Thiopurine methyltransferase deficiency;THIOPURINES, POOR METABOLISM OF, 1	10208641,12880540,15819814,15967990,8561894,8644731,9177237,9336428,9931345,9931346				loss of function	germline	Genetic Alliance:Thiopurine+S+methyltranferase+deficiency/54;Genetic Testing Registry (GTR):GTR000299976;Genetic Testing Registry (GTR):GTR000502252;Genetic Testing Registry (GTR):GTR000509706;Genetic Testing Registry (GTR):GTR000520079;Genetic Testing Registry (GTR):GTR000522313;Genetic Testing Registry (GTR):GTR000522314;Genetic Testing Registry (GTR):GTR000525921;Genetic Testing Registry (GTR):GTR000553222;MedGen:C0342801;OMIM:187680.0001;OMIM:187680.0002;OMIM:187680.0003;OMIM:187680.0004;OMIM:187680.0005;OMIM:187680.0006;OMIM:187680.0007;OMIM:610460;Office of Rare Diseases:5173;Office of Rare Diseases:9153;PharmGKB:PA356;SNOMED CT:238012003
6	32007584	T	A	Haplotype	31662	RCV000012947	33507	CYP21A2	NM_000500.7:c.710T>A	NP_000491.4:p.Ile237Asn	NM_000500.7:c.710T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	15623806,20301350,2249999,2845408					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757
6	32007587	T	A	Haplotype	31662	RCV000012947	27212	CYP21A2	NM_000500.7:c.713T>A	NP_000491.4:p.Val238Glu	NM_000500.7:c.713T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	15623806,20301350,2249999,2845408					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757
6	32007587	T	A	Haplotype	65613	RCV000055823	27212	CYP21A2	NM_000500.7:c.713T>A	NP_000491.4:p.Val238Glu	NM_000500.7:c.713T>A:missense variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	21-hydroxylase deficiency;21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia	20301350					not provided	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757
6	32007593	T	A	Haplotype	31662	RCV000012947	40032	CYP21A2	NM_000500.7:c.719T>A	NP_000491.4:p.Met240Lys	NM_000500.7:c.719T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	15623806,20301350,2249999,2845408					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757
6	32007593	T	A	Haplotype	65613	RCV000055823	40032	CYP21A2	NM_000500.7:c.719T>A	NP_000491.4:p.Met240Lys	NM_000500.7:c.719T>A:missense variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	21-hydroxylase deficiency;21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia	20301350					not provided	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757
6	32007887	G	T	Haplotype	12182	RCV000417198	27190	CYP21A2	NM_000500.7:c.844G>T	NP_000491.4:p.Val282Leu	NM_000500.7:c.844G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272,12915679,20301350,7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757
6	32007959	G	GT	Haplotype	12182	RCV000417198	76519	CYP21A2	NM_000500.7:c.923dupT	NP_000491.4:p.Leu308Phefs	NM_000500.7:c.923dupT:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272,12915679,20301350,7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757
6	32008198	C	T	Haplotype	12182	RCV000417198	27208	CYP21A2	NM_000500.7:c.955C>T	NP_000491.4:p.Gln319Ter	NM_000500.7:c.955C>T:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272,12915679,20301350,7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757
6	32008312	C	T	Haplotype	12182	RCV000417198	27191	CYP21A2	NM_000500.7:c.1069C>T	NP_000491.4:p.Arg357Trp	NM_000500.7:c.1069C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272,12915679,20301350,7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757
6	39877666	G	A	Haplotype	208497	RCV000190510	205013	MOCS1	NM_001075098.3:c.1015C>T	NP_001068566.1:p.Arg339Trp	NM_001075098.3:c.1015C>T:missense variant;NR_033233.1:n.1022C>T:non-coding transcript variant	Likely benign	Likely benign	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Molybdenum cofactor deficiency, complementation group A	21031595		Antenatal			germline	Genetics Home Reference:molybdenum-cofactor-deficiency;MedGen:C1854988;OMIM:252150;Orphanet:833
6	39880653	C	T	Haplotype	208497	RCV000190510	205014	MOCS1	NM_005943.5:c.853G>A	NP_005934.2:p.Glu285Lys	NM_001075098.3:c.853G>A:missense variant;NR_033233.1:n.860G>A:non-coding transcript variant	Likely benign	Likely benign	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Molybdenum cofactor deficiency, complementation group A	21031595		Antenatal			germline	Genetics Home Reference:molybdenum-cofactor-deficiency;MedGen:C1854988;OMIM:252150;Orphanet:833
6	49580217	C	T	Haplotype	13065	RCV000013940	38460	RHAG	NM_000324.2:c.838G>A	NP_000315.2:p.Gly280Arg	NM_000324.2:c.838G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Rh-null hemolytic anemia, regulator type;RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	9915949					germline	MedGen:C4016364
6	49580247	C	T	Haplotype	13065	RCV000013940	28104	RHAG	NM_000324.2:c.808G>A	NP_000315.2:p.Val270Ile	NM_000324.2:c.808G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Rh-null hemolytic anemia, regulator type;RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	9915949					germline	MedGen:C4016364
6	52288909	C	A	Haplotype	2067	RCV000002148	17106	EFHC1	NM_018100.3:c.229C>A	NP_060570.2:p.Pro77Thr	NM_018100.3:c.229C>A:missense variant;NR_033327.1:n.444C>A:non-coding transcript variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Myoclonic epilepsy, juvenile 1;MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	12439895,15258581					germline	
6	52317574	G	A	Haplotype	2067	RCV000002148	38421	EFHC1	NM_018100.3:c.662G>A	NP_060570.2:p.Arg221His	NM_018100.3:c.662G>A:missense variant;NR_033327.1:n.877G>A:non-coding transcript variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Myoclonic epilepsy, juvenile 1;MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	12439895,15258581					germline	
6	129601216	A	C	Haplotype	190218	RCV000170437	188050	LAMA2	NM_000426.3:c.2461A>C	NP_000417.2:p.Thr821Pro	NM_000426.3:c.2461A>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Merosin deficient congenital muscular dystrophy;Merosin deficient congenital muscular dystrophy	20301468,21078917,22420014,22675738	Autosomal recessive inheritance	Neonatal	1-9 / 1 000 000		germline	GeneReviews:NBK1291;Genetic Alliance:Muscular+dystrophy+congenital%2C+merosin+negative/4985;Genetic Testing Registry (GTR):GTR000334601;Genetic Testing Registry (GTR):GTR000502396;Genetic Testing Registry (GTR):GTR000506307;Genetic Testing Registry (GTR):GTR000506308;Genetic Testing Registry (GTR):GTR000508586;Genetic Testing Registry (GTR):GTR000512397;Genetic Testing Registry (GTR):GTR000514604;Genetic Testing Registry (GTR):GTR000518953;Genetic Testing Registry (GTR):GTR000553541;MedGen:C1263858;OMIM:607855;Office of Rare Diseases:3843;Orphanet:258;SNOMED CT:111503008
6	129823841	T	C	Haplotype	190218	RCV000170437	188051	LAMA2	NM_000426.3:c.8282T>C	NP_000417.2:p.Ile2761Thr	NM_000426.3:c.8282T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Merosin deficient congenital muscular dystrophy;Merosin deficient congenital muscular dystrophy	20301468,21078917,22420014,22675738	Autosomal recessive inheritance	Neonatal	1-9 / 1 000 000		germline	GeneReviews:NBK1291;Genetic Alliance:Muscular+dystrophy+congenital%2C+merosin+negative/4985;Genetic Testing Registry (GTR):GTR000334601;Genetic Testing Registry (GTR):GTR000502396;Genetic Testing Registry (GTR):GTR000506307;Genetic Testing Registry (GTR):GTR000506308;Genetic Testing Registry (GTR):GTR000508586;Genetic Testing Registry (GTR):GTR000512397;Genetic Testing Registry (GTR):GTR000514604;Genetic Testing Registry (GTR):GTR000518953;Genetic Testing Registry (GTR):GTR000553541;MedGen:C1263858;OMIM:607855;Office of Rare Diseases:3843;Orphanet:258;SNOMED CT:111503008
6	152697578	C	T	Haplotype	92124	RCV000077790	97550	SYNE1	NM_033071.3:c.9283G>A	NP_149062.1:p.Ala3095Thr	NM_182961.3:c.9262G>A:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	OMIM	Intellectual functioning disability;VARIANT OF UNKNOWN SIGNIFICANCE	21956720,24123876					germline	MedGen:C0025362;SNOMED CT:228156007;SNOMED CT:91138005
6	152784621	T	C	Haplotype	92124	RCV000077790	97551	SYNE1	NM_033071.3:c.1985A>G	NP_149062.1:p.Gln662Arg	NM_182961.3:c.1964A>G:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	OMIM	Intellectual functioning disability;VARIANT OF UNKNOWN SIGNIFICANCE	21956720,24123876					germline	MedGen:C0025362;SNOMED CT:228156007;SNOMED CT:91138005
7	87072999	G	C	Haplotype	217883	RCV000201938	214536	ABCB4	NM_018849.2:c.1210C>G	NP_061337.1:p.Pro404Ala	NM_018849.2:c.1210C>G:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Progressive familial intrahepatic cholestasis 3	17726488,9419367	Autosomal recessive inheritance		1-9 / 100 000		germline	Genetic Alliance:Cholestasis%2C+Progressive+Familial+Intrahepatic+3/1351;Genetic Testing Registry (GTR):GTR000500352;Genetic Testing Registry (GTR):GTR000506478;Genetic Testing Registry (GTR):GTR000512463;Genetic Testing Registry (GTR):GTR000514610;Genetic Testing Registry (GTR):GTR000552156;Genetic Testing Registry (GTR):GTR000552234;Genetic Testing Registry (GTR):GTR000552355;Genetics Home Reference:progressive-familial-intrahepatic-cholestasis;MedGen:C1865643;OMIM:602347;Office of Rare Diseases:1289;Orphanet:79305
7	87082365	C	T	Haplotype	217883	RCV000201938	214537	ABCB4	NM_018849.2:c.431G>A	NP_061337.1:p.Arg144Gln	NM_018849.2:c.431G>A:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Progressive familial intrahepatic cholestasis 3	17726488,9419367	Autosomal recessive inheritance		1-9 / 100 000		germline	Genetic Alliance:Cholestasis%2C+Progressive+Familial+Intrahepatic+3/1351;Genetic Testing Registry (GTR):GTR000500352;Genetic Testing Registry (GTR):GTR000506478;Genetic Testing Registry (GTR):GTR000512463;Genetic Testing Registry (GTR):GTR000514610;Genetic Testing Registry (GTR):GTR000552156;Genetic Testing Registry (GTR):GTR000552234;Genetic Testing Registry (GTR):GTR000552355;Genetics Home Reference:progressive-familial-intrahepatic-cholestasis;MedGen:C1865643;OMIM:602347;Office of Rare Diseases:1289;Orphanet:79305
7	107336408	A	C	Haplotype	4816	RCV000005085	38434	SLC26A4	NM_000441.1:c.1468A>C	NP_000432.1:p.Ile490Leu	NM_000441.1:c.1468A>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Enlarged vestibular aqueduct syndrome;DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	18310264,20301607,20301640,9500541		Infancy			germline	GeneReviews:NBK1467;Genetic Alliance:Enlarged+Vestibular+Aqueduct+Syndrome/2542;Genetic Testing Registry (GTR):GTR000500213;MedGen:C1863752;OMIM:600791;OMIM:601093.0001;OMIM:601093.0002;OMIM:602208.0008;OMIM:602208.0009;OMIM:605646.0004;OMIM:605646.0009;OMIM:605646.0010;OMIM:605646.0011;OMIM:605646.0012;OMIM:605646.0013;OMIM:605646.0014;OMIM:605646.0015;OMIM:605646.0027;OMIM:605646.0028;OMIM:605646.0029;OMIM:605646.0030;OMIM:605646.0031;Office of Rare Diseases:8651;Orphanet:90636
7	107336429	G	A	Haplotype	4816	RCV000005085	19855	SLC26A4	NM_000441.1:c.1489G>A	NP_000432.1:p.Gly497Ser	NM_000441.1:c.1489G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Enlarged vestibular aqueduct syndrome;DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	18310264,20301607,20301640,9500541		Infancy			germline	GeneReviews:NBK1467;Genetic Alliance:Enlarged+Vestibular+Aqueduct+Syndrome/2542;Genetic Testing Registry (GTR):GTR000500213;MedGen:C1863752;OMIM:600791;OMIM:601093.0001;OMIM:601093.0002;OMIM:602208.0008;OMIM:602208.0009;OMIM:605646.0004;OMIM:605646.0009;OMIM:605646.0010;OMIM:605646.0011;OMIM:605646.0012;OMIM:605646.0013;OMIM:605646.0014;OMIM:605646.0015;OMIM:605646.0027;OMIM:605646.0028;OMIM:605646.0029;OMIM:605646.0030;OMIM:605646.0031;Office of Rare Diseases:8651;Orphanet:90636
7	117171029	G	A	Haplotype	209047	RCV000190992	22148	CFTR	NM_000492.3:c.350G>A	NP_000483.3:p.Arg117His	NM_000492.3:c.350G>A:missense variant	Pathogenic	Pathogenic	reviewed by expert panel	reviewed by expert panel	CFTR2	Cystic fibrosis;Cystic fibrosis	11280952,12394352,15789152,17761616,19888064,19914443,19914445,20301428,20605539,20675678,21422883,21938795,22475884,23974870,24014130,25431289,25981758,9580754	Autosomal recessive inheritance	All ages	1 in 2000-4000 depending on the population studied.;1-9 / 100 000;1:3200	loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000061757;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000321636;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000327577;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000500100;Genetic Testing Registry (GTR):GTR000500101;Genetic Testing Registry (GTR):GTR000500102;Genetic Testing Registry (GTR):GTR000500302;Genetic Testing Registry (GTR):GTR000500303;Genetic Testing Registry (GTR):GTR000500978;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000503389;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000553017;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008
7	117180359	C	A	Haplotype	40200	RCV000007589	22208	CFTR	NM_000492.3:c.1075C>A	NP_000483.3:p.Gln359Lys	NM_000492.3:c.1075C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952,12394352,15789152,17761616,19888064,19914443,19914445,20301428,20605539,20675678,21422883,21938795,22475884,24014130,25431289,25981758,7679367,9580754	Autosomal recessive inheritance	All ages	1 in 2000-4000 depending on the population studied.;1-9 / 100 000;1:3200	loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000061757;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000321636;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000327577;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000500100;Genetic Testing Registry (GTR):GTR000500101;Genetic Testing Registry (GTR):GTR000500102;Genetic Testing Registry (GTR):GTR000500302;Genetic Testing Registry (GTR):GTR000500303;Genetic Testing Registry (GTR):GTR000500978;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000503389;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000553017;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008
7	117180363	C	A	Haplotype	40200	RCV000007589	38441	CFTR	NM_000492.3:c.1079C>A	NP_000483.3:p.Thr360Lys	NM_000492.3:c.1079C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952,12394352,15789152,17761616,19888064,19914443,19914445,20301428,20605539,20675678,21422883,21938795,22475884,24014130,25431289,25981758,7679367,9580754	Autosomal recessive inheritance	All ages	1 in 2000-4000 depending on the population studied.;1-9 / 100 000;1:3200	loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000061757;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000321636;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000327577;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000500100;Genetic Testing Registry (GTR):GTR000500101;Genetic Testing Registry (GTR):GTR000500102;Genetic Testing Registry (GTR):GTR000500302;Genetic Testing Registry (GTR):GTR000500303;Genetic Testing Registry (GTR):GTR000500978;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000503389;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000553017;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008
7	117243663	C	T	Haplotype	7239	RCV000007661	22244	CFTR	NM_000492.3:c.2735C>T	NP_000483.3:p.Ser912Leu	NM_000492.3:c.2735C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952,12394352,15744523,15789152,17761616,19888064,19914443,19914445,20301428,20605539,20675678,21422883,21938795,22475884,24014130,25431289,25981758,8528204,9580754	Autosomal recessive inheritance	All ages	1 in 2000-4000 depending on the population studied.;1-9 / 100 000;1:3200	loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000061757;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000321636;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000327577;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000500100;Genetic Testing Registry (GTR):GTR000500101;Genetic Testing Registry (GTR):GTR000500102;Genetic Testing Registry (GTR):GTR000500302;Genetic Testing Registry (GTR):GTR000500303;Genetic Testing Registry (GTR):GTR000500978;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000503389;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000553017;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008
7	117282505	G	T	Haplotype	7239	RCV000007661	22278	CFTR	NM_000492.3:c.3731G>T	NP_000483.3:p.Gly1244Val	NM_000492.3:c.3731G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952,12394352,15744523,15789152,17761616,19888064,19914443,19914445,20301428,20605539,20675678,21422883,21938795,22475884,24014130,25431289,25981758,8528204,9580754	Autosomal recessive inheritance	All ages	1 in 2000-4000 depending on the population studied.;1-9 / 100 000;1:3200	loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000061757;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000321636;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000327577;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000500100;Genetic Testing Registry (GTR):GTR000500101;Genetic Testing Registry (GTR):GTR000500102;Genetic Testing Registry (GTR):GTR000500302;Genetic Testing Registry (GTR):GTR000500303;Genetic Testing Registry (GTR):GTR000500978;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000503389;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000553017;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008
8	1719428	C	T	Haplotype	217887	RCV000201947	214538	CLN8	NM_018941.3:c.208C>T	NP_061764.2:p.Arg70Cys	NM_018941.3:c.208C>T:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Ceroid lipofuscinosis neuronal 8	16570191,20301601		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1428;MedGen:C1838570;OMIM:600143;Office of Rare Diseases:4010;Orphanet:168491;Orphanet:228354;Orphanet:79264
8	1728664	C	G	Haplotype	217887	RCV000201947	106601	CLN8	NM_018941.3:c.792C>G	NP_061764.2:p.Asn264Lys	NM_018941.3:c.792C>G:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Ceroid lipofuscinosis neuronal 8	16570191,20301601		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1428;MedGen:C1838570;OMIM:600143;Office of Rare Diseases:4010;Orphanet:168491;Orphanet:228354;Orphanet:79264
8	30922450	A	T	Haplotype	5453	RCV000005786	20492	WRN	NM_000553.4:c.375A>T	NP_000544.2:p.Lys125Asn	NM_000553.4:c.375A>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Werner syndrome;WERNER SYNDROME	16673358,20301687,22258520		Adolescent	1-9 / 1 000 000		germline	GeneReviews:NBK1514;Genetic Alliance:Werner%27s+syndrome/7471;Genetics Home Reference:werner-syndrome;MedGen:C0043119;OMIM:277700;Office of Rare Diseases:7885;Orphanet:902;SNOMED CT:51626007
8	30922478	A	G	Haplotype	5453	RCV000005786	38386	WRN	NM_000553.4:c.403A>G	NP_000544.2:p.Lys135Glu	NM_000553.4:c.403A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Werner syndrome;WERNER SYNDROME	16673358,20301687,22258520		Adolescent	1-9 / 1 000 000		germline	GeneReviews:NBK1514;Genetic Alliance:Werner%27s+syndrome/7471;Genetics Home Reference:werner-syndrome;MedGen:C0043119;OMIM:277700;Office of Rare Diseases:7885;Orphanet:902;SNOMED CT:51626007
8	38271684	G	C	Haplotype	16292	RCV000030930	38475	FGFR1	NM_023110.2:c.2172C>G	NP_075598.2:p.Asn724Lys	NM_023110.2:c.2172C>G:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Kallmann syndrome 2;HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	16606836,20301509,21682876	Autosomal dominant inheritance		1-9 / 100 000;1:30,000 in males and 1:125,000 in females	loss of function	germline	Endocrinology Clinic, Seth G.S. Medical College:FGFR1sn_4;GeneReviews:NBK1334;Genetic Alliance:Kallmann+syndrome+2/3947;Genetic Testing Registry (GTR):GTR000508944;Genetic Testing Registry (GTR):GTR000511562;Genetic Testing Registry (GTR):GTR000511608;Genetic Testing Registry (GTR):GTR000511609;Genetic Testing Registry (GTR):GTR000511610;Genetic Testing Registry (GTR):GTR000511611;Genetic Testing Registry (GTR):GTR000511612;Genetic Testing Registry (GTR):GTR000511613;Genetic Testing Registry (GTR):GTR000512869;MedGen:C1563720;OMIM:136350.0004;OMIM:136350.0013;OMIM:136350.0014;OMIM:136350.0015;OMIM:136350.0016;OMIM:136350.0020;OMIM:136350.0023;OMIM:136350.0024;OMIM:136350.0025;OMIM:147950;Office of Rare Diseases:3070;Orphanet:478
8	38271691	G	T	Haplotype	16292	RCV000030930	31331	FGFR1	NM_023110.2:c.2165C>A	NP_075598.2:p.Pro722His	NM_023110.2:c.2165C>A:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Kallmann syndrome 2;HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	16606836,20301509,21682876	Autosomal dominant inheritance		1-9 / 100 000;1:30,000 in males and 1:125,000 in females	loss of function	germline	Endocrinology Clinic, Seth G.S. Medical College:FGFR1sn_4;GeneReviews:NBK1334;Genetic Alliance:Kallmann+syndrome+2/3947;Genetic Testing Registry (GTR):GTR000508944;Genetic Testing Registry (GTR):GTR000511562;Genetic Testing Registry (GTR):GTR000511608;Genetic Testing Registry (GTR):GTR000511609;Genetic Testing Registry (GTR):GTR000511610;Genetic Testing Registry (GTR):GTR000511611;Genetic Testing Registry (GTR):GTR000511612;Genetic Testing Registry (GTR):GTR000511613;Genetic Testing Registry (GTR):GTR000512869;MedGen:C1563720;OMIM:136350.0004;OMIM:136350.0013;OMIM:136350.0014;OMIM:136350.0015;OMIM:136350.0016;OMIM:136350.0020;OMIM:136350.0023;OMIM:136350.0024;OMIM:136350.0025;OMIM:147950;Office of Rare Diseases:3070;Orphanet:478
8	143994266	A	G	Haplotype	16876	RCV000018372	31916	CYP11B2	NM_000498.3:c.1157T>C	NP_000489.3:p.Val386Ala	NM_000498.3:c.1157T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Corticosterone methyloxidase type 2 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	1346492,1594605,3262827,4121586,830445,838841	Autosomal recessive inheritance	Childhood		loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+2+deficiency/8102;Genetic Testing Registry (GTR):GTR000500407;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:C3463917;OMIM:610600;Orphanet:427
8	143994266	A	G	Haplotype	16877	RCV000018373	31916	CYP11B2	NM_000498.3:c.1157T>C	NP_000489.3:p.Val386Ala	NM_000498.3:c.1157T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Corticosterone methyloxidase type 1 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	9814506	Autosomal recessive inheritance	Childhood		loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+1+deficiency/8101;Genetic Testing Registry (GTR):GTR000500407;Genetic Testing Registry (GTR):GTR000507687;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:CN074214;OMIM:203400;Office of Rare Diseases:5660;Orphanet:427
8	143996463	T	G	Haplotype	16877	RCV000018373	38484	CYP11B2	NM_000498.3:c.594A>C	NP_000489.3:p.Glu198Asp	NM_000498.3:c.594A>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Corticosterone methyloxidase type 1 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	9814506	Autosomal recessive inheritance	Childhood		loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+1+deficiency/8101;Genetic Testing Registry (GTR):GTR000500407;Genetic Testing Registry (GTR):GTR000507687;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:CN074214;OMIM:203400;Office of Rare Diseases:5660;Orphanet:427
8	143996516	G	A	Haplotype	16876	RCV000018372	31915	CYP11B2	NM_000498.3:c.541C>T	NP_000489.3:p.Arg181Trp	NM_000498.3:c.541C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Corticosterone methyloxidase type 2 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	1346492,1594605,3262827,4121586,830445,838841	Autosomal recessive inheritance	Childhood		loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+2+deficiency/8102;Genetic Testing Registry (GTR):GTR000500407;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:C3463917;OMIM:610600;Orphanet:427
9	2115860	G	C	Haplotype	374221	RCV000415335	361134	SMARCA2	NM_003070.4:c.3495G>C	NP_003061.3:p.Gln1165His	NM_003070.4:c.3495G>C:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Laboratory of Molecular Genetics,CHU RENNES	Nicolaides-Baraitser syndrome;Nicolaides Baraitser syndrome	26468571	Autosomal dominant inheritance	Infancy	<1 / 1 000 000		de novo	GeneReviews:NBK321516;Genetic Alliance:Nicolaides+Baraitser+syndrome/5221;Genetic Testing Registry (GTR):GTR000500623;Genetic Testing Registry (GTR):GTR000506329;Genetic Testing Registry (GTR):GTR000506330;Genetic Testing Registry (GTR):GTR000511780;Genetic Testing Registry (GTR):GTR000551668;Genetics Home Reference:nicolaides-baraitser-syndrome;MedGen:C1303073;OMIM:601358;Orphanet:3051;SNOMED CT:401046009
9	2123873	G	A	Haplotype	374221	RCV000415335	361135	SMARCA2	NM_003070.4:c.3917G>A	NP_003061.3:p.Arg1306Lys	NM_003070.4:c.3917G>A:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Laboratory of Molecular Genetics,CHU RENNES	Nicolaides-Baraitser syndrome;Nicolaides Baraitser syndrome	26468571	Autosomal dominant inheritance	Infancy	<1 / 1 000 000		de novo	GeneReviews:NBK321516;Genetic Alliance:Nicolaides+Baraitser+syndrome/5221;Genetic Testing Registry (GTR):GTR000500623;Genetic Testing Registry (GTR):GTR000506329;Genetic Testing Registry (GTR):GTR000506330;Genetic Testing Registry (GTR):GTR000511780;Genetic Testing Registry (GTR):GTR000551668;Genetics Home Reference:nicolaides-baraitser-syndrome;MedGen:C1303073;OMIM:601358;Orphanet:3051;SNOMED CT:401046009
9	34646572	CCAGT	C	Haplotype	140570	RCV000128642	36445	GALT	NM_000155.3:c.-67-52_-67-49delGTCA		NM_000155.3:c.-119_-116del:2KB upstream variant;NM_000155.3:c.-67-52_-67-49delGTCA:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase;Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	10408771,10424825,10649501,11216901,11286503,11754113,15633893,15841485,16838075,19224951,2011574,20301691,22475884,25473725	Autosomal recessive inheritance		1-9 / 100 000		germline	GeneReviews:NBK1518;Genetic Alliance:Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206;Genetic Testing Registry (GTR):GTR000502919;Genetic Testing Registry (GTR):GTR000503048;Genetic Testing Registry (GTR):GTR000503054;Genetic Testing Registry (GTR):GTR000507573;Genetic Testing Registry (GTR):GTR000509820;Genetic Testing Registry (GTR):GTR000514614;Genetic Testing Registry (GTR):GTR000529378;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000553865;MedGen:C0268151;OMIM:230400;Office of Rare Diseases:2424;Orphanet:352;Orphanet:79239;SNOMED CT:124354006
9	34648418	C	T	Haplotype	3620	RCV000003804	18659	GALT	NM_000155.3:c.652C>T	NP_000146.2:p.Leu218=	NM_000155.3:c.652C>T:synonymous variant	Benign	Benign	no assertion criteria provided	no assertion criteria provided	OMIM	GALT POLYMORPHISM (LOS ANGELES, D1);GALT POLYMORPHISM (LOS ANGELES, D1)	10408771,10424825,19224951,2011574,4759900,8522334,9012409					germline	OMIM:606999.0012
9	34649442	A	G	Haplotype	140570	RCV000128642	18652	GALT	NM_000155.3:c.940A>G	NP_000146.2:p.Asn314Asp	NM_000155.3:c.940A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase;Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	10408771,10424825,10649501,11216901,11286503,11754113,15633893,15841485,16838075,19224951,2011574,20301691,22475884,25473725	Autosomal recessive inheritance		1-9 / 100 000		germline	GeneReviews:NBK1518;Genetic Alliance:Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206;Genetic Testing Registry (GTR):GTR000502919;Genetic Testing Registry (GTR):GTR000503048;Genetic Testing Registry (GTR):GTR000503054;Genetic Testing Registry (GTR):GTR000507573;Genetic Testing Registry (GTR):GTR000509820;Genetic Testing Registry (GTR):GTR000514614;Genetic Testing Registry (GTR):GTR000529378;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000553865;MedGen:C0268151;OMIM:230400;Office of Rare Diseases:2424;Orphanet:352;Orphanet:79239;SNOMED CT:124354006
9	34649442	A	G	Haplotype	3620	RCV000003804	18652	GALT	NM_000155.3:c.940A>G	NP_000146.2:p.Asn314Asp	NM_000155.3:c.940A>G:missense variant	Benign	Benign	no assertion criteria provided	no assertion criteria provided	OMIM	GALT POLYMORPHISM (LOS ANGELES, D1);GALT POLYMORPHISM (LOS ANGELES, D1)	10408771,10424825,19224951,2011574,4759900,8522334,9012409					germline	OMIM:606999.0012
9	37424827	TCC	T	Haplotype	204246	RCV000186453	200618	GRHPR	NM_012203.1:c.84-13_84-12delCC		NM_012203.1:c.84-13_84-12delCC:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type II;Primary hyperoxaluria, type II	14635115,20301742	Autosomal recessive inheritance		<1 / 1 000 000;unknown, <1 per million	loss of function	germline	GeneReviews:NBK2692;Genetic Alliance:Primary+hyperoxaluria+type+2/5948;Genetic Testing Registry (GTR):GTR000118462;Genetic Testing Registry (GTR):GTR000328129;Genetic Testing Registry (GTR):GTR000507682;Genetic Testing Registry (GTR):GTR000522211;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268165;OMIM:260000;Office of Rare Diseases:2836;Orphanet:416;Orphanet:93599;SNOMED CT:40951006
9	37424833	TCCCC	T	Haplotype	204246	RCV000186453	200619	GRHPR	NM_012203.1:c.84-8_84-5delCCCC		NM_012203.1:c.84-8_84-5delCCCC:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type II;Primary hyperoxaluria, type II	14635115,20301742	Autosomal recessive inheritance		<1 / 1 000 000;unknown, <1 per million	loss of function	germline	GeneReviews:NBK2692;Genetic Alliance:Primary+hyperoxaluria+type+2/5948;Genetic Testing Registry (GTR):GTR000118462;Genetic Testing Registry (GTR):GTR000328129;Genetic Testing Registry (GTR):GTR000507682;Genetic Testing Registry (GTR):GTR000522211;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0268165;OMIM:260000;Office of Rare Diseases:2836;Orphanet:416;Orphanet:93599;SNOMED CT:40951006
9	101340316	T	C	Haplotype	3331	RCV000003495	18370	GABBR2	NM_005458.7:c.360A>G	NP_005449.5:p.Ala120=	NM_005458.7:c.360A>G:synonymous variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Tobacco addiction, susceptibility to;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO	15759211					germline	Genetic Alliance:Tobacco+addiction%2C+susceptibility+to/9410;MedGen:C1861063;OMIM:188890;OMIM:607340.0001;OMIM:607340.0002
9	127262853	G	A	Haplotype	12809	RCV000013657	38458	NR5A1	NM_004959.4:c.386C>T	NP_004950.2:p.Pro129Leu	NM_004959.4:c.386C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Premature ovarian failure 7;PREMATURE OVARIAN FAILURE 7	19246354,20887963					germline	Genetic Alliance:Premature+ovarian+failure+7/9153;MedGen:C2751825;OMIM:612964
9	127262853	G	A	Haplotype	12809	RCV000022775	38458	NR5A1	NM_004959.4:c.386C>T	NP_004950.2:p.Pro129Leu	NM_004959.4:c.386C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spermatogenic failure 8	19246354,20887963					germline	Genetic Alliance:Spermatogenic+failure+8/9327;MedGen:C3151406;OMIM:613957
9	127262871	C	G	Haplotype	12809	RCV000013657	27848	NR5A1	NM_004959.4:c.368G>C	NP_004950.2:p.Gly123Ala	NM_004959.4:c.368G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Premature ovarian failure 7;PREMATURE OVARIAN FAILURE 7	19246354,20887963					germline	Genetic Alliance:Premature+ovarian+failure+7/9153;MedGen:C2751825;OMIM:612964
9	127262871	C	G	Haplotype	12809	RCV000022775	27848	NR5A1	NM_004959.4:c.368G>C	NP_004950.2:p.Gly123Ala	NM_004959.4:c.368G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spermatogenic failure 8	19246354,20887963					germline	Genetic Alliance:Spermatogenic+failure+8/9327;MedGen:C3151406;OMIM:613957
9	135203105	G	A	Haplotype	2294	RCV000002384	38425	SETX	NM_015046.5:c.3880C>T	NP_055861.3:p.Arg1294Cys	NM_015046.5:c.3880C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spinocerebellar ataxia autosomal recessive 1;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	16717225,20050888,20301317,20301333		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1154;Genetic Alliance:Spinocerebellar+ataxia+autosomal+recessive+1/6771;Genetics Home Reference:ataxia-with-oculomotor-apraxia;MedGen:C1853761;OMIM:606002;Office of Rare Diseases:4949;Orphanet:64753
9	135203176	G	A	Phase unknown	157525	RCV000144869	167387	SETX	NM_015046.5:c.3809C>T	NP_055861.3:p.Pro1270Leu	NM_015046.5:c.3809C>T:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	20301532,25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001
9	135203908	C	CTCA	Distinct chromosomes	157528	RCV000144873	167390	SETX	NM_015046.5:c.3075_3076insTGA	NP_055861.3:p.Arg1026_Lys1360delinsTer	NM_015046.5:c.3075_3076insTGA:inframe_variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type|spasticity;Charcot-Marie-Tooth disease	20301532,25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001
9	135205028	G	T	Haplotype	2293	RCV000002383	38424	SETX	NM_015046.5:c.1957C>A	NP_055861.3:p.Gln653Lys	NM_015046.5:c.1957C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spinocerebellar ataxia autosomal recessive 1;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	17096168,20050888,20301317,20301333		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1154;Genetic Alliance:Spinocerebellar+ataxia+autosomal+recessive+1/6771;Genetics Home Reference:ataxia-with-oculomotor-apraxia;MedGen:C1853761;OMIM:606002;Office of Rare Diseases:4949;Orphanet:64753
9	135205178	T	C	Haplotype	2293	RCV000002383	17332	SETX	NM_015046.5:c.1807A>G	NP_055861.3:p.Asn603Asp	NM_015046.5:c.1807A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spinocerebellar ataxia autosomal recessive 1;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	17096168,20050888,20301317,20301333		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1154;Genetic Alliance:Spinocerebellar+ataxia+autosomal+recessive+1/6771;Genetics Home Reference:ataxia-with-oculomotor-apraxia;MedGen:C1853761;OMIM:606002;Office of Rare Diseases:4949;Orphanet:64753
9	135224757	C	T	Phase unknown	157525	RCV000144869	167386	SETX	NM_015046.5:c.59G>A	NP_055861.3:p.Arg20His	NM_015046.5:c.59G>A:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	20301532,25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001
9	136131315	C	G	Haplotype	17738	RCV000019312	38414	ABO	NM_020469.2:c.803G>C	NP_065202.2:p.Gly268Ala	NM_020469.2:c.803G>C:missense variant	association	association	no assertion criteria provided	no assertion criteria provided	OMIM	ABO blood group system;ABO BLOOD GROUP SYSTEM, CIS-AB PHENOTYPE	14170898,6775529,8456556					germline	MedGen:C0000778;OMIM:110300.0001;OMIM:110300.0002;OMIM:110300.0003;OMIM:110300.0004;OMIM:110300.0005;OMIM:616093;SNOMED CT:63915006
9	136131651	G	A	Haplotype	17738	RCV000019312	32777	ABO	NM_020469.2:c.467C>T	NP_065202.2:p.Pro156Leu	NM_020469.2:c.467C>T:missense variant	association	association	no assertion criteria provided	no assertion criteria provided	OMIM	ABO blood group system;ABO BLOOD GROUP SYSTEM, CIS-AB PHENOTYPE	14170898,6775529,8456556					germline	MedGen:C0000778;OMIM:110300.0001;OMIM:110300.0002;OMIM:110300.0003;OMIM:110300.0004;OMIM:110300.0005;OMIM:616093;SNOMED CT:63915006
9	136301982	C	G	Haplotype	5813	RCV000006169	20852	ADAMTS13	NM_139025.4:c.1342C>G	NP_620594.1:p.Gln448Glu	NM_139025.4:c.1342C>G:missense variant;NR_024514.2:n.993-2504C>G:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Upshaw-Schulman syndrome;THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	12181489					germline	Genetic Alliance:Thrombotic+thrombocytopenic+purpura%2C+congenital/7089;Genetics Home Reference:thrombotic-thrombocytopenic-purpura;MedGen:C1268935;OMIM:274150;Office of Rare Diseases:9430;SNOMED CT:373420004
9	136302956	G	A	Haplotype	5813	RCV000006169	38438	ADAMTS13	NM_139025.4:c.1523G>A	NP_620594.1:p.Cys508Tyr	NM_139025.4:c.1523G>A:missense variant;NR_024514.2:n.993-1530G>A:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Upshaw-Schulman syndrome;THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	12181489					germline	Genetic Alliance:Thrombotic+thrombocytopenic+purpura%2C+congenital/7089;Genetics Home Reference:thrombotic-thrombocytopenic-purpura;MedGen:C1268935;OMIM:274150;Office of Rare Diseases:9430;SNOMED CT:373420004
9	136501794	G	A	Haplotype	1752	RCV000001822	16791	DBH	NM_000787.3:c.301G>A	NP_000778.3:p.Val101Met	NM_000787.3:c.301G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Dopamine beta hydroxylase deficiency;DOPAMINE BETA-HYDROXYLASE DEFICIENCY	11857564,20301647		Infancy	<1 / 1 000 000		germline	GeneReviews:NBK1474;Genetic Alliance:Dopamine+Beta+Hydroxylase+Deficiency/2316;MedGen:C1857209;OMIM:223360;Office of Rare Diseases:1903;Orphanet:230
9	136512976	G	A	Haplotype	1752	RCV000001822	38418	DBH	NM_000787.3:c.1033G>A	NP_000778.3:p.Asp345Asn	NM_000787.3:c.1033G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Dopamine beta hydroxylase deficiency;DOPAMINE BETA-HYDROXYLASE DEFICIENCY	11857564,20301647		Infancy	<1 / 1 000 000		germline	GeneReviews:NBK1474;Genetic Alliance:Dopamine+Beta+Hydroxylase+Deficiency/2316;MedGen:C1857209;OMIM:223360;Office of Rare Diseases:1903;Orphanet:230
10	43609944	G	C	Haplotype	13906	RCV000014920	28945	RET	NM_020975.4:c.1896G>C	NP_066124.1:p.Glu632Asp	NM_020975.4:c.1896G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Multiple endocrine neoplasia, type 2a;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	11739416,19469690,20301434,21863057,23788249,24893135,25356965,25394175,27854360,3078962,7907913,8099202,8103403,8918855	Autosomal dominant inheritance		1-9 / 100 000		germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia+type+2A/4956;Genetic Testing Registry (GTR):GTR000334280;Genetic Testing Registry (GTR):GTR000501433;Genetic Testing Registry (GTR):GTR000501488;Genetic Testing Registry (GTR):GTR000501592;Genetic Testing Registry (GTR):GTR000501593;Genetic Testing Registry (GTR):GTR000501594;Genetic Testing Registry (GTR):GTR000501595;Genetic Testing Registry (GTR):GTR000508799;Genetic Testing Registry (GTR):GTR000509383;Genetic Testing Registry (GTR):GTR000509729;Genetic Testing Registry (GTR):GTR000509879;Genetic Testing Registry (GTR):GTR000510673;Genetic Testing Registry (GTR):GTR000520029;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000522323;Genetic Testing Registry (GTR):GTR000528040;Genetic Testing Registry (GTR):GTR000528367;Genetic Testing Registry (GTR):GTR000528534;Genetic Testing Registry (GTR):GTR000528651;Genetic Testing Registry (GTR):GTR000528909;Genetic Testing Registry (GTR):GTR000528911;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000528913;MeSH:D018813;MedGen:C0025268;OMIM:164761.0001;OMIM:164761.0002;OMIM:164761.0003;OMIM:164761.0004;OMIM:164761.0005;OMIM:164761.0006;OMIM:164761.0007;OMIM:164761.0008;OMIM:164761.0009;OMIM:164761.0010;OMIM:164761.0011;OMIM:164761.0012;OMIM:164761.0024;OMIM:164761.0025;OMIM:164761.0033;OMIM:164761.0040;OMIM:164761.0047;OMIM:164761.0049;OMIM:171400;Orphanet:653;SNOMED CT:61808009
10	43609945	C	G	Haplotype	13906	RCV000014920	38399	RET	NM_020975.4:c.1897C>G	NP_066124.1:p.Leu633Val	NM_020975.4:c.1897C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Multiple endocrine neoplasia, type 2a;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	11739416,19469690,20301434,21863057,23788249,24893135,25356965,25394175,27854360,3078962,7907913,8099202,8103403,8918855	Autosomal dominant inheritance		1-9 / 100 000		germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia+type+2A/4956;Genetic Testing Registry (GTR):GTR000334280;Genetic Testing Registry (GTR):GTR000501433;Genetic Testing Registry (GTR):GTR000501488;Genetic Testing Registry (GTR):GTR000501592;Genetic Testing Registry (GTR):GTR000501593;Genetic Testing Registry (GTR):GTR000501594;Genetic Testing Registry (GTR):GTR000501595;Genetic Testing Registry (GTR):GTR000508799;Genetic Testing Registry (GTR):GTR000509383;Genetic Testing Registry (GTR):GTR000509729;Genetic Testing Registry (GTR):GTR000509879;Genetic Testing Registry (GTR):GTR000510673;Genetic Testing Registry (GTR):GTR000520029;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000522323;Genetic Testing Registry (GTR):GTR000528040;Genetic Testing Registry (GTR):GTR000528367;Genetic Testing Registry (GTR):GTR000528534;Genetic Testing Registry (GTR):GTR000528651;Genetic Testing Registry (GTR):GTR000528909;Genetic Testing Registry (GTR):GTR000528911;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000528913;MeSH:D018813;MedGen:C0025268;OMIM:164761.0001;OMIM:164761.0002;OMIM:164761.0003;OMIM:164761.0004;OMIM:164761.0005;OMIM:164761.0006;OMIM:164761.0007;OMIM:164761.0008;OMIM:164761.0009;OMIM:164761.0010;OMIM:164761.0011;OMIM:164761.0012;OMIM:164761.0024;OMIM:164761.0025;OMIM:164761.0033;OMIM:164761.0040;OMIM:164761.0047;OMIM:164761.0049;OMIM:171400;Orphanet:653;SNOMED CT:61808009
10	43609948	T	C	Haplotype	13906	RCV000014920	28956	RET	NM_020975.4:c.1900T>C	NP_066124.1:p.Cys634Arg	NM_020975.4:c.1900T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Multiple endocrine neoplasia, type 2a;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	11739416,19469690,20301434,21863057,23788249,24893135,25356965,25394175,27854360,3078962,7907913,8099202,8103403,8918855	Autosomal dominant inheritance		1-9 / 100 000		germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia+type+2A/4956;Genetic Testing Registry (GTR):GTR000334280;Genetic Testing Registry (GTR):GTR000501433;Genetic Testing Registry (GTR):GTR000501488;Genetic Testing Registry (GTR):GTR000501592;Genetic Testing Registry (GTR):GTR000501593;Genetic Testing Registry (GTR):GTR000501594;Genetic Testing Registry (GTR):GTR000501595;Genetic Testing Registry (GTR):GTR000508799;Genetic Testing Registry (GTR):GTR000509383;Genetic Testing Registry (GTR):GTR000509729;Genetic Testing Registry (GTR):GTR000509879;Genetic Testing Registry (GTR):GTR000510673;Genetic Testing Registry (GTR):GTR000520029;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000522323;Genetic Testing Registry (GTR):GTR000528040;Genetic Testing Registry (GTR):GTR000528367;Genetic Testing Registry (GTR):GTR000528534;Genetic Testing Registry (GTR):GTR000528651;Genetic Testing Registry (GTR):GTR000528909;Genetic Testing Registry (GTR):GTR000528911;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000528913;MeSH:D018813;MedGen:C0025268;OMIM:164761.0001;OMIM:164761.0002;OMIM:164761.0003;OMIM:164761.0004;OMIM:164761.0005;OMIM:164761.0006;OMIM:164761.0007;OMIM:164761.0008;OMIM:164761.0009;OMIM:164761.0010;OMIM:164761.0011;OMIM:164761.0012;OMIM:164761.0024;OMIM:164761.0025;OMIM:164761.0033;OMIM:164761.0040;OMIM:164761.0047;OMIM:164761.0049;OMIM:171400;Orphanet:653;SNOMED CT:61808009
10	43614996	G	A	Haplotype	13945	RCV000014972	28984	RET	NM_020975.4:c.2410G>A	NP_066124.1:p.Val804Met	NM_020975.4:c.2410G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Multiple endocrine neoplasia, type 2b;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	11739416,11788682,19469690,20301434,21863057,23788249,24893135,25356965,27854360,8797874,8918855	Autosomal dominant inheritance		1-9 / 100 000		germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia%2C+type+2B/4958;Genetic Testing Registry (GTR):GTR000021494;Genetic Testing Registry (GTR):GTR000323826;Genetic Testing Registry (GTR):GTR000501433;Genetic Testing Registry (GTR):GTR000501488;Genetic Testing Registry (GTR):GTR000501594;Genetic Testing Registry (GTR):GTR000501596;Genetic Testing Registry (GTR):GTR000508800;Genetic Testing Registry (GTR):GTR000509383;Genetic Testing Registry (GTR):GTR000509729;Genetic Testing Registry (GTR):GTR000510675;Genetic Testing Registry (GTR):GTR000512292;Genetic Testing Registry (GTR):GTR000520029;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000522323;Genetic Testing Registry (GTR):GTR000528040;Genetic Testing Registry (GTR):GTR000528367;Genetic Testing Registry (GTR):GTR000528534;Genetic Testing Registry (GTR):GTR000528651;Genetic Testing Registry (GTR):GTR000528909;Genetic Testing Registry (GTR):GTR000528911;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000528913;MeSH:D018814;MedGen:C0025269;OMIM:162300;OMIM:164761.0013;OMIM:164761.0043;Orphanet:653;SNOMED CT:6153000;SNOMED CT:61530001
10	43615632	C	G	Haplotype	13945	RCV000014972	36303	RET	NM_020975.4:c.2711C>G	NP_066124.1:p.Ser904Cys	NM_020975.4:c.2711C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Multiple endocrine neoplasia, type 2b;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	11739416,11788682,19469690,20301434,21863057,23788249,24893135,25356965,27854360,8797874,8918855	Autosomal dominant inheritance		1-9 / 100 000		germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia%2C+type+2B/4958;Genetic Testing Registry (GTR):GTR000021494;Genetic Testing Registry (GTR):GTR000323826;Genetic Testing Registry (GTR):GTR000501433;Genetic Testing Registry (GTR):GTR000501488;Genetic Testing Registry (GTR):GTR000501594;Genetic Testing Registry (GTR):GTR000501596;Genetic Testing Registry (GTR):GTR000508800;Genetic Testing Registry (GTR):GTR000509383;Genetic Testing Registry (GTR):GTR000509729;Genetic Testing Registry (GTR):GTR000510675;Genetic Testing Registry (GTR):GTR000512292;Genetic Testing Registry (GTR):GTR000520029;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000522323;Genetic Testing Registry (GTR):GTR000528040;Genetic Testing Registry (GTR):GTR000528367;Genetic Testing Registry (GTR):GTR000528534;Genetic Testing Registry (GTR):GTR000528651;Genetic Testing Registry (GTR):GTR000528909;Genetic Testing Registry (GTR):GTR000528911;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000528913;MeSH:D018814;MedGen:C0025269;OMIM:162300;OMIM:164761.0013;OMIM:164761.0043;Orphanet:653;SNOMED CT:6153000;SNOMED CT:61530001
10	64573251	C	A	Haplotype	16751	RCV000018235	38481	EGR2	NM_000399.4:c.1147G>T	NP_000390.2:p.Asp383Tyr	NM_000399.4:c.1147G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Neuropathy, congenital hypomyelinating, autosomal dominant;NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	9537424					germline	MedGen:CN069993
10	64573252	A	C	Haplotype	16751	RCV000018235	31790	EGR2	NM_000399.4:c.1146T>G	NP_000390.2:p.Ser382Arg	NM_000399.4:c.1146T>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Neuropathy, congenital hypomyelinating, autosomal dominant;NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	9537424					germline	MedGen:CN069993
10	72643759	C	T	Haplotype	180130	RCV000156929	178310	PCBD1	NM_000281.3:c.263G>A	NP_000272.1:p.Arg88Gln	NM_000281.3:c.263G>A:missense variant;NM_001323004.1:c.216+1150G>A:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hyperphenylalaninemia, BH4-deficient, D;HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	24848070,9760199	Autosomal recessive inheritance		1-9 / 1 000 000		germline	Genetic Alliance:Hyperphenylalaninemia+with+primapterinuria/3595;Genetic Testing Registry (GTR):GTR000500613;Genetic Testing Registry (GTR):GTR000500614;MedGen:C1849700;OMIM:264070;Orphanet:238583
10	72645611	C	A	Haplotype	180130	RCV000156929	178311	PCBD1	NM_000281.3:c.79G>T	NP_000272.1:p.Glu27Ter	NM_000281.3:c.79G>T:nonsense;NM_001289797.1:c.-69G>T:5 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hyperphenylalaninemia, BH4-deficient, D;HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	24848070,9760199	Autosomal recessive inheritance		1-9 / 1 000 000		germline	Genetic Alliance:Hyperphenylalaninemia+with+primapterinuria/3595;Genetic Testing Registry (GTR):GTR000500613;Genetic Testing Registry (GTR):GTR000500614;MedGen:C1849700;OMIM:264070;Orphanet:238583
10	96073100	T	C	Haplotype	266012	RCV000256386	260792	PLCE1	NM_016341.3:c.6093T>C	NP_057425.3:p.Thr2031=	NM_016341.3:c.6093T>C:synonymous variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Nephrotic syndrome, type 3			All ages			germline	Genetic Alliance:Nephrotic+syndrome%2C+type+3/8988;MedGen:C1853124;OMIM:610725;Orphanet:656
10	96084728	G	A	Haplotype	266012	RCV000256386	260793	PLCE1	NM_016341.3:c.6800G>A	NP_057425.3:p.Arg2267Gln	NM_016341.3:c.6800G>A:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Nephrotic syndrome, type 3			All ages			germline	Genetic Alliance:Nephrotic+syndrome%2C+type+3/8988;MedGen:C1853124;OMIM:610725;Orphanet:656
10	96702047	C	T	Haplotype	177709	RCV000154312	23448	CYP2C9	NM_000771.3:c.430C>T	NP_000762.2:p.Arg144Cys	NM_000771.3:c.430C>T:missense variant	drug response	drug response	no assertion criteria provided	no assertion criteria provided	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Warfarin response;Warfarin Metabolism	18281915,18281922,20504253,24251364,26186657			Alelle frequencies: CYP2C9*2- Caucasians 15%, Hispanics 7%, African-Americans 3%, Asians 3%: CYP2C9*3- Caucasians 6%, Hispanics 6%, African-Americans 2%, Asians 4%: VKORC1*2 (-1639G>A) - Caucasians 41%, Hispanics 44%, African-Americans 11%, Asians 90%.		germline	Genetic Alliance:Warfarin+response/9469;Genetic Testing Registry (GTR):GTR000500237;MedGen:CN078029;OMIM:122700;OMIM:122720.0001;OMIM:122720.0005;OMIM:608547.0002;OMIM:608547.0003;OMIM:608547.0004;OMIM:608547.0005;OMIM:608547.0007;PharmGKB:PA451906
10	96741053	A	C	Haplotype	163021	RCV000150378	23447	CYP2C9	NM_000771.3:c.1075A>C	NP_000762.2:p.Ile359Leu	NM_000771.3:c.1075A>C:missense variant	drug response	drug response	no assertion criteria provided	no assertion criteria provided	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Warfarin response;Warfarin Metabolism	18281915,18281922,20504253,24251364,26186657			Alelle frequencies: CYP2C9*2- Caucasians 15%, Hispanics 7%, African-Americans 3%, Asians 3%: CYP2C9*3- Caucasians 6%, Hispanics 6%, African-Americans 2%, Asians 4%: VKORC1*2 (-1639G>A) - Caucasians 41%, Hispanics 44%, African-Americans 11%, Asians 90%.		germline	Genetic Alliance:Warfarin+response/9469;Genetic Testing Registry (GTR):GTR000500237;MedGen:CN078029;OMIM:122700;OMIM:122720.0001;OMIM:122720.0005;OMIM:608547.0002;OMIM:608547.0003;OMIM:608547.0004;OMIM:608547.0005;OMIM:608547.0007;PharmGKB:PA451906
10	120790050	G	A	Haplotype	65392	RCV000055619	76326	NANOS1	NM_199461.3:c.737G>A	NP_955631.1:p.Arg246His	NM_199461.3:c.737G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spermatogenic failure 12;SPERMATOGENIC FAILURE 12	23315541					germline	MedGen:C3809427;OMIM:615413
10	120790139	CG	TA	Haplotype	65392	RCV000055619	76327	NANOS1	NM_199461.3:c.826_827delCGinsTA	NP_955631.1:p.Arg276Tyr	NM_199461.3:c.826_827delCGinsTA:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spermatogenic failure 12;SPERMATOGENIC FAILURE 12	23315541					germline	MedGen:C3809427;OMIM:615413
10	135339605	G	C	Haplotype	16887	RCV000018383	136523	CYP2E1	NM_000773.3:c.-1295G>C		NM_000773.3:c.-1295G>C:2KB upstream variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	CYP2E1*5B ALLELE;CYP2E1*5B ALLELE	10543395,1778977,19444287					germline	OMIM:124040.0001
10	135339845	C	T	Haplotype	16887	RCV000018383	136524	CYP2E1	NM_000773.3:c.-1055C>T		NM_000773.3:c.-1055C>T:2KB upstream variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	CYP2E1*5B ALLELE;CYP2E1*5B ALLELE	10543395,1778977,19444287					germline	OMIM:124040.0001
11	2593319	G	A	Haplotype	3146	RCV000003296	18157	KCNQ1	NM_000218.2:c.760G>A	NP_000209.2:p.Val254Met	NM_000218.2:c.760G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Long QT syndrome 1;LONG QT SYNDROME 1	10973849,12820704,14678125,1475667,14756674,20301308,21810866,23788249,25356965,27854360,8528244,9386136	Autosomal dominant inheritance		1-5 / 10 000		germline	GeneReviews:NBK1129;Genetic Alliance:Long+QT+syndrome+1/4297;Genetic Testing Registry (GTR):GTR000260589;Genetic Testing Registry (GTR):GTR000323829;Genetic Testing Registry (GTR):GTR000500450;Genetic Testing Registry (GTR):GTR000502615;Genetic Testing Registry (GTR):GTR000510878;Genetic Testing Registry (GTR):GTR000519387;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520076;Genetic Testing Registry (GTR):GTR000521333;Genetic Testing Registry (GTR):GTR000523357;Genetic Testing Registry (GTR):GTR000523361;Genetic Testing Registry (GTR):GTR000528497;Genetic Testing Registry (GTR):GTR000528500;Genetic Testing Registry (GTR):GTR000552366;MedGen:C0035828;OMIM:192500;Office of Rare Diseases:3284;Orphanet:101016;Orphanet:768;SNOMED CT:20852007
11	2608920	G	A	Haplotype	3146	RCV000003296	38428	KCNQ1	NM_181798.1:c.868G>A	NP_000209.2:p.Val417Met	NM_000218.2:c.1249G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Long QT syndrome 1;LONG QT SYNDROME 1	10973849,12820704,14678125,1475667,14756674,20301308,21810866,23788249,25356965,27854360,8528244,9386136	Autosomal dominant inheritance		1-5 / 10 000		germline	GeneReviews:NBK1129;Genetic Alliance:Long+QT+syndrome+1/4297;Genetic Testing Registry (GTR):GTR000260589;Genetic Testing Registry (GTR):GTR000323829;Genetic Testing Registry (GTR):GTR000500450;Genetic Testing Registry (GTR):GTR000502615;Genetic Testing Registry (GTR):GTR000510878;Genetic Testing Registry (GTR):GTR000519387;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520076;Genetic Testing Registry (GTR):GTR000521333;Genetic Testing Registry (GTR):GTR000523357;Genetic Testing Registry (GTR):GTR000523361;Genetic Testing Registry (GTR):GTR000528497;Genetic Testing Registry (GTR):GTR000528500;Genetic Testing Registry (GTR):GTR000552366;MedGen:C0035828;OMIM:192500;Office of Rare Diseases:3284;Orphanet:101016;Orphanet:768;SNOMED CT:20852007
11	5246839	T	A	Haplotype	15617	RCV000016884	38409	HBB	NM_000518.4:c.433A>T	NP_000509.1:p.Lys145Ter	NM_000518.4:c.433A>T:nonsense	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN KOCHI;HEMOGLOBIN KOCHI	15768550					germline	OMIM:141900.0532
11	5246844	G	A	Haplotype	15337	RCV000016580	38472	HBB	NM_000518.4:c.428C>T	NP_000509.1:p.Ala143Val	NM_000518.4:c.428C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN S (TRAVIS);HEMOGLOBIN S (TRAVIS)	1634360,19257					germline	OMIM:141900.0247
11	5246848	G	C	Haplotype	15617	RCV000016884	30656	HBB	NM_000518.4:c.424C>G	NP_000509.1:p.Leu142Val	NM_000518.4:c.424C>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN KOCHI;HEMOGLOBIN KOCHI	15768550					germline	OMIM:141900.0532
11	5246905	A	G	Haplotype	15581	RCV000016848	30619	HBB	NM_000518.4:c.367T>C	NP_000509.1:p.Phe123Leu	NM_000518.4:c.367T>C:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN CASABLANCA;HEMOGLOBIN CASABLANCA	10870883					germline	OMIM:141900.0493
11	5246908	C	G	Haplotype	15366	RCV000016617	30191	HBB	NM_000518.4:c.364G>C	NP_000509.1:p.Glu122Gln	NM_000518.4:c.364G>C:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN T (CAMBODIA);HEMOGLOBIN T (CAMBODIA)	1177278,1244906,12709369,15108284,16370495,16540414,19440680,19460936,20437613,20704537,20838957,21119755,2930724,4613830,640855,893136					germline	OMIM:141900.0276
11	5246908	C	G	Haplotype	15496	RCV000016758	30191	HBB	NM_000518.4:c.364G>C	NP_000509.1:p.Glu122Gln	NM_000518.4:c.364G>C:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN CLEVELAND;HEMOGLOBIN CLEVELAND	1177278,1244906,12709369,15108284,16370495,16540414,1787096,19440680,19460936,20437613,20704537,20838957,21119755,2930724,4613830,640855,893136					germline	OMIM:141900.0407
11	5246908	C	G	Haplotype	15591	RCV000016858	30191	HBB	NM_000518.4:c.364G>C	NP_000509.1:p.Glu122Gln	NM_000518.4:c.364G>C:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN D (AGRI);HEMOGLOBIN D (AGRI)	11570725,1177278,1244906,12709369,15108284,16370495,16540414,19440680,19460936,20437613,20704537,20838957,21119755,2930724,4613830,640855,893136					germline	OMIM:141900.0502
11	5246908	C	T	Haplotype	15335	RCV000016577	30331	HBB	NM_000518.4:c.364G>A	NP_000509.1:p.Glu122Lys	NM_000518.4:c.364G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Sickle cell-Hemoglobin O Arab disease;HEMOGLOBIN S (OMAN)	10203101,1112610,11179419,14282052,15108284,15502081,15543018,15710580,15710581,1732017,18254282,19783722,20704537,20854120,25052315,2930724,3859465,5481775,5915974,6716421,8195007,893136,9049622,9834244					germline	MedGen:C1264000;OMIM:141900.0245;SNOMED CT:127048005
11	5246908	C	T	Haplotype	15596	RCV000016863	30331	HBB	NM_000518.4:c.364G>A	NP_000509.1:p.Glu122Lys	NM_000518.4:c.364G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN O (TIBESTI);HEMOGLOBIN O (TIBESTI)	1112610,11179419,11939508,14282052,15108284,15502081,15543018,15710580,15710581,1732017,18254282,19783722,20704537,20854120,2930724,3859465,5481775,5915974,6716421,8195007,893136,9049622,9834244					germline	OMIM:141900.0507
11	5246913	C	T	Haplotype	15165	RCV000016336	38469	HBB	NM_000518.4:c.359G>A	NP_000509.1:p.Gly120Asp	NM_000518.4:c.359G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN FANNIN-LUBBOCK;HEMOGLOBIN FANNIN-LUBBOCK	20942,7852084					germline	OMIM:141900.0075
11	5246913	C	T	Haplotype	15262	RCV000016486	38469	HBB	NM_000518.4:c.359G>A	NP_000509.1:p.Gly120Asp	NM_000518.4:c.359G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN MASUDA;HEMOGLOBIN MASUDA	2634673					germline	OMIM:141900.0172
11	5246929	G	T	Haplotype	15262	RCV000016486	30525	HBB	NM_000518.4:c.343C>A	NP_000509.1:p.Leu115Met	NM_000518.4:c.343C>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN MASUDA;HEMOGLOBIN MASUDA	2634673					germline	OMIM:141900.0172
11	5246938	C	G	Haplotype	15165	RCV000016336	30204	HBB	NM_000518.4:c.334G>C	NP_000509.1:p.Val112Leu	NM_000518.4:c.334G>C:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN FANNIN-LUBBOCK;HEMOGLOBIN FANNIN-LUBBOCK	20942,7852084					germline	OMIM:141900.0075
11	5247827	C	T	Haplotype	15541	RCV000016807	30280	HBB	NM_000518.4:c.295G>A	NP_000509.1:p.Val99Met	NM_000518.4:c.295G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN MEDICINE LAKE;HEMOGLOBIN MEDICINE LAKE	7860732					germline	OMIM:141900.0452
11	5247836	T	C	Haplotype	15098	RCV000016251	30317	HBB	NM_000518.4:c.286A>G	NP_000509.1:p.Lys96Glu	NM_000518.4:c.286A>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN ARLINGTON PARK;HEMOGLOBIN ARLINGTON PARK	893139					germline	OMIM:141900.0010
11	5247842	A	G	Haplotype	15496	RCV000016758	30336	HBB	NM_000518.4:c.280T>C	NP_000509.1:p.Cys94Arg	NM_000518.4:c.280T>C:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN CLEVELAND;HEMOGLOBIN CLEVELAND	1177278,1244906,12709369,15108284,16370495,16540414,1787096,19440680,19460936,20437613,20704537,20838957,21119755,2930724,4613830,640855,893136					germline	OMIM:141900.0407
11	5247844	T	G	Haplotype	15516	RCV000016780	30326	HBB	NM_000518.4:c.278A>C	NP_000509.1:p.His93Pro	NM_000518.4:c.278A>C:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN DUINO;HEMOGLOBIN DUINO	1511986					germline	OMIM:141900.0427
11	5247851	C	T	Haplotype	15610	RCV000016877	30130	HBB	NM_000518.4:c.271G>A	NP_000509.1:p.Glu91Lys	NM_000518.4:c.271G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN S (CAMEROON);HEMOGLOBIN S (CAMEROON)	15182055					germline	OMIM:141900.0521
11	5247863	C	G	Haplotype	15313	RCV000016553	30650	HBB	NM_000518.4:c.259G>C	NP_000509.1:p.Ala87Pro	NM_000518.4:c.259G>C:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN POISSY;HEMOGLOBIN POISSY	3841063					germline	OMIM:141900.0223
11	5247902	C	T	Haplotype	15127	RCV000016286	30283	HBB	NM_000518.4:c.220G>A	NP_000509.1:p.Asp74Asn	NM_000518.4:c.220G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (GEORGETOWN)	13943409,5069596,5490239,5928902					germline	OMIM:141900.0039;OMIM:141900.0040
11	5247917	G	A	Haplotype	15612	RCV000016879	30652	HBB	NM_000518.4:c.205C>T	NP_000509.1:p.Leu69Phe	NM_000518.4:c.205C>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN JAMAICA PLAIN;HEMOGLOBIN JAMAICA PLAIN	15470216,6166632					germline	OMIM:141900.0523
11	5247925	T	A	Haplotype	15581	RCV000016848	30250	HBB	NM_000518.4:c.197A>T	NP_000509.1:p.Lys66Met	NM_000518.4:c.197A>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN CASABLANCA;HEMOGLOBIN CASABLANCA	10870883					germline	OMIM:141900.0493
11	5247946	G	C	Haplotype	15128	RCV000030905	30437	HBB	NM_000518.4:c.176C>G	NP_000509.1:p.Pro59Arg	NM_000518.4:c.176C>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (ZIGUINCHOR)	1225575,893143					germline	OMIM:141900.0039;OMIM:141900.0040
11	5247953	C	G	Haplotype	15313	RCV000016553	30227	HBB	NM_000518.4:c.169G>C	NP_000509.1:p.Gly57Arg	NM_000518.4:c.169G>C:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN POISSY;HEMOGLOBIN POISSY	3841063					germline	OMIM:141900.0223
11	5247965	C	T	Haplotype	15497	RCV000016759	30341	HBB	NM_000518.4:c.157G>A	NP_000509.1:p.Asp53Asn	NM_000518.4:c.157G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN GRENOBLE;HEMOGLOBIN GRENOBLE	10335988,15008267,16178917,18932067,2079433,5097135,640855					germline	OMIM:141900.0408
11	5247968	G	A	Haplotype	15497	RCV000016759	30536	HBB	NM_000518.4:c.154C>T	NP_000509.1:p.Pro52Ser	NM_000518.4:c.154C>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN GRENOBLE;HEMOGLOBIN GRENOBLE	10335988,15008267,16178917,18932067,2079433,5097135,640855					germline	OMIM:141900.0408
11	5248024	A	T	Haplotype	15541	RCV000016807	30572	HBB	NM_000518.4:c.98T>A	NP_000509.1:p.Leu33Gln	NM_000518.4:c.98T>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN MEDICINE LAKE;HEMOGLOBIN MEDICINE LAKE	7860732					germline	OMIM:141900.0452
11	5248173	C	T	Haplotype	15366	RCV000016617	30200	HBB	NM_000518.4:c.79G>A	NP_000509.1:p.Glu27Lys	NM_000518.4:c.79G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN T (CAMBODIA);HEMOGLOBIN T (CAMBODIA)	1177278,1244906,12709369,15108284,16370495,16540414,19440680,19460936,20437613,20704537,20838957,21119755,2930724,4613830,640855,893136					germline	OMIM:141900.0276
11	5248182	C	T	Haplotype	15334	RCV000016576	38470	HBB	NM_000518.4:c.70G>A	NP_000509.1:p.Val24Ile	NM_000518.4:c.70G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN S (ANTILLES);HEMOGLOBIN S (ANTILLES)	2189492,3467311,9166865					germline	OMIM:141900.0244
11	5248218	C	T	Haplotype	15596	RCV000016863	30228	HBB	NM_000518.4:c.34G>A	NP_000509.1:p.Val12Ile	NM_000518.4:c.34G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN O (TIBESTI);HEMOGLOBIN O (TIBESTI)	1112610,11179419,11939508,14282052,15108284,15502081,15543018,15710580,15710581,1732017,18254282,19783722,20704537,20854120,2930724,3859465,5481775,5915974,6716421,8195007,893136,9049622,9834244					germline	OMIM:141900.0507
11	5248223	G	T	Haplotype	15591	RCV000016858	30658	HBB	NM_000518.4:c.29C>A	NP_000509.1:p.Ser10Tyr	NM_000518.4:c.29C>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN D (AGRI);HEMOGLOBIN D (AGRI)	11570725,1177278,1244906,12709369,15108284,16370495,16540414,19440680,19460936,20437613,20704537,20838957,21119755,2930724,4613830,640855,893136					germline	OMIM:141900.0502
11	5248232	T	A	Haplotype	15127	RCV000016286	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (GEORGETOWN)	13943409,5069596,5490239,5928902					germline	OMIM:141900.0039;OMIM:141900.0040
11	5248232	T	A	Haplotype	15128	RCV000030905	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (ZIGUINCHOR)	1225575,893143					germline	OMIM:141900.0039;OMIM:141900.0040
11	5248232	T	A	Haplotype	15334	RCV000016576	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN S (ANTILLES);HEMOGLOBIN S (ANTILLES)	2189492,3467311,9166865					germline	OMIM:141900.0244
11	5248232	T	A	Haplotype	15335	RCV000016577	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Sickle cell-Hemoglobin O Arab disease;HEMOGLOBIN S (OMAN)	10203101,1112610,11179419,14282052,15108284,15502081,15543018,15710580,15710581,1732017,18254282,19783722,20704537,20854120,25052315,2930724,3859465,5481775,5915974,6716421,8195007,893136,9049622,9834244					germline	MedGen:C1264000;OMIM:141900.0245;SNOMED CT:127048005
11	5248232	T	A	Haplotype	15336	RCV000016579	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN S (PROVIDENCE);HEMOGLOBIN S (PROVIDENCE)	3191036					germline	OMIM:141900.0246
11	5248232	T	A	Haplotype	15337	RCV000016580	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN S (TRAVIS);HEMOGLOBIN S (TRAVIS)	1634360,19257					germline	OMIM:141900.0247
11	5248232	T	A	Haplotype	15610	RCV000016877	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN S (CAMEROON);HEMOGLOBIN S (CAMEROON)	15182055					germline	OMIM:141900.0521
11	5248232	T	A	Haplotype	15612	RCV000016879	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN JAMAICA PLAIN;HEMOGLOBIN JAMAICA PLAIN	15470216,6166632					germline	OMIM:141900.0523
11	5248233	C	T	Haplotype	15098	RCV000016251	30165	HBB	NM_000518.4:c.19G>A	NP_000509.1:p.Glu7Lys	NM_000518.4:c.19G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN ARLINGTON PARK;HEMOGLOBIN ARLINGTON PARK	893139					germline	OMIM:141900.0010
11	5269623	G	C	Haplotype	15036	RCV000016180	38468	HBG1	NM_000559.2:c.410C>G	NP_000550.2:p.Ala137Gly	NM_000559.2:c.410C>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN F (CHARLOTTE);HEMOGLOBIN F (CHARLOTTE)	1714434					germline	OMIM:142200.0032
11	5269624	C	A	Haplotype	15041	RCV000016185	30080	HBG1	NM_000559.2:c.409G>T	NP_000550.2:p.Ala137Ser	NM_000559.2:c.409G>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN F (PORTO TORRES);HEMOGLOBIN F (PORTO TORRES)	15666429					germline	OMIM:142200.0037
11	5270686	G	A	Haplotype	15036	RCV000016180	30044	HBG1	NM_000559.2:c.227C>T	NP_000550.2:p.Thr76Ile	NM_000559.2:c.227C>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN F (CHARLOTTE);HEMOGLOBIN F (CHARLOTTE)	1714434					germline	OMIM:142200.0032
11	5270686	G	A	Haplotype	15041	RCV000016185	30044	HBG1	NM_000559.2:c.227C>T	NP_000550.2:p.Thr76Ile	NM_000559.2:c.227C>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN F (PORTO TORRES);HEMOGLOBIN F (PORTO TORRES)	15666429					germline	OMIM:142200.0037
11	36596373	C	T	Haplotype	13157	RCV000014043	28196	RAG1	NM_000448.2:c.1519C>T	NP_000439.1:p.Arg507Trp	NM_000448.2:c.1519C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Combined cellular and humoral immune defects with granulomas;COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	18463379					germline	Genetic Alliance:Combined+cellular+and+humoral+immune+defects+with+granulomas/8008;MedGen:C2673536;OMIM:233650
11	36597064	G	A	Haplotype	13157	RCV000014043	28188	RAG1	NM_000448.2:c.2210G>A	NP_000439.1:p.Arg737His	NM_000448.2:c.2210G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Combined cellular and humoral immune defects with granulomas;COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	18463379					germline	Genetic Alliance:Combined+cellular+and+humoral+immune+defects+with+granulomas/8008;MedGen:C2673536;OMIM:233650
11	44129522	T	G	Haplotype	218894	RCV000203245	137950	EXT2	NM_000401.3:c.359T>G	NP_997005.1:p.Met87Arg	NM_207122.1:c.260T>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Seizures, scoliosis, and macrocephaly syndrome;SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME (1 family)	26246518					germline	MedGen:C4225248;OMIM:616682
11	44129545	C	T	Haplotype	218894	RCV000203245	215653	EXT2	NM_000401.3:c.382C>T	NP_997005.1:p.Arg95Cys	NM_207122.1:c.283C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Seizures, scoliosis, and macrocephaly syndrome;SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME (1 family)	26246518					germline	MedGen:C4225248;OMIM:616682
11	66113551	G	A	Haplotype	51008	RCV000043695	65678	B4GAT1	NM_006876.2:c.1217C>T	NP_006867.1:p.Ala406Val	NM_006876.2:c.1217C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 13;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13	23359570		Infancy	<1 / 1 000 000		germline	MedGen:C3809042;OMIM:615287;Orphanet:899
11	66113600	T	C	Haplotype	51008	RCV000043695	65679	B4GAT1	NM_006876.2:c.1168A>G	NP_006867.1:p.Asn390Asp	NM_006876.2:c.1168A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 13;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13	23359570		Infancy	<1 / 1 000 000		germline	MedGen:C3809042;OMIM:615287;Orphanet:899
11	71936057	C	CG	Haplotype	235823	RCV000224773	237478	INPPL1	NM_001567.3:c.35dupG	NP_001558.3:p.Ala13Argfs	NM_001567.3:c.35dupG:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567		Neonatal	<1 / 1 000 000		unknown	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007
11	71940602	G	C	Haplotype	235822	RCV000224420	237479	INPPL1	NM_001567.3:c.753G>C	NP_001558.3:p.Gln251His	NM_001567.3:c.753G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567		Neonatal	<1 / 1 000 000		inherited	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007
11	71940720	CAG	C	Haplotype	235825	RCV000224914	237480	INPPL1	NM_001567.3:c.768_769delAG	NP_001558.3:p.Glu258Alafs	NM_001567.3:c.768_769delAG:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567		Neonatal	<1 / 1 000 000		inherited	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007
11	71943347	GTCACC	G	Haplotype	235823	RCV000224773	237481	INPPL1	NM_001567.3:c.1687_1691delACCTC	NP_001558.3:p.Thr563Glyfs	NM_001567.3:c.1687_1691delACCTC:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567		Neonatal	<1 / 1 000 000		unknown	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007
11	71945660	G	A	Haplotype	235825	RCV000224914	48075	INPPL1	NM_001567.3:c.2415+1G>A		NM_001567.3:c.2415+1G>A:splice donor variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567		Neonatal	<1 / 1 000 000		inherited	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007
11	121037361	C	T	Haplotype	7013	RCV000007428	22052	TECTA	NM_005422.2:c.5458C>T	NP_005413.2:p.Leu1820Phe	NM_005422.2:c.5458C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Deafness, autosomal dominant 12;DEAFNESS, AUTOSOMAL DOMINANT 12	20301607,9590290		Childhood			germline	GeneReviews:NBK1434;Genetic Alliance:Deafness%2C+autosomal+dominant+12/8133;MedGen:C1832187;OMIM:601543;Orphanet:90635
11	121037374	G	A	Haplotype	7013	RCV000007428	38440	TECTA	NM_005422.2:c.5471G>A	NP_005413.2:p.Gly1824Asp	NM_005422.2:c.5471G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Deafness, autosomal dominant 12;DEAFNESS, AUTOSOMAL DOMINANT 12	20301607,9590290		Childhood			germline	GeneReviews:NBK1434;Genetic Alliance:Deafness%2C+autosomal+dominant+12/8133;MedGen:C1832187;OMIM:601543;Orphanet:90635
12	57894189	G	A	Haplotype	189364	RCV000169765	187252	MARS	NM_004990.3:c.1177G>A	NP_004981.2:p.Ala393Thr	NM_004990.3:c.1177G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Institute of Human Genetics, Klinikum rechts der Isar	Pulmonary alveolar proteinosis;Pulmonary alveolar proteinosis						germline	MedGen:C0034050;SNOMED CT:10501004
12	57894189	G	A	Haplotype	189364	RCV000173000	187252	MARS	NM_004990.3:c.1177G>A	NP_004981.2:p.Ala393Thr	NM_004990.3:c.1177G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Interstitial lung and liver disease;INTERSTITIAL LUNG AND LIVER DISEASE	25913036					germline	MedGen:C3809651;OMIM:615486
12	57906083	C	T	Haplotype	189364	RCV000169765	187253	MARS	NM_004990.3:c.1700C>T	NP_004981.2:p.Ser567Leu	NM_004990.3:c.1700C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Institute of Human Genetics, Klinikum rechts der Isar	Pulmonary alveolar proteinosis;Pulmonary alveolar proteinosis						germline	MedGen:C0034050;SNOMED CT:10501004
12	57906083	C	T	Haplotype	189364	RCV000173000	187253	MARS	NM_004990.3:c.1700C>T	NP_004981.2:p.Ser567Leu	NM_004990.3:c.1700C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Interstitial lung and liver disease;INTERSTITIAL LUNG AND LIVER DISEASE	25913036					germline	MedGen:C3809651;OMIM:615486
12	80752660	A	G	Haplotype	229122	RCV000217831	230419	OTOGL	NM_173591.3:c.6220A>G	NP_775862.3:p.Ile2074Val	NM_173591.3:c.6220A>G:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
12	80752661	T	C	Haplotype	229122	RCV000217831	230420	OTOGL	NM_173591.3:c.6221T>C	NP_775862.3:p.Ile2074Thr	NM_173591.3:c.6221T>C:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
12	102151032	G	A	Haplotype	39094	RCV000032361	47698	GNPTAB	NM_024312.4:c.3392C>T	NP_077288.2:p.Ser1131Phe	NM_024312.4:c.3392C>T:missense variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	I cell disease;Mucolipidosis II	20301728		Neonatal	1-9 / 1 000 000		not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576
12	102151034	A	AG	Haplotype	39094	RCV000032361	47699	GNPTAB	NM_024312.4:c.3388_3389insC	NP_077288.2:p.Val1130Alafs	NM_024312.4:c.3388_3389insC:frameshift variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	I cell disease;Mucolipidosis II	20301728		Neonatal	1-9 / 1 000 000		not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576
12	102155393	G	A	Haplotype	39093	RCV000032360	47696	GNPTAB	NM_024312.4:c.2864C>T	NP_077288.2:p.Ala955Val	NM_024312.4:c.2864C>T:missense variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	I cell disease;Mucolipidosis II	20301728		Neonatal	1-9 / 1 000 000		not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576
12	102155474	T	C	Haplotype	39093	RCV000032360	47697	GNPTAB	NM_024312.4:c.2783A>G	NP_077288.2:p.Lys928Arg	NM_024312.4:c.2783A>G:missense variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	I cell disease;Mucolipidosis II	20301728		Neonatal	1-9 / 1 000 000		not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576
12	102174357	T	G	Haplotype	39095	RCV000032362	47700	GNPTAB	NM_024312.4:c.614A>C	NP_077288.2:p.Gln205Pro	NM_024312.4:c.614A>C:missense variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	I cell disease;Mucolipidosis II	20301728		Neonatal	1-9 / 1 000 000		not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576
12	102179816	A	T	Haplotype	39095	RCV000032362	47701	GNPTAB	NM_024312.4:c.545T>A	NP_077288.2:p.Val182Asp	NM_024312.4:c.545T>A:missense variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	I cell disease;Mucolipidosis II	20301728		Neonatal	1-9 / 1 000 000		not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576
12	103246681	G	A	Haplotype	217885	RCV000201954	15623	PAH	NM_000277.1:c.754C>T	NP_000268.1:p.Arg252Trp	NM_000277.1:c.754C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Phenylketonuria	20301677,21915151,24385074,24667081,2574153,9429153	Autosomal recessive inheritance		1-9 / 100 000	loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000271419;Genetic Testing Registry (GTR):GTR000311734;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000501645;Genetic Testing Registry (GTR):GTR000501648;Genetic Testing Registry (GTR):GTR000502151;Genetic Testing Registry (GTR):GTR000502914;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006
12	103246700	C	T	Haplotype	402236	RCV000454199	98655	PAH	NM_000277.1:c.735G>A	NP_000268.1:p.Val245=	NM_000277.1:c.735G>A:synonymous variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Phenylketonuria	20301677,21915151,24385074,24667081,25741868	Autosomal recessive inheritance		1-9 / 100 000	loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000271419;Genetic Testing Registry (GTR):GTR000311734;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000501645;Genetic Testing Registry (GTR):GTR000501648;Genetic Testing Registry (GTR):GTR000502151;Genetic Testing Registry (GTR):GTR000502914;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006
12	103246712	GC	G	Haplotype	402236	RCV000454199	108542	PAH	NM_000277.1:c.722delG	NP_000268.1:p.Arg241Profs	NM_000277.1:c.722delG:frameshift variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Phenylketonuria	20301677,21915151,24385074,24667081,25741868	Autosomal recessive inheritance		1-9 / 100 000	loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000271419;Genetic Testing Registry (GTR):GTR000311734;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000501645;Genetic Testing Registry (GTR):GTR000501648;Genetic Testing Registry (GTR):GTR000502151;Genetic Testing Registry (GTR):GTR000502914;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006
12	103271835	C	A	Haplotype	217885	RCV000201954	214540	PAH	NM_000277.1:c.353-507G>T		NM_000277.1:c.353-507G>T:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Phenylketonuria	20301677,21915151,24385074,24667081,2574153,9429153	Autosomal recessive inheritance		1-9 / 100 000	loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000271419;Genetic Testing Registry (GTR):GTR000311734;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000501645;Genetic Testing Registry (GTR):GTR000501648;Genetic Testing Registry (GTR):GTR000502151;Genetic Testing Registry (GTR):GTR000502914;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006
13	20763313	G	T	Haplotype	267367	RCV000258130	186856	GJB2	NM_004004.5:c.408C>A	NP_003995.2:p.Tyr136Ter	NM_004004.5:c.408C>A:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Deafness, autosomal recessive 1A;DEAFNESS, AUTOSOMAL RECESSIVE 1A	1,12560944,15633193,20301449,20301607,20497192,24785414	Autosomal recessive inheritance	Infancy	Congenital deafness affects 1 in 1,000 births;Congenital deafness affects 1 in 1,000 births.;DFNB1 accounts for approximately 50% of congenital, severe-to-profound, autosomal recessive nonsyndromic hearing loss in the United States, France, Britain, and New Zealand/Australia [Denoyelle et al 1997, Green et al 1999]. Its approximate prevalence in the general population is 14:100,000, based on the following calculation: the incidence of congenital hereditary hearing impairment is 1:2000 neonates, of which 70% have nonsyndromic hearing loss. Seventy-five to 80% of cases of nonsyndromic hearing loss are autosomal recessive: of these, 50% result from GJB2 mutations. Thus, 5:10,000 x 0.7 x 0.8 x 0.5 = 14:100,000.		germline	GeneReviews:NBK1272;Genetic Alliance:Deafness%2C+autosomal+recessive+1A/8159;Genetic Testing Registry (GTR):GTR000056463;Genetic Testing Registry (GTR):GTR000073172;Genetic Testing Registry (GTR):GTR000091949;Genetic Testing Registry (GTR):GTR000091951;Genetic Testing Registry (GTR):GTR000256512;Genetic Testing Registry (GTR):GTR000323135;Genetic Testing Registry (GTR):GTR000323596;Genetic Testing Registry (GTR):GTR000326557;Genetic Testing Registry (GTR):GTR000335368;Genetic Testing Registry (GTR):GTR000500213;Genetic Testing Registry (GTR):GTR000501122;Genetic Testing Registry (GTR):GTR000501789;Genetic Testing Registry (GTR):GTR000501790;Genetic Testing Registry (GTR):GTR000501845;Genetic Testing Registry (GTR):GTR000502361;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000510415;Genetic Testing Registry (GTR):GTR000512701;Genetic Testing Registry (GTR):GTR000519426;Genetic Testing Registry (GTR):GTR000529595;Genetic Testing Registry (GTR):GTR000552033;MedGen:C2673759;OMIM:220290;Office of Rare Diseases:1697;Orphanet:90636
13	20763380	T	C	Haplotype	177819	RCV000154452	53906	GJB2	NM_004004.5:c.341A>G	NP_003995.2:p.Glu114Gly	NM_004004.5:c.341A>G:missense variant	Likely benign	Likely benign	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	10607953,10983956,12746422,15070423,17041943,17666888,20083784,20201936,20668687,21298213,23826813,24033266,9529365					germline	MedGen:CN169374
13	20763587	C	T	Haplotype	267367	RCV000258130	32072	GJB2	NM_004004.5:c.134G>A	NP_003995.2:p.Gly45Glu	NM_004004.5:c.134G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Deafness, autosomal recessive 1A;DEAFNESS, AUTOSOMAL RECESSIVE 1A	1,12560944,15633193,20301449,20301607,20497192,24785414	Autosomal recessive inheritance	Infancy	Congenital deafness affects 1 in 1,000 births;Congenital deafness affects 1 in 1,000 births.;DFNB1 accounts for approximately 50% of congenital, severe-to-profound, autosomal recessive nonsyndromic hearing loss in the United States, France, Britain, and New Zealand/Australia [Denoyelle et al 1997, Green et al 1999]. Its approximate prevalence in the general population is 14:100,000, based on the following calculation: the incidence of congenital hereditary hearing impairment is 1:2000 neonates, of which 70% have nonsyndromic hearing loss. Seventy-five to 80% of cases of nonsyndromic hearing loss are autosomal recessive: of these, 50% result from GJB2 mutations. Thus, 5:10,000 x 0.7 x 0.8 x 0.5 = 14:100,000.		germline	GeneReviews:NBK1272;Genetic Alliance:Deafness%2C+autosomal+recessive+1A/8159;Genetic Testing Registry (GTR):GTR000056463;Genetic Testing Registry (GTR):GTR000073172;Genetic Testing Registry (GTR):GTR000091949;Genetic Testing Registry (GTR):GTR000091951;Genetic Testing Registry (GTR):GTR000256512;Genetic Testing Registry (GTR):GTR000323135;Genetic Testing Registry (GTR):GTR000323596;Genetic Testing Registry (GTR):GTR000326557;Genetic Testing Registry (GTR):GTR000335368;Genetic Testing Registry (GTR):GTR000500213;Genetic Testing Registry (GTR):GTR000501122;Genetic Testing Registry (GTR):GTR000501789;Genetic Testing Registry (GTR):GTR000501790;Genetic Testing Registry (GTR):GTR000501845;Genetic Testing Registry (GTR):GTR000502361;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000510415;Genetic Testing Registry (GTR):GTR000512701;Genetic Testing Registry (GTR):GTR000519426;Genetic Testing Registry (GTR):GTR000529595;Genetic Testing Registry (GTR):GTR000552033;MedGen:C2673759;OMIM:220290;Office of Rare Diseases:1697;Orphanet:90636
13	20763642	C	T	Haplotype	177819	RCV000154452	44943	GJB2	NM_004004.5:c.79G>A	NP_003995.2:p.Val27Ile	NM_004004.5:c.79G>A:missense variant	Likely benign	Likely benign	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	10607953,10983956,12746422,15070423,17041943,17666888,20083784,20201936,20668687,21298213,23826813,24033266,9529365					germline	MedGen:CN169374
13	52515247	C	T	Haplotype	3863	RCV000004067	38430	ATP7B	NM_000053.3:c.3526G>A	NP_000044.2:p.Gly1176Arg	NM_000053.3:c.3526G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Wilson disease;WILSON DISEASE	15845031,18506894,20301685,20482602,27854360	Autosomal recessive inheritance	Childhood	1-9 / 100 000;Wilson disease is an autosomal recessive disorder with a prevalence of 1/30,000, and a carrier frequency of 1/90.	loss of function	germline	GeneReviews:NBK1512;Genetic Alliance:Wilson+disease/7506;Genetic Testing Registry (GTR):GTR000260623;Genetic Testing Registry (GTR):GTR000295690;Genetic Testing Registry (GTR):GTR000313617;Genetic Testing Registry (GTR):GTR000327805;Genetic Testing Registry (GTR):GTR000500144;Genetic Testing Registry (GTR):GTR000501125;Genetic Testing Registry (GTR):GTR000503091;Genetic Testing Registry (GTR):GTR000507952;Genetic Testing Registry (GTR):GTR000508735;Genetic Testing Registry (GTR):GTR000509712;Genetic Testing Registry (GTR):GTR000515523;Genetic Testing Registry (GTR):GTR000520457;Genetic Testing Registry (GTR):GTR000521900;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528632;Genetic Testing Registry (GTR):GTR000528928;Genetic Testing Registry (GTR):GTR000530035;Genetic Testing Registry (GTR):GTR000530097;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000552345;Genetic Testing Registry (GTR):GTR000553937;Genetics Home Reference:wilson-disease;MedGen:C0019202;OMIM:277900;Office of Rare Diseases:7893;Orphanet:905;SNOMED CT:88518009
13	52515330	A	G	Haplotype	3863	RCV000004067	18902	ATP7B	NM_000053.3:c.3443T>C	NP_000044.2:p.Ile1148Thr	NM_000053.3:c.3443T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Wilson disease;WILSON DISEASE	15845031,18506894,20301685,20482602,27854360	Autosomal recessive inheritance	Childhood	1-9 / 100 000;Wilson disease is an autosomal recessive disorder with a prevalence of 1/30,000, and a carrier frequency of 1/90.	loss of function	germline	GeneReviews:NBK1512;Genetic Alliance:Wilson+disease/7506;Genetic Testing Registry (GTR):GTR000260623;Genetic Testing Registry (GTR):GTR000295690;Genetic Testing Registry (GTR):GTR000313617;Genetic Testing Registry (GTR):GTR000327805;Genetic Testing Registry (GTR):GTR000500144;Genetic Testing Registry (GTR):GTR000501125;Genetic Testing Registry (GTR):GTR000503091;Genetic Testing Registry (GTR):GTR000507952;Genetic Testing Registry (GTR):GTR000508735;Genetic Testing Registry (GTR):GTR000509712;Genetic Testing Registry (GTR):GTR000515523;Genetic Testing Registry (GTR):GTR000520457;Genetic Testing Registry (GTR):GTR000521900;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528632;Genetic Testing Registry (GTR):GTR000528928;Genetic Testing Registry (GTR):GTR000530035;Genetic Testing Registry (GTR):GTR000530097;Genetic Testing Registry (GTR):GTR000552033;Genetic Testing Registry (GTR):GTR000552345;Genetic Testing Registry (GTR):GTR000553937;Genetics Home Reference:wilson-disease;MedGen:C0019202;OMIM:277900;Office of Rare Diseases:7893;Orphanet:905;SNOMED CT:88518009
13	103701773	G	A	Haplotype	8241	RCV000008724	38442	SLC10A2	NM_000452.2:c.785C>T	NP_000443.1:p.Thr262Met	NM_000452.2:c.785C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Bile acid malabsorption, primary;BILE ACID MALABSORPTION, PRIMARY	9109432					germline	Genetic Alliance:Bile+acid+malabsorption%2C+primary/7818;MedGen:C2750087;OMIM:613291
13	103703640	A	G	Haplotype	8241	RCV000008724	23280	SLC10A2	NM_000452.2:c.728T>C	NP_000443.1:p.Leu243Pro	NM_000452.2:c.728T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Bile acid malabsorption, primary;BILE ACID MALABSORPTION, PRIMARY	9109432					germline	Genetic Alliance:Bile+acid+malabsorption%2C+primary/7818;MedGen:C2750087;OMIM:613291
14	29237048	C	G	Phase unknown	189607	RCV000170068	169055	FOXG1	NM_005249.4:c.563C>G	NP_005240.3:p.Ala188Gly	NM_005249.4:c.563C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	RettBASE	not provided;Not provided						de novo	MedGen:CN221809
14	29237129	TC	CT	Phase unknown	189607	RCV000170068	187407	FOXG1	NM_005249.4:c.644_645delTCinsCT	NP_005240.3:p.Phe215Ser	NM_005249.4:c.644_645delTCinsCT:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	RettBASE	not provided;Not provided						de novo	MedGen:CN221809
14	32031331	G	A	Haplotype	7	RCV000000017	15046	NUBPL	NM_025152.2:c.166G>A	NP_079428.2:p.Gly56Arg	NM_025152.2:c.166G>A:missense variant;NR_120408.1:n.221G>A:non-coding transcript variant	Pathogenic	Pathogenic;Pathogenic	criteria provided, single submitter	no assertion criteria provided;criteria provided, single submitter	OMIM;Baylor Miraca Genetics Laboratories	Mitochondrial complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY;Mitochondrial complex I deficiency	20818383,22072591,23553477,24088041,26633545		All ages			germline;maternal;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609
14	32319298	T	C	Haplotype	7	RCV000000017	59458	NUBPL	NM_025152.2:c.815-27T>C		NM_025152.2:c.815-27T>C:intron variant	Pathogenic	Pathogenic;Pathogenic	criteria provided, single submitter	no assertion criteria provided;criteria provided, single submitter	OMIM;Baylor Miraca Genetics Laboratories	Mitochondrial complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY;Mitochondrial complex I deficiency	20818383,22072591,23553477,24088041,26633545		All ages			germline;maternal;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609
14	51378443	AGTAC	A	Haplotype	38368	RCV000020505	46929	PYGL	NM_002863.4:c.1969+1_1969+4delGTAC		NM_002863.4:c.1969+1_1969+4delGTAC:intron variant	Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Glycogen storage disease, type VI;Glycogen Storage Disease Type VI	17705025,20301760	Autosomal recessive inheritance	Childhood			not provided	GeneReviews:NBK5941;Genetic Alliance:Glycogen+Storage+Disease+Type+6/3126;Genetic Testing Registry (GTR):GTR000500854;Genetic Testing Registry (GTR):GTR000506624;Genetic Testing Registry (GTR):GTR000507589;MedGen:C0017925;OMIM:232700;Office of Rare Diseases:6529;Orphanet:369;SNOMED CT:237971004;SNOMED CT:29291001
14	51378448	CTTTTT	AAAAAG	Haplotype	38368	RCV000020505	46930	PYGL	NM_002863.4:c.1964_1969invAAAAAG	NP_002854.3:p.Glu655_Lys656del		Pathogenic	pathologic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Glycogen storage disease, type VI;Glycogen Storage Disease Type VI	17705025,20301760	Autosomal recessive inheritance	Childhood			not provided	GeneReviews:NBK5941;Genetic Alliance:Glycogen+Storage+Disease+Type+6/3126;Genetic Testing Registry (GTR):GTR000500854;Genetic Testing Registry (GTR):GTR000506624;Genetic Testing Registry (GTR):GTR000507589;MedGen:C0017925;OMIM:232700;Office of Rare Diseases:6529;Orphanet:369;SNOMED CT:237971004;SNOMED CT:29291001
14	75570544	C	A	Haplotype	242987	RCV000234965	248590	NEK9	NM_033116.5:c.1731+1G>T		NM_033116.5:c.1731+1G>T:splice donor variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Nevus comedonicus;NEVUS COMEDONICUS, SOMATIC	27153399					somatic	MedGen:C0265987;OMIM:617025
14	75570561	C	A	Haplotype	242987	RCV000234965	244069	NEK9	NM_033116.5:c.1715G>T	NP_149107.4:p.Gly572Val	NM_033116.5:c.1715G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Nevus comedonicus;NEVUS COMEDONICUS, SOMATIC	27153399					somatic	MedGen:C0265987;OMIM:617025
14	94847386	G	A	Haplotype	219354	RCV000205893	33000	SERPINA1	NM_001127707.1:c.739C>T	NP_001121179.1:p.Arg247Cys	NM_001127701.1:c.739C>T:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	HerediLab, Inc.	Alpha-1-antitrypsin deficiency	15685488,20301692,24121147	Autosomal recessive inheritance;Codominant	All ages	1-5 / 10 000		germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;Genetic Testing Registry (GTR):GTR000258149;Genetic Testing Registry (GTR):GTR000260627;Genetic Testing Registry (GTR):GTR000320960;Genetic Testing Registry (GTR):GTR000500212;Genetic Testing Registry (GTR):GTR000500302;Genetic Testing Registry (GTR):GTR000500303;Genetic Testing Registry (GTR):GTR000506377;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000519425;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007
14	94849061	C	T	Haplotype	17972	RCV000019572	33011	SERPINA1	NM_001127701.1:c.514G>A	NP_001121173.1:p.Gly172Arg	NM_001127701.1:c.514G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	PI M(NICHINAN);PI M(NICHINAN)	2309708,6162902					germline	OMIM:107400.0017
14	94849345	GAGA	G	Haplotype	17972	RCV000019572	321860	SERPINA1	NM_001127701.1:c.227_229delTCT	NP_001121173.1:p.Phe76del	NM_001127701.1:c.227_229delTCT:inframe_variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	PI M(NICHINAN);PI M(NICHINAN)	2309708,6162902					germline	OMIM:107400.0017
14	94849388	G	A	Haplotype	219354	RCV000205893	33013	SERPINA1	NM_001127701.1:c.187C>T	NP_001121173.1:p.Arg63Cys	NM_001127701.1:c.187C>T:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	HerediLab, Inc.	Alpha-1-antitrypsin deficiency	15685488,20301692,24121147	Autosomal recessive inheritance;Codominant	All ages	1-5 / 10 000		germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;Genetic Testing Registry (GTR):GTR000258149;Genetic Testing Registry (GTR):GTR000260627;Genetic Testing Registry (GTR):GTR000320960;Genetic Testing Registry (GTR):GTR000500212;Genetic Testing Registry (GTR):GTR000500302;Genetic Testing Registry (GTR):GTR000500303;Genetic Testing Registry (GTR):GTR000506377;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000519425;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007
15	40763815	C	G	Haplotype	2338	RCV000002428	17377	CHST14	NM_130468.3:c.403C>G	NP_569735.1:p.Arg135Gly	NM_130468.3:c.403C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Ehlers-Danlos syndrome, musculocontractural type;EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1	11666007,20004762	Autosomal recessive inheritance	Infancy	<1 / 1 000 000		germline	Genetic Alliance:Adducted+Thumb+and+Clubfoot+Syndrome/216;Genetic Testing Registry (GTR):GTR000327667;Genetic Testing Registry (GTR):GTR000501091;Genetic Testing Registry (GTR):GTR000506316;Genetic Testing Registry (GTR):GTR000506317;Genetic Testing Registry (GTR):GTR000552603;Genetics Home Reference:ehlers-danlos-syndrome;MedGen:C1866294;OMIM:601776;Orphanet:2953
15	40763822	T	A	Haplotype	2338	RCV000002428	38426	CHST14	NM_130468.3:c.410T>A	NP_569735.1:p.Leu137Gln	NM_130468.3:c.410T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Ehlers-Danlos syndrome, musculocontractural type;EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1	11666007,20004762	Autosomal recessive inheritance	Infancy	<1 / 1 000 000		germline	Genetic Alliance:Adducted+Thumb+and+Clubfoot+Syndrome/216;Genetic Testing Registry (GTR):GTR000327667;Genetic Testing Registry (GTR):GTR000501091;Genetic Testing Registry (GTR):GTR000506316;Genetic Testing Registry (GTR):GTR000506317;Genetic Testing Registry (GTR):GTR000552603;Genetics Home Reference:ehlers-danlos-syndrome;MedGen:C1866294;OMIM:601776;Orphanet:2953
15	50782626	T	G	Haplotype	161994	RCV000149419	171716	USP8	NM_005154.4:c.2138T>G	NP_005145.3:p.Leu713Arg	NM_001128610.2:c.2138T>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Institute of Human Genetics, Klinikum rechts der Isar	Pituitary dependent hypercortisolism;Pituitary dependent hypercortisolism	22720333		Adult	1-9 / 100 000		somatic	GeneReviews:NBK97965;Genetic Alliance:Pituitary+dependent+hypercortisolism/9118;MedGen:C0221406;OMIM:219090;OMIM:605555.0008;Orphanet:96253;SNOMED CT:190502001
15	50782638	A	G	Haplotype	161994	RCV000149419	171717	USP8	NM_005154.4:c.2150A>G	NP_005145.3:p.Tyr717Cys	NM_001128610.2:c.2150A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Institute of Human Genetics, Klinikum rechts der Isar	Pituitary dependent hypercortisolism;Pituitary dependent hypercortisolism	22720333		Adult	1-9 / 100 000		somatic	GeneReviews:NBK97965;Genetic Alliance:Pituitary+dependent+hypercortisolism/9118;MedGen:C0221406;OMIM:219090;OMIM:605555.0008;Orphanet:96253;SNOMED CT:190502001
15	51250689	G	A	Haplotype	224506	RCV000210065	226246	AP4E1	NM_007347.4:c.1549G>A	NP_031373.2:p.Val517Ile	NM_007347.4:c.1549G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Stuttering, familial persistent 1;STUTTERING, FAMILIAL PERSISTENT, 1	23239121,26544806					germline	Gene:100049541;MedGen:C3489627;OMIM:184450
15	51289577	G	A	Haplotype	224506	RCV000210065	226245	AP4E1	NM_007347.4:c.2401G>A	NP_031373.2:p.Glu801Lys	NM_007347.4:c.2401G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Stuttering, familial persistent 1;STUTTERING, FAMILIAL PERSISTENT, 1	23239121,26544806					germline	Gene:100049541;MedGen:C3489627;OMIM:184450
15	72643548	C	T	Haplotype	3923	RCV000004129	38431	HEXA	NM_000520.5:c.598G>A	NP_000511.2:p.Val200Met	NM_000520.5:c.598G>A:missense variant;NR_134869.1:n.1099G>A:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Tay-Sachs disease, B1 variant;TAY-SACHS DISEASE, B1 VARIANT	1415222,2976595,8198136,8659543					germline	MedGen:C1848916
15	72643572	C	G	Haplotype	3923	RCV000004129	18962	HEXA	NM_000520.5:c.574G>C	NP_000511.2:p.Val192Leu	NM_000520.5:c.574G>C:missense variant;NR_134869.1:n.1075G>C:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Tay-Sachs disease, B1 variant;TAY-SACHS DISEASE, B1 VARIANT	1415222,2976595,8198136,8659543					germline	MedGen:C1848916
15	89866657	C	G	Phase unknown	157526	RCV000144870	28546	POLG	NM_002693.2:c.2243G>C	NP_002684.1:p.Trp748Ser	NM_002693.2:c.2243G>C:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	15477547,15824347,20301532,22189570,25025039					not applicable	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001
15	89870237	C	G	Phase unknown	157526	RCV000144870	28549	POLG	NM_002693.2:c.1491G>C	NP_002684.1:p.Gln497His	NM_002693.2:c.1491G>C:missense variant	Uncertain significance	Uncertain significance	no assertion criteria provided	no assertion criteria provided	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	15477547,15824347,20301532,22189570,25025039					not applicable	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001
16	223509	C	G	Haplotype	375745	RCV000417222	362631	HBA2	NM_000517.4:c.339C>G	NP_000508.1:p.His113Gln	NM_000517.4:c.339C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	alpha Thalassemia	20301608,25052315,8735302	Autosomal recessive inheritance	All ages	>1 / 1000		germline	GeneReviews:NBK1435;Genetic Alliance:Alpha-Thalassemia/333;Genetic Testing Registry (GTR):GTR000260577;Genetic Testing Registry (GTR):GTR000501271;Genetic Testing Registry (GTR):GTR000501387;Genetic Testing Registry (GTR):GTR000502833;Genetic Testing Registry (GTR):GTR000510793;Genetic Testing Registry (GTR):GTR000510796;Genetic Testing Registry (GTR):GTR000512435;Genetic Testing Registry (GTR):GTR000514598;Genetic Testing Registry (GTR):GTR000520116;Genetic Testing Registry (GTR):GTR000521180;Genetic Testing Registry (GTR):GTR000521182;Genetic Testing Registry (GTR):GTR000521288;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528544;Genetic Testing Registry (GTR):GTR000529069;Genetic Testing Registry (GTR):GTR000553543;Genetic Testing Registry (GTR):GTR000553649;MedGen:C0002312;OMIM:604131;Orphanet:846;SNOMED CT:68913001
16	223509	CCTCCCCGCCGAG	C	Haplotype	375745	RCV000417222	362632	HBA2	NM_000517.4:c.340_351delCTCCCCGCCGAG	NP_000508.1:p.Leu114_Glu117del		Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	alpha Thalassemia	20301608,25052315,8735302	Autosomal recessive inheritance	All ages	>1 / 1000		germline	GeneReviews:NBK1435;Genetic Alliance:Alpha-Thalassemia/333;Genetic Testing Registry (GTR):GTR000260577;Genetic Testing Registry (GTR):GTR000501271;Genetic Testing Registry (GTR):GTR000501387;Genetic Testing Registry (GTR):GTR000502833;Genetic Testing Registry (GTR):GTR000510793;Genetic Testing Registry (GTR):GTR000510796;Genetic Testing Registry (GTR):GTR000512435;Genetic Testing Registry (GTR):GTR000514598;Genetic Testing Registry (GTR):GTR000520116;Genetic Testing Registry (GTR):GTR000521180;Genetic Testing Registry (GTR):GTR000521182;Genetic Testing Registry (GTR):GTR000521288;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528544;Genetic Testing Registry (GTR):GTR000529069;Genetic Testing Registry (GTR):GTR000553543;Genetic Testing Registry (GTR):GTR000553649;MedGen:C0002312;OMIM:604131;Orphanet:846;SNOMED CT:68913001
16	227067	A	G	Haplotype	15762	RCV000017073	30800	HBA1	NM_000558.4:c.235A>G	NP_000549.1:p.Asn79Asp	NM_000558.4:c.235A>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN J (SINGAPORE);HEMOGLOBIN J (SINGAPORE)	5085670					germline	OMIM:141800.0075
16	227071	C	G	Haplotype	15762	RCV000017073	38474	HBA1	NM_000558.4:c.239C>G	NP_000549.1:p.Ala80Gly	NM_000558.4:c.239C>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	HEMOGLOBIN J (SINGAPORE);HEMOGLOBIN J (SINGAPORE)	5085670					germline	OMIM:141800.0075
16	1254325	G	A	Haplotype	2704	RCV000002823	17743	CACNA1H	NM_021098.2:c.2318G>A	NP_066921.2:p.Gly773Asp	NM_021098.2:c.2318G>A:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Epilepsy, childhood absence 6;EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	12891677,15888660		Adolescent	1-9 / 100 000		germline	Genetic Alliance:Epilepsy%2C+childhood+absence+6/8325;MedGen:C2749872;OMIM:611942;Orphanet:64280
16	1254369	C	T	Haplotype	2704	RCV000002823	38427	CACNA1H	NM_021098.2:c.2362C>T	NP_066921.2:p.Arg788Cys	NM_021098.2:c.2362C>T:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Epilepsy, childhood absence 6;EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	12891677,15888660		Adolescent	1-9 / 100 000		germline	Genetic Alliance:Epilepsy%2C+childhood+absence+6/8325;MedGen:C2749872;OMIM:611942;Orphanet:64280
16	1545525	C	T	Haplotype	236230	RCV000225207	237798	TELO2	NM_016111.3:c.514C>T	NP_057195.2:p.Gln172Ter	NM_016111.3:c.514C>T:nonsense	Pathogenic	Pathogenic;Pathogenic	criteria provided, single submitter	no assertion criteria provided;criteria provided, single submitter	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	You-Hoover-Fong syndrome;YOU-HOOVER-FONG SYNDROME	27132593					germline	MedGen:C4310778;OMIM:616954
16	1555603	G	A	Haplotype	236230	RCV000225207	237812	TELO2	NM_016111.3:c.2034+1G>A		NM_016111.3:c.2034+1G>A:splice donor variant	Pathogenic	Pathogenic;Pathogenic	criteria provided, single submitter	no assertion criteria provided;criteria provided, single submitter	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	You-Hoover-Fong syndrome;YOU-HOOVER-FONG SYNDROME	27132593					germline	MedGen:C4310778;OMIM:616954
16	2110651	T	A	Haplotype	65347	RCV000055571	76281	TSC2	NM_000548.4:c.976-20T>A		NM_000548.4:c.976-20T>A:intron variant	not provided	not provided	no assertion provided	no assertion provided	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	20301399,23519317,23788249,27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000
16	2131729	C	CCTGTACAAGTCA	Haplotype	64881	RCV000055081	75810	TSC2	NM_000548.4:c.3745_3756dupCTGTACAAGTCA	NP_000539.2:p.Leu1253_Ser1254insTyrLysSerLeu	NM_000548.4:c.3745_3756dupCTGTACAAGTCA:inframe_variant	not provided	not provided	no assertion provided	no assertion provided	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	15798777,20301399,23519317,23788249,27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000
16	2134579	GCC	G	Haplotype	65324	RCV000055548	76256	TSC2	NM_000548.4:c.4358_4359delCC	NP_000539.2:p.Pro1453Glnfs	NM_000548.4:c.4358_4359delCC:frameshift variant	not provided	not provided	no assertion provided	no assertion provided	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	11468687,20301399,23519317,23788249,27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000
16	2134583	AGTGGCCTCCGGC	A	Haplotype	65324	RCV000055548	76257	TSC2	NM_000548.4:c.4361_4372delGTGGCCTCCGGC	NP_000539.2:p.Ser1454_Pro1458delinsThr	NM_000548.4:c.4361_4372delGTGGCCTCCGGC:inframe_variant	not provided	not provided	no assertion provided	no assertion provided	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	11468687,20301399,23519317,23788249,27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000
16	2135279	TACGACACCC	T	Haplotype	65183	RCV000055400	76115	TSC2	NM_000548.4:c.4621_4629delGACACCCAC	NP_000539.2:p.Asp1541_His1543del	NM_000548.4:c.4621_4629delGACACCCAC:inframe_variant	not provided	not provided	no assertion provided	no assertion provided	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	20301399,23519317,23788249,27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000
16	3293405	C	T	Haplotype	2555	RCV000002664	17578	MEFV	NM_000243.2:c.2082G>A	NP_000234.1:p.Met694Ile	NM_000243.2:c.2082G>A:missense variant;NM_001198536.1:c.*286G>A:3 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial mediterranean fever, autosomal dominant;FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	10024914,10090880,10364520,10612841,10787449,10980540,11484206,11938447,12401847,12929299,12955725,15942916,16255051,17331080,18097735,19967574,20041150,20301405,20534143,9668175		Adolescent	>1 / 1000		germline	Genetic Alliance:Familial+mediterranean+fever%2C+autosomal+dominant/8401;MedGen:C1851347;OMIM:134610;Orphanet:342
16	3304626	C	G	Haplotype	2555	RCV000002664	17581	MEFV	NM_000243.2:c.442G>C	NP_000234.1:p.Glu148Gln	NM_000243.2:c.442G>C:missense variant;NM_001198536.1:c.277+1685G>C:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial mediterranean fever, autosomal dominant;FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	10024914,10090880,10364520,10612841,10787449,10980540,11484206,11938447,12401847,12929299,12955725,15942916,16255051,17331080,18097735,19967574,20041150,20301405,20534143,9668175		Adolescent	>1 / 1000		germline	Genetic Alliance:Familial+mediterranean+fever%2C+autosomal+dominant/8401;MedGen:C1851347;OMIM:134610;Orphanet:342
16	14687212	A	AT	Phase unknown	180663	RCV000162315	178829	PARN	NM_002582.3:c.863dupA	NP_002573.1:p.Asn288Lysfs	NM_002582.3:c.863dupA:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Bone Marrow Failure laboratory,Queen Mary University London	Dyskeratosis congenita;Dyskeratosis congenita	20301779	Autosomal dominant inheritance				germline	GeneReviews:NBK22301;Genetic Alliance:Dyskeratosis+congenita/9566;Genetic Testing Registry (GTR):GTR000500027;Genetic Testing Registry (GTR):GTR000501116;Genetic Testing Registry (GTR):GTR000514651;Genetic Testing Registry (GTR):GTR000519421;Genetic Testing Registry (GTR):GTR000520395;Genetic Testing Registry (GTR):GTR000520398;Genetic Testing Registry (GTR):GTR000525856;Genetic Testing Registry (GTR):GTR000528069;Genetic Testing Registry (GTR):GTR000528909;Genetic Testing Registry (GTR):GTR000529459;Genetic Testing Registry (GTR):GTR000551316;Genetic Testing Registry (GTR):GTR000552115;MedGen:C0265965;OMIM:PS127550;SNOMED CT:74911008
16	14702130	ATACT	A	Phase unknown	180663	RCV000162315	178830	PARN	NM_002582.3:c.659+4_659+7delAGTA		NM_002582.3:c.659+4_659+7delAGTA:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Bone Marrow Failure laboratory,Queen Mary University London	Dyskeratosis congenita;Dyskeratosis congenita	20301779	Autosomal dominant inheritance				germline	GeneReviews:NBK22301;Genetic Alliance:Dyskeratosis+congenita/9566;Genetic Testing Registry (GTR):GTR000500027;Genetic Testing Registry (GTR):GTR000501116;Genetic Testing Registry (GTR):GTR000514651;Genetic Testing Registry (GTR):GTR000519421;Genetic Testing Registry (GTR):GTR000520395;Genetic Testing Registry (GTR):GTR000520398;Genetic Testing Registry (GTR):GTR000525856;Genetic Testing Registry (GTR):GTR000528069;Genetic Testing Registry (GTR):GTR000528909;Genetic Testing Registry (GTR):GTR000529459;Genetic Testing Registry (GTR):GTR000551316;Genetic Testing Registry (GTR):GTR000552115;MedGen:C0265965;OMIM:PS127550;SNOMED CT:74911008
16	15812194	C	T	Haplotype	14131	RCV000015192	29170	MYH11	NM_001040113.1:c.5294G>A	NP_001035202.1:p.Arg1765Gln	NM_001040113.1:c.5294G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	14722581,16444274,20301299,23788249,24882528,25173340,25356965,27854360	Autosomal dominant inheritance				germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetic Testing Registry (GTR):GTR000500400;Genetic Testing Registry (GTR):GTR000500403;Genetic Testing Registry (GTR):GTR000512363;Genetic Testing Registry (GTR):GTR000523358;Genetic Testing Registry (GTR):GTR000523829;Genetic Testing Registry (GTR):GTR000525815;Genetic Testing Registry (GTR):GTR000525817;Genetic Testing Registry (GTR):GTR000525822;Genetic Testing Registry (GTR):GTR000525925;Genetic Testing Registry (GTR):GTR000528386;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876
16	15815278	C	A	Haplotype	14131	RCV000015192	75290	MYH11	NM_001040113.1:c.4599+1G>T		NM_001040113.1:c.4599+1G>T:splice donor variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	14722581,16444274,20301299,23788249,24882528,25173340,25356965,27854360	Autosomal dominant inheritance				germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetic Testing Registry (GTR):GTR000500400;Genetic Testing Registry (GTR):GTR000500403;Genetic Testing Registry (GTR):GTR000512363;Genetic Testing Registry (GTR):GTR000523358;Genetic Testing Registry (GTR):GTR000523829;Genetic Testing Registry (GTR):GTR000525815;Genetic Testing Registry (GTR):GTR000525817;Genetic Testing Registry (GTR):GTR000525822;Genetic Testing Registry (GTR):GTR000525925;Genetic Testing Registry (GTR):GTR000528386;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876
16	30097630	C	T	Haplotype	188053	RCV000167863	255673	TBX6	NM_004608.3:c.1227G>A	NP_004599.2:p.Pro409=	NM_004608.3:c.1227G>A:synonymous variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spondylocostal dysostosis 5;SPONDYLOCOSTAL DYSOSTOSIS 5	25564734					germline	Genetics Home Reference:spondylocostal-dysostosis;MedGen:C1852521;OMIM:122600
16	30102802	T	C	Haplotype	188053	RCV000167863	418555	TBX6	NM_004608.3:c.-48-240A>G		NM_004608.3:c.-48-240A>G:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spondylocostal dysostosis 5;SPONDYLOCOSTAL DYSOSTOSIS 5	25564734					germline	Genetics Home Reference:spondylocostal-dysostosis;MedGen:C1852521;OMIM:122600
16	30103160	C	A	Haplotype	188053	RCV000167863	185945	TBX6	NM_004608.3:c.-49+34G>T		NM_004608.3:c.-49+34G>T:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Spondylocostal dysostosis 5;SPONDYLOCOSTAL DYSOSTOSIS 5	25564734					germline	Genetics Home Reference:spondylocostal-dysostosis;MedGen:C1852521;OMIM:122600
16	47730319	T	C	Haplotype	13621	RCV000014591	28660	PHKB	NM_000293.2:c.2923T>C	NP_000284.1:p.Tyr975His	NM_000293.2:c.2923T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Glycogen storage disease IXb;GLYCOGEN STORAGE DISEASE IXb	21634085,9215682		Childhood			germline	GeneReviews:NBK55061;Genetic Alliance:Glycogen+storage+disease+IXb/8483;MedGen:C1849812;OMIM:261750;Orphanet:79240
16	47730322	G	T	Haplotype	13621	RCV000014591	38463	PHKB	NM_000293.2:c.2926G>T	NP_000284.1:p.Glu976Ter	NM_000293.2:c.2926G>T:nonsense	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Glycogen storage disease IXb;GLYCOGEN STORAGE DISEASE IXb	21634085,9215682		Childhood			germline	GeneReviews:NBK55061;Genetic Alliance:Glycogen+storage+disease+IXb/8483;MedGen:C1849812;OMIM:261750;Orphanet:79240
16	56902267	C	T	Haplotype	8596	RCV000009127	23635	SLC12A3	NM_000339.2:c.488C>T	NP_000330.2:p.Thr163Met	NM_000339.2:c.488C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial hypokalemia-hypomagnesemia;GITELMAN SYNDROME	17000984,21343949		Childhood	1-9 / 100 000		germline	Genetic Alliance:Familial+hypokalemia-hypomagnesemia/8399;MedGen:C0268450;OMIM:263800;Orphanet:358;SNOMED CT:3188003
16	56928506	G	A	Haplotype	8596	RCV000009127	38443	SLC12A3	NM_000339.2:c.2612G>A	NP_000330.2:p.Arg871His	NM_000339.2:c.2612G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial hypokalemia-hypomagnesemia;GITELMAN SYNDROME	17000984,21343949		Childhood	1-9 / 100 000		germline	Genetic Alliance:Familial+hypokalemia-hypomagnesemia/8399;MedGen:C0268450;OMIM:263800;Orphanet:358;SNOMED CT:3188003
16	67976470	G	A	Haplotype	3667	RCV000003852	38429	LCAT	NM_000229.1:c.544C>T	NP_000220.1:p.Arg182Cys	NM_000229.1:c.544C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Norum disease;LCAT DEFICIENCY	8432868		All ages	<1 / 1 000 000		germline	Genetic Alliance:Norum+disease/5271;MedGen:C0023195;OMIM:245900;Office of Rare Diseases:4011;Orphanet:650;Orphanet:79293
16	67976842	C	T	Haplotype	3667	RCV000003852	18706	LCAT	NM_000229.1:c.349G>A	NP_000220.1:p.Ala117Thr	NM_000229.1:c.349G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Norum disease;LCAT DEFICIENCY	8432868		All ages	<1 / 1 000 000		germline	Genetic Alliance:Norum+disease/5271;MedGen:C0023195;OMIM:245900;Office of Rare Diseases:4011;Orphanet:650;Orphanet:79293
16	88786582	G	A	Haplotype	55809	RCV000049235	70465	PIEZO1	NM_001142864.3:c.6059C>T	NP_001136336.2:p.Ala2020Val	NM_001142864.3:c.6059C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS	23479567,9718354		Infancy	<1 / 1 000 000		germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004
16	88793552	G	A	Haplotype	55809	RCV000049235	70466	PIEZO1	NM_001142864.3:c.3350C>T	NP_001136336.2:p.Ser1117Leu	NM_001142864.3:c.3350C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS	23479567,9718354		Infancy	<1 / 1 000 000		germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004
16	88800060	C	T	Haplotype	55813	RCV000049238	70476	PIEZO1	NM_001142864.3:c.2423G>A	NP_001136336.2:p.Arg808Gln	NM_001142864.3:c.2423G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	11001917,23479567,9827909		Infancy	<1 / 1 000 000		germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004
16	88800139	C	T	Haplotype	55813	RCV000049238	70475	PIEZO1	NM_001142864.3:c.2344G>A	NP_001136336.2:p.Gly782Ser	NM_001142864.3:c.2344G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	11001917,23479567,9827909		Infancy	<1 / 1 000 000		germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004
16	88801252	G	C	Haplotype	55813	RCV000049238	70469	PIEZO1	NM_001142864.3:c.1848+31C>G		NM_001142864.3:c.1848+31C>G:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	11001917,23479567,9827909		Infancy	<1 / 1 000 000		germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004
17	7123838	C	T	Haplotype	1631	RCV000001698	16670	ACADVL	NM_000018.3:c.194C>T	NP_000009.1:p.Pro65Leu	NM_000018.3:c.194C>T:missense variant;NM_001033859.2:c.139-85C>T:intron variant;NM_001270448.1:c.-35C>T:5 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Very long chain acyl-CoA dehydrogenase deficiency;VLCAD DEFICIENCY	10790204,20301763,27209629	Autosomal recessive inheritance	Infancy	1 - 9 / 100 000;1-9 / 100 000		germline	GeneReviews:NBK6816;Genetic Alliance:VLCAD+deficiency/7410;Genetic Testing Registry (GTR):GTR000328131;Genetic Testing Registry (GTR):GTR000501713;Genetic Testing Registry (GTR):GTR000501716;Genetic Testing Registry (GTR):GTR000506347;Genetic Testing Registry (GTR):GTR000514645;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519384;Genetic Testing Registry (GTR):GTR000521370;Genetic Testing Registry (GTR):GTR000521512;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000530051;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0342784;OMIM:201475;Office of Rare Diseases:5508;Orphanet:26793;SNOMED CT:237996001;SNOMED CT:237997005
17	7125387	A	C	Haplotype	1631	RCV000001698	38417	ACADVL	NM_000018.3:c.739A>C	NP_000009.1:p.Lys247Gln	NM_000018.3:c.739A>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Very long chain acyl-CoA dehydrogenase deficiency;VLCAD DEFICIENCY	10790204,20301763,27209629	Autosomal recessive inheritance	Infancy	1 - 9 / 100 000;1-9 / 100 000		germline	GeneReviews:NBK6816;Genetic Alliance:VLCAD+deficiency/7410;Genetic Testing Registry (GTR):GTR000328131;Genetic Testing Registry (GTR):GTR000501713;Genetic Testing Registry (GTR):GTR000501716;Genetic Testing Registry (GTR):GTR000506347;Genetic Testing Registry (GTR):GTR000514645;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519384;Genetic Testing Registry (GTR):GTR000521370;Genetic Testing Registry (GTR):GTR000521512;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000530051;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0342784;OMIM:201475;Office of Rare Diseases:5508;Orphanet:26793;SNOMED CT:237996001;SNOMED CT:237997005
17	7918017	G	C	Haplotype	9354	RCV000009948	24393	GUCY2D	NM_000180.3:c.2511G>C	NP_000171.1:p.Glu837Asp	NM_000180.3:c.2511G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10647719,11565546,9097965,9618177	Autosomal dominant inheritance	Childhood	1-9 / 100 000		germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetic Testing Registry (GTR):GTR000501118;Genetic Testing Registry (GTR):GTR000520022;Genetic Testing Registry (GTR):GTR000520023;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872
17	7918017	G	C	Haplotype	9356	RCV000009950	24393	GUCY2D	NM_000180.3:c.2511G>C	NP_000171.1:p.Glu837Asp	NM_000180.3:c.2511G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	9683616	Autosomal dominant inheritance	Childhood	1-9 / 100 000		germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetic Testing Registry (GTR):GTR000501118;Genetic Testing Registry (GTR):GTR000520022;Genetic Testing Registry (GTR):GTR000520023;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872
17	7918018	C	A	Haplotype	9354	RCV000009948	38445	GUCY2D	NM_000180.3:c.2512C>A	NP_000171.1:p.Arg838Ser	NM_000180.3:c.2512C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10647719,11565546,9097965,9618177	Autosomal dominant inheritance	Childhood	1-9 / 100 000		germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetic Testing Registry (GTR):GTR000501118;Genetic Testing Registry (GTR):GTR000520022;Genetic Testing Registry (GTR):GTR000520023;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872
17	7918018	C	T	Haplotype	9356	RCV000009950	24394	GUCY2D	NM_000180.3:c.2512C>T	NP_000171.1:p.Arg838Cys	NM_000180.3:c.2512C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	9683616	Autosomal dominant inheritance	Childhood	1-9 / 100 000		germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetic Testing Registry (GTR):GTR000501118;Genetic Testing Registry (GTR):GTR000520022;Genetic Testing Registry (GTR):GTR000520023;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872
17	7918022	C	T	Haplotype	9356	RCV000009950	38391	GUCY2D	NM_000180.3:c.2516C>T	NP_000171.1:p.Thr839Met	NM_000180.3:c.2516C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	9683616	Autosomal dominant inheritance	Childhood	1-9 / 100 000		germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetic Testing Registry (GTR):GTR000501118;Genetic Testing Registry (GTR):GTR000520022;Genetic Testing Registry (GTR):GTR000520023;Genetic Testing Registry (GTR):GTR000520060;Genetic Testing Registry (GTR):GTR000553865;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872
17	17118608	G	TC	Haplotype	3377	RCV000003544	243924	FLCN	NM_144997.5:c.1323delCinsGA	NP_659434.2:p.His442Thrfs	NM_144997.5:c.1323delCinsGA:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Multiple fibrofolliculomas;BIRT-HOGG-DUBE SYNDROME	19320655,19562744,20301695,24319509,25394175	Autosomal dominant inheritance	Adult	1-9 / 1 000 000		germline	GeneReviews:NBK1522;Genetic Alliance:Multiple+fibrofolliculomas/8920;Genetic Testing Registry (GTR):GTR000501362;Genetic Testing Registry (GTR):GTR000501366;Genetic Testing Registry (GTR):GTR000501438;Genetic Testing Registry (GTR):GTR000501439;Genetic Testing Registry (GTR):GTR000501440;Genetic Testing Registry (GTR):GTR000510973;Genetic Testing Registry (GTR):GTR000520030;Genetic Testing Registry (GTR):GTR000522559;Genetic Testing Registry (GTR):GTR000528534;Genetics Home Reference:birt-hogg-dube-syndrome;MedGen:C0346010;OMIM:135150;Office of Rare Diseases:2322;Orphanet:122;SNOMED CT:110985001
17	17118626	AAACTCTGTAAC	A	Haplotype	3377	RCV000003544	18416	FLCN	NM_144997.5:c.1301-7_1304delGTTACAGAGTT		NM_144997.5:c.1301-7_1304delGTTACAGAGTT:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Multiple fibrofolliculomas;BIRT-HOGG-DUBE SYNDROME	19320655,19562744,20301695,24319509,25394175	Autosomal dominant inheritance	Adult	1-9 / 1 000 000		germline	GeneReviews:NBK1522;Genetic Alliance:Multiple+fibrofolliculomas/8920;Genetic Testing Registry (GTR):GTR000501362;Genetic Testing Registry (GTR):GTR000501366;Genetic Testing Registry (GTR):GTR000501438;Genetic Testing Registry (GTR):GTR000501439;Genetic Testing Registry (GTR):GTR000501440;Genetic Testing Registry (GTR):GTR000510973;Genetic Testing Registry (GTR):GTR000520030;Genetic Testing Registry (GTR):GTR000522559;Genetic Testing Registry (GTR):GTR000528534;Genetics Home Reference:birt-hogg-dube-syndrome;MedGen:C0346010;OMIM:135150;Office of Rare Diseases:2322;Orphanet:122;SNOMED CT:110985001
17	29577934	TA	T	Haplotype	217112	RCV000200907	213715	NF1	NM_001042492.2:c.4110+1798del		NM_000267.3:c.4110+1798del:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Medical Genomics Laboratory,Department of Genetics UAB	Neurofibromatosis, type 1;Neurofibromatosis, type 1	10862084,15604628,17636453,20065170,20301288,20301471,24893135,26189818	Autosomal dominant inheritance	Infancy	1-5 / 10 000;1:3,000	loss of function	unknown	GeneReviews:NBK1109;Genetic Alliance:Neurofibromatosis+type+1/5174;Genetic Testing Registry (GTR):GTR000260605;Genetic Testing Registry (GTR):GTR000335545;Genetic Testing Registry (GTR):GTR000500115;Genetic Testing Registry (GTR):GTR000500672;Genetic Testing Registry (GTR):GTR000500881;Genetic Testing Registry (GTR):GTR000500970;Genetic Testing Registry (GTR):GTR000500971;Genetic Testing Registry (GTR):GTR000500972;Genetic Testing Registry (GTR):GTR000501087;Genetic Testing Registry (GTR):GTR000501088;Genetic Testing Registry (GTR):GTR000509686;Genetic Testing Registry (GTR):GTR000510677;Genetic Testing Registry (GTR):GTR000510679;Genetic Testing Registry (GTR):GTR000511186;Genetic Testing Registry (GTR):GTR000511188;Genetic Testing Registry (GTR):GTR000514608;Genetic Testing Registry (GTR):GTR000514913;Genetic Testing Registry (GTR):GTR000514981;Genetic Testing Registry (GTR):GTR000515566;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520393;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000521399;Genetic Testing Registry (GTR):GTR000521505;Genetic Testing Registry (GTR):GTR000521546;Genetic Testing Registry (GTR):GTR000522322;Genetic Testing Registry (GTR):GTR000528459;Genetic Testing Registry (GTR):GTR000528529;Genetic Testing Registry (GTR):GTR000528533;Genetic Testing Registry (GTR):GTR000528913;Genetic Testing Registry (GTR):GTR000528930;Genetic Testing Registry (GTR):GTR000529017;Genetic Testing Registry (GTR):GTR000529068;Genetic Testing Registry (GTR):GTR000551630;Genetic Testing Registry (GTR):GTR000552183;Genetic Testing Registry (GTR):GTR000552305;MedGen:C0027831;OMIM:162200;OMIM:613113.0001;OMIM:613113.0002;OMIM:613113.0003;OMIM:613113.0004;OMIM:613113.0005;OMIM:613113.0006;OMIM:613113.0007;OMIM:613113.0008;OMIM:613113.0009;OMIM:613113.0012;OMIM:613113.0013;OMIM:613113.0014;OMIM:613113.0015;OMIM:613113.0016;OMIM:613113.0021;OMIM:613113.0022;OMIM:613113.0023;OMIM:613113.0024;OMIM:613113.0025;OMIM:613113.0026;OMIM:613113.0027;OMIM:613113.0029;OMIM:613113.0030;OMIM:613113.0031;OMIM:613113.0032;OMIM:613113.0037;OMIM:613113.0038;OMIM:613113.0040;OMIM:613113.0041;OMIM:613113.0042;OMIM:613113.0043;OMIM:613113.0044;OMIM:613113.0046;Office of Rare Diseases:7866;Orphanet:636;Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia,Universidade Católica de Brasília:R34;SNOMED CT:92824003
17	41247892	T	C	Haplotype	236265	RCV000225499	46245	BRCA1	NM_007294.3:c.641A>G	NP_009225.1:p.Asp214Gly	NM_007294.3:c.641A>G:missense variant;NR_027676.1:n.777A>G:non-coding transcript variant	Benign	Benign	reviewed by expert panel	reviewed by expert panel	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Breast-ovarian cancer, familial 1	1,10,15604628,17392385,17508274,17924331,19305347,20,20065170,20301425,23188549,23788249,23918944,24366376,24366402,24432435,24493721,25356965,25394175,27008870,27854360,3,548,70	Autosomal dominant inheritance	All ages	1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.	loss of function	germline	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520117;Genetic Testing Registry (GTR):GTR000520118;Genetic Testing Registry (GTR):GTR000520119;Genetic Testing Registry (GTR):GTR000520122;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552078;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;Genetics Home Reference:ovarian-cancer;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145
17	41247941	T	G	Haplotype	236265	RCV000225499	46242	BRCA1	NM_007294.3:c.594-2A>C		NM_007294.3:c.594-2A>C:splice acceptor variant	Benign	Benign	reviewed by expert panel	reviewed by expert panel	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Breast-ovarian cancer, familial 1	1,10,15604628,17392385,17508274,17924331,19305347,20,20065170,20301425,23188549,23788249,23918944,24366376,24366402,24432435,24493721,25356965,25394175,27008870,27854360,3,548,70	Autosomal dominant inheritance	All ages	1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.	loss of function	germline	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520117;Genetic Testing Registry (GTR):GTR000520118;Genetic Testing Registry (GTR):GTR000520119;Genetic Testing Registry (GTR):GTR000520122;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552078;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;Genetics Home Reference:ovarian-cancer;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145
17	42988737	C	T	Haplotype	190352	RCV000192152	77412	GFAP	NM_002055.4:c.994G>A	NP_002046.1:p.Glu332Lys	NM_002055.4:c.994G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Alexander's disease;Alexander's disease	18004641,20301351,21533827		All ages	<1 / 1 000 000		germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007
17	42988743	G	C	Haplotype	190352	RCV000192152	77410	GFAP	NM_002055.4:c.988C>G	NP_002046.1:p.Arg330Gly	NM_002055.4:c.988C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Alexander's disease;Alexander's disease	18004641,20301351,21533827		All ages	<1 / 1 000 000		germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007
17	42990750	C	G	Haplotype	190336	RCV000192110	77391	GFAP	NM_002055.4:c.667G>C	NP_002046.1:p.Glu223Gln	NM_002055.4:c.667G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Alexander's disease;Alexander's disease	14707518,15060693,19444543,20301351,21533827		All ages	<1 / 1 000 000		germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007
17	42992619	C	T	Haplotype	190336	RCV000192110	31209	GFAP	NM_002055.4:c.236G>A	NP_002046.1:p.Arg79His	NM_002055.4:c.236G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Alexander's disease;Alexander's disease	14707518,15060693,19444543,20301351,21533827		All ages	<1 / 1 000 000		germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007
17	62019163	C	T	Haplotype	21158	RCV000020275	34011	SCN4A	NM_000334.4:c.4479G>A	NP_000325.4:p.Met1493Ile	NM_000334.4:c.4479G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Hyperkalemic Periodic Paralysis Type 1	10930446,20298421,20301669		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1496;GeneTests:2133;Genetic Alliance:Hyperkalemic+Periodic+Paralysis+Type+1/8591;MedGen:CN074266;OMIM:170500;Orphanet:682
17	62019174	A	G	Haplotype	21158	RCV000020275	34010	SCN4A	NM_000334.4:c.4468T>C	NP_000325.4:p.Phe1490Leu	NM_000334.4:c.4468T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Hyperkalemic Periodic Paralysis Type 1	10930446,20298421,20301669		Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1496;GeneTests:2133;Genetic Alliance:Hyperkalemic+Periodic+Paralysis+Type+1/8591;MedGen:CN074266;OMIM:170500;Orphanet:682
17	73513145	T	C	Haplotype	2121	RCV000002203	38422	TSEN54	NM_207346.2:c.277T>C	NP_997229.2:p.Ser93Pro	NM_207346.2:c.277T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Pontocerebellar hypoplasia type 4;PONTOCEREBELLAR HYPOPLASIA, TYPE 4	18711368,20301773	Autosomal recessive inheritance	Antenatal	<1 / 1 000 000		germline	GeneReviews:NBK9673;Genetic Alliance:Pontocerebellar+hypoplasia+type+4/5866;Genetic Testing Registry (GTR):GTR000320599;Genetic Testing Registry (GTR):GTR000500167;Genetic Testing Registry (GTR):GTR000500222;Genetic Testing Registry (GTR):GTR000507730;Genetic Testing Registry (GTR):GTR000507731;Genetic Testing Registry (GTR):GTR000512857;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553541;MedGen:C1856974;OMIM:225753;Office of Rare Diseases:343;Orphanet:166063
17	73518081	G	T	Haplotype	2121	RCV000002203	17159	TSEN54	NM_207346.2:c.919G>T	NP_997229.2:p.Ala307Ser	NM_207346.2:c.919G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Pontocerebellar hypoplasia type 4;PONTOCEREBELLAR HYPOPLASIA, TYPE 4	18711368,20301773	Autosomal recessive inheritance	Antenatal	<1 / 1 000 000		germline	GeneReviews:NBK9673;Genetic Alliance:Pontocerebellar+hypoplasia+type+4/5866;Genetic Testing Registry (GTR):GTR000320599;Genetic Testing Registry (GTR):GTR000500167;Genetic Testing Registry (GTR):GTR000500222;Genetic Testing Registry (GTR):GTR000507730;Genetic Testing Registry (GTR):GTR000507731;Genetic Testing Registry (GTR):GTR000512857;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000553541;MedGen:C1856974;OMIM:225753;Office of Rare Diseases:343;Orphanet:166063
18	3215156	CAC	GAG	Haplotype	229030	RCV000221703	230906	MYOM1	NM_003803.3:c.64_66delGTGinsCTC	NP_003794.3:p.Val22Leu	NM_003803.3:c.64_66delGTGinsCTC:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
18	3215157	A	C	Haplotype	229030	RCV000221703	230904	MYOM1	NM_003803.3:c.65T>G	NP_003794.3:p.Val22Gly	NM_003803.3:c.65T>G:missense variant	Uncertain significance	Uncertain significance	criteria provided, single submitter	criteria provided, single submitter	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374
18	50994293	A	G	Haplotype	375288	RCV000416369	362059	DCC	NM_005215.3:c.3649A>G	NP_005206.2:p.Met1217Val	NM_005215.3:c.3649A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Neurogenetics Research, Murdoch Childrens Research Institute	Corpus callosum agenesis		Autosomal recessive inheritance				germline	Genetic Alliance:Agenesis+of+the+Corpus+Callosum/263;Genetic Testing Registry (GTR):GTR000331025;Genetic Testing Registry (GTR):GTR000512629;Genetic Testing Registry (GTR):GTR000520970;MedGen:C0175754;OMIM:217990;Office of Rare Diseases:1535;Orphanet:200
18	51013178	G	A	Haplotype	375288	RCV000416369	362060	DCC	NM_005215.3:c.3748G>A	NP_005206.2:p.Ala1250Thr	NM_005215.3:c.3748G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Neurogenetics Research, Murdoch Childrens Research Institute	Corpus callosum agenesis		Autosomal recessive inheritance				germline	Genetic Alliance:Agenesis+of+the+Corpus+Callosum/263;Genetic Testing Registry (GTR):GTR000331025;Genetic Testing Registry (GTR):GTR000512629;Genetic Testing Registry (GTR):GTR000520970;MedGen:C0175754;OMIM:217990;Office of Rare Diseases:1535;Orphanet:200
18	55217985	A	C	Haplotype	561	RCV000000591	38381	FECH	NM_001012515.2:c.1249T>G	NP_001012533.1:p.Cys417Gly	NM_000140.3:c.1231T>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Erythropoietic protoporphyria;PROTOPORPHYRIA, ERYTHROPOIETIC	10942404,23016163		Infancy	<1 / 1 000 000		germline	GeneReviews:NBK100826;Genetic Alliance:Erythropoietic+Protoporphyria/2648;MedGen:C0162568;OMIM:177000;Office of Rare Diseases:4527;Orphanet:79278;SNOMED CT:51022005
18	55217991	G	A	Haplotype	561	RCV000000591	38382	FECH	NM_001012515.2:c.1243C>T	NP_001012533.1:p.Pro415Ser	NM_000140.3:c.1225C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Erythropoietic protoporphyria;PROTOPORPHYRIA, ERYTHROPOIETIC	10942404,23016163		Infancy	<1 / 1 000 000		germline	GeneReviews:NBK100826;Genetic Alliance:Erythropoietic+Protoporphyria/2648;MedGen:C0162568;OMIM:177000;Office of Rare Diseases:4527;Orphanet:79278;SNOMED CT:51022005
18	55217992	A	T	Haplotype	561	RCV000000591	15600	FECH	NM_001012515.2:c.1242T>A	NP_001012533.1:p.Asn414Lys	NM_000140.3:c.1224T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Erythropoietic protoporphyria;PROTOPORPHYRIA, ERYTHROPOIETIC	10942404,23016163		Infancy	<1 / 1 000 000		germline	GeneReviews:NBK100826;Genetic Alliance:Erythropoietic+Protoporphyria/2648;MedGen:C0162568;OMIM:177000;Office of Rare Diseases:4527;Orphanet:79278;SNOMED CT:51022005
19	853329	G	T	Haplotype	16747	RCV000018231	31786	ELANE	NM_001972.3:c.292G>T	NP_001963.1:p.Val98Leu	NM_001972.3:c.292G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Severe congenital neutropenia autosomal dominant;NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	17436313,20301705	Autosomal dominant inheritance	Infancy	<1 / 1 000 000		germline	GeneReviews:NBK1533;Genetic Alliance:Severe+congenital+neutropenia+autosomal+dominant/6527;Genetic Testing Registry (GTR):GTR000302019;Genetic Testing Registry (GTR):GTR000309228;Genetic Testing Registry (GTR):GTR000501114;Genetic Testing Registry (GTR):GTR000509067;Genetic Testing Registry (GTR):GTR000512562;Genetic Testing Registry (GTR):GTR000519424;Genetic Testing Registry (GTR):GTR000519601;Genetic Testing Registry (GTR):GTR000528303;Genetic Testing Registry (GTR):GTR000528905;Genetic Testing Registry (GTR):GTR000529138;Genetic Testing Registry (GTR):GTR000552055;MedGen:C1859966;OMIM:130130.0006;OMIM:130130.0007;OMIM:130130.0008;OMIM:130130.0009;OMIM:130130.0010;OMIM:130130.0011;OMIM:202700;Office of Rare Diseases:9558;Orphanet:486
19	853338	G	T	Haplotype	16747	RCV000018231	38480	ELANE	NM_001972.3:c.301G>T	NP_001963.1:p.Val101Leu	NM_001972.3:c.301G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Severe congenital neutropenia autosomal dominant;NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	17436313,20301705	Autosomal dominant inheritance	Infancy	<1 / 1 000 000		germline	GeneReviews:NBK1533;Genetic Alliance:Severe+congenital+neutropenia+autosomal+dominant/6527;Genetic Testing Registry (GTR):GTR000302019;Genetic Testing Registry (GTR):GTR000309228;Genetic Testing Registry (GTR):GTR000501114;Genetic Testing Registry (GTR):GTR000509067;Genetic Testing Registry (GTR):GTR000512562;Genetic Testing Registry (GTR):GTR000519424;Genetic Testing Registry (GTR):GTR000519601;Genetic Testing Registry (GTR):GTR000528303;Genetic Testing Registry (GTR):GTR000528905;Genetic Testing Registry (GTR):GTR000529138;Genetic Testing Registry (GTR):GTR000552055;MedGen:C1859966;OMIM:130130.0006;OMIM:130130.0007;OMIM:130130.0008;OMIM:130130.0009;OMIM:130130.0010;OMIM:130130.0011;OMIM:202700;Office of Rare Diseases:9558;Orphanet:486
19	863114	T	G	Haplotype	16565	RCV000018033	31604	CFD	NM_001928.3:c.638T>G	NP_001919.2:p.Val213Gly	NM_001928.3:c.638T>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Complement factor d deficiency;COMPLEMENT FACTOR D DEFICIENCY	16527897	Autosomal recessive inheritance				germline	Genetic Alliance:Complement+factor+d+deficiency/8033;MedGen:C1851396;OMIM:613912
19	863116	T	C	Haplotype	16565	RCV000018033	38479	CFD	NM_001928.3:c.640T>C	NP_001919.2:p.Cys214Arg	NM_001928.3:c.640T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Complement factor d deficiency;COMPLEMENT FACTOR D DEFICIENCY	16527897	Autosomal recessive inheritance				germline	Genetic Alliance:Complement+factor+d+deficiency/8033;MedGen:C1851396;OMIM:613912
19	5844343	C	T	Haplotype	17716	RCV000019289	38486	FUT3	NM_000149.3:c.508G>A	NP_000140.1:p.Gly170Ser	NM_000149.3:c.508G>A:missense variant	association	association	no assertion criteria provided	no assertion criteria provided	OMIM	Le(-) PHENOTYPE;Le(-) PHENOTYPE	8219240					germline	OMIM:111100.0001
19	5844792	A	C	Haplotype	17716	RCV000019289	32755	FUT3	NM_000149.3:c.59T>G	NP_000140.1:p.Leu20Arg	NM_000149.3:c.59T>G:missense variant	association	association	no assertion criteria provided	no assertion criteria provided	OMIM	Le(-) PHENOTYPE;Le(-) PHENOTYPE	8219240					germline	OMIM:111100.0001
19	11216228	T	TGTGATG	Haplotype	250923	RCV000238362	245688	LDLR	NM_000527.4:c.649_654dupGATGGT	NP_000518.1:p.Gly218_Gly219insAspGly	NM_000527.4:c.649_654dupGATGGT:inframe_variant;NM_001195800.1:c.314-1837_314-1832dup:intron variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	LDLR-LOVD, British Heart Foundation	Familial hypercholesterolemia	15177124,21600525,22364837,23725921,23788249,24404629,24418289,24636176,25053660,25356965,25404096,27854360,7649546	Autosomal dominant inheritance		1-9 / 1 000 000		germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;Genetic Testing Registry (GTR):GTR000203962;Genetic Testing Registry (GTR):GTR000260633;Genetic Testing Registry (GTR):GTR000320944;Genetic Testing Registry (GTR):GTR000321567;Genetic Testing Registry (GTR):GTR000500234;Genetic Testing Registry (GTR):GTR000500235;Genetic Testing Registry (GTR):GTR000500236;Genetic Testing Registry (GTR):GTR000512385;Genetic Testing Registry (GTR):GTR000520922;Genetic Testing Registry (GTR):GTR000521881;Genetic Testing Registry (GTR):GTR000523352;Genetic Testing Registry (GTR):GTR000523354;Genetic Testing Registry (GTR):GTR000525924;Genetic Testing Registry (GTR):GTR000528325;Genetic Testing Registry (GTR):GTR000528380;Genetic Testing Registry (GTR):GTR000528697;Genetic Testing Registry (GTR):GTR000528701;Genetic Testing Registry (GTR):GTR000552211;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000
19	11218079	G	A	Haplotype	430765	RCV000495914	181238	LDLR	NM_000527.4:c.829G>A	NP_000518.1:p.Glu277Lys	NM_000527.4:c.829G>A:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124,21600525,22364837,23725921,23788249,24404629,24418289,24636176,25053660,25356965,25404096,25741868,27854360	Autosomal dominant inheritance		1-9 / 1 000 000		germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;Genetic Testing Registry (GTR):GTR000203962;Genetic Testing Registry (GTR):GTR000260633;Genetic Testing Registry (GTR):GTR000320944;Genetic Testing Registry (GTR):GTR000321567;Genetic Testing Registry (GTR):GTR000500234;Genetic Testing Registry (GTR):GTR000500235;Genetic Testing Registry (GTR):GTR000500236;Genetic Testing Registry (GTR):GTR000512385;Genetic Testing Registry (GTR):GTR000520922;Genetic Testing Registry (GTR):GTR000521881;Genetic Testing Registry (GTR):GTR000523352;Genetic Testing Registry (GTR):GTR000523354;Genetic Testing Registry (GTR):GTR000525924;Genetic Testing Registry (GTR):GTR000528325;Genetic Testing Registry (GTR):GTR000528380;Genetic Testing Registry (GTR):GTR000528697;Genetic Testing Registry (GTR):GTR000528701;Genetic Testing Registry (GTR):GTR000552211;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000
19	11218182	A	G	Haplotype	430769	RCV000495938	245864	LDLR	NM_000527.4:c.932A>G	NP_000518.1:p.Lys311Arg	NM_000527.4:c.932A>G:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124,21600525,22364837,23725921,23788249,24404629,24418289,24636176,25053660,25356965,25404096,25741868,27854360	Autosomal dominant inheritance		1-9 / 1 000 000		germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;Genetic Testing Registry (GTR):GTR000203962;Genetic Testing Registry (GTR):GTR000260633;Genetic Testing Registry (GTR):GTR000320944;Genetic Testing Registry (GTR):GTR000321567;Genetic Testing Registry (GTR):GTR000500234;Genetic Testing Registry (GTR):GTR000500235;Genetic Testing Registry (GTR):GTR000500236;Genetic Testing Registry (GTR):GTR000512385;Genetic Testing Registry (GTR):GTR000520922;Genetic Testing Registry (GTR):GTR000521881;Genetic Testing Registry (GTR):GTR000523352;Genetic Testing Registry (GTR):GTR000523354;Genetic Testing Registry (GTR):GTR000525924;Genetic Testing Registry (GTR):GTR000528325;Genetic Testing Registry (GTR):GTR000528380;Genetic Testing Registry (GTR):GTR000528697;Genetic Testing Registry (GTR):GTR000528701;Genetic Testing Registry (GTR):GTR000552211;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000
19	11218189	C	G	Haplotype	430769	RCV000495938	245873	LDLR	NM_000527.4:c.939C>G	NP_000518.1:p.Cys313Trp	NM_000527.4:c.939C>G:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124,21600525,22364837,23725921,23788249,24404629,24418289,24636176,25053660,25356965,25404096,25741868,27854360	Autosomal dominant inheritance		1-9 / 1 000 000		germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;Genetic Testing Registry (GTR):GTR000203962;Genetic Testing Registry (GTR):GTR000260633;Genetic Testing Registry (GTR):GTR000320944;Genetic Testing Registry (GTR):GTR000321567;Genetic Testing Registry (GTR):GTR000500234;Genetic Testing Registry (GTR):GTR000500235;Genetic Testing Registry (GTR):GTR000500236;Genetic Testing Registry (GTR):GTR000512385;Genetic Testing Registry (GTR):GTR000520922;Genetic Testing Registry (GTR):GTR000521881;Genetic Testing Registry (GTR):GTR000523352;Genetic Testing Registry (GTR):GTR000523354;Genetic Testing Registry (GTR):GTR000525924;Genetic Testing Registry (GTR):GTR000528325;Genetic Testing Registry (GTR):GTR000528380;Genetic Testing Registry (GTR):GTR000528697;Genetic Testing Registry (GTR):GTR000528701;Genetic Testing Registry (GTR):GTR000552211;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000
19	11224035	T	C	Haplotype	430765	RCV000495914	246074	LDLR	NM_000527.4:c.1268T>C	NP_000518.1:p.Ile423Thr	NM_000527.4:c.1268T>C:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124,21600525,22364837,23725921,23788249,24404629,24418289,24636176,25053660,25356965,25404096,25741868,27854360	Autosomal dominant inheritance		1-9 / 1 000 000		germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;Genetic Testing Registry (GTR):GTR000203962;Genetic Testing Registry (GTR):GTR000260633;Genetic Testing Registry (GTR):GTR000320944;Genetic Testing Registry (GTR):GTR000321567;Genetic Testing Registry (GTR):GTR000500234;Genetic Testing Registry (GTR):GTR000500235;Genetic Testing Registry (GTR):GTR000500236;Genetic Testing Registry (GTR):GTR000512385;Genetic Testing Registry (GTR):GTR000520922;Genetic Testing Registry (GTR):GTR000521881;Genetic Testing Registry (GTR):GTR000523352;Genetic Testing Registry (GTR):GTR000523354;Genetic Testing Registry (GTR):GTR000525924;Genetic Testing Registry (GTR):GTR000528325;Genetic Testing Registry (GTR):GTR000528380;Genetic Testing Registry (GTR):GTR000528697;Genetic Testing Registry (GTR):GTR000528701;Genetic Testing Registry (GTR):GTR000552211;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000
19	11226873	A	C	Haplotype	3737	RCV000003935	18776	LDLR	NM_000527.4:c.1690A>C	NP_000518.1:p.Asn564His	NM_000527.4:c.1690A>C:missense variant	Pathogenic, other	other;Pathogenic	criteria provided, single submitter	no assertion criteria provided;criteria provided, single submitter	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;FH AARHUS;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	1439789,15177124,21600525,22364837,23725921,23788249,24404629,24418289,24636176,25053660,25356965,25404096,25741868,27854360,8528204,9143924	Autosomal dominant inheritance		1-9 / 1 000 000		germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;Genetic Testing Registry (GTR):GTR000203962;Genetic Testing Registry (GTR):GTR000260633;Genetic Testing Registry (GTR):GTR000320944;Genetic Testing Registry (GTR):GTR000321567;Genetic Testing Registry (GTR):GTR000500234;Genetic Testing Registry (GTR):GTR000500235;Genetic Testing Registry (GTR):GTR000500236;Genetic Testing Registry (GTR):GTR000512385;Genetic Testing Registry (GTR):GTR000520922;Genetic Testing Registry (GTR):GTR000521881;Genetic Testing Registry (GTR):GTR000523352;Genetic Testing Registry (GTR):GTR000523354;Genetic Testing Registry (GTR):GTR000525924;Genetic Testing Registry (GTR):GTR000528325;Genetic Testing Registry (GTR):GTR000528380;Genetic Testing Registry (GTR):GTR000528697;Genetic Testing Registry (GTR):GTR000528701;Genetic Testing Registry (GTR):GTR000552211;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000
19	11230901	A	C	Haplotype	430800	RCV000495898	424334	LDLR	NM_000527.4:c.1979A>C	NP_000518.1:p.Gln660Pro	NM_000527.4:c.1979A>C:missense variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124,21600525,22364837,23725921,23788249,24404629,24418289,24636176,25053660,25356965,25404096,25741868,27854360	Autosomal dominant inheritance		1-9 / 1 000 000		germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;Genetic Testing Registry (GTR):GTR000203962;Genetic Testing Registry (GTR):GTR000260633;Genetic Testing Registry (GTR):GTR000320944;Genetic Testing Registry (GTR):GTR000321567;Genetic Testing Registry (GTR):GTR000500234;Genetic Testing Registry (GTR):GTR000500235;Genetic Testing Registry (GTR):GTR000500236;Genetic Testing Registry (GTR):GTR000512385;Genetic Testing Registry (GTR):GTR000520922;Genetic Testing Registry (GTR):GTR000521881;Genetic Testing Registry (GTR):GTR000523352;Genetic Testing Registry (GTR):GTR000523354;Genetic Testing Registry (GTR):GTR000525924;Genetic Testing Registry (GTR):GTR000528325;Genetic Testing Registry (GTR):GTR000528380;Genetic Testing Registry (GTR):GTR000528697;Genetic Testing Registry (GTR):GTR000528701;Genetic Testing Registry (GTR):GTR000552211;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000
19	11238731	G	A	Haplotype	430800	RCV000495898	424344	LDLR	NM_000527.4:c.2359G>A	NP_000518.1:p.Val787Met	NM_000527.4:c.2359G>A:missense variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124,21600525,22364837,23725921,23788249,24404629,24418289,24636176,25053660,25356965,25404096,25741868,27854360	Autosomal dominant inheritance		1-9 / 1 000 000		germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;Genetic Testing Registry (GTR):GTR000203962;Genetic Testing Registry (GTR):GTR000260633;Genetic Testing Registry (GTR):GTR000320944;Genetic Testing Registry (GTR):GTR000321567;Genetic Testing Registry (GTR):GTR000500234;Genetic Testing Registry (GTR):GTR000500235;Genetic Testing Registry (GTR):GTR000500236;Genetic Testing Registry (GTR):GTR000512385;Genetic Testing Registry (GTR):GTR000520922;Genetic Testing Registry (GTR):GTR000521881;Genetic Testing Registry (GTR):GTR000523352;Genetic Testing Registry (GTR):GTR000523354;Genetic Testing Registry (GTR):GTR000525924;Genetic Testing Registry (GTR):GTR000528325;Genetic Testing Registry (GTR):GTR000528380;Genetic Testing Registry (GTR):GTR000528697;Genetic Testing Registry (GTR):GTR000528701;Genetic Testing Registry (GTR):GTR000552211;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000
19	11240191	CTCCTCGTCT	C	Haplotype	3737	RCV000003935	71434	LDLR	NM_000527.4:c.2397_2405delCGTCTTCCT	NP_000518.1:p.Val800_Leu802del	NM_000527.4:c.2397_2405delCGTCTTCCT:inframe_variant	Pathogenic, other	other;Pathogenic	criteria provided, single submitter	no assertion criteria provided;criteria provided, single submitter	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;FH AARHUS;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	1439789,15177124,21600525,22364837,23725921,23788249,24404629,24418289,24636176,25053660,25356965,25404096,25741868,27854360,8528204,9143924	Autosomal dominant inheritance		1-9 / 1 000 000		germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;Genetic Testing Registry (GTR):GTR000203962;Genetic Testing Registry (GTR):GTR000260633;Genetic Testing Registry (GTR):GTR000320944;Genetic Testing Registry (GTR):GTR000321567;Genetic Testing Registry (GTR):GTR000500234;Genetic Testing Registry (GTR):GTR000500235;Genetic Testing Registry (GTR):GTR000500236;Genetic Testing Registry (GTR):GTR000512385;Genetic Testing Registry (GTR):GTR000520922;Genetic Testing Registry (GTR):GTR000521881;Genetic Testing Registry (GTR):GTR000523352;Genetic Testing Registry (GTR):GTR000523354;Genetic Testing Registry (GTR):GTR000525924;Genetic Testing Registry (GTR):GTR000528325;Genetic Testing Registry (GTR):GTR000528380;Genetic Testing Registry (GTR):GTR000528697;Genetic Testing Registry (GTR):GTR000528701;Genetic Testing Registry (GTR):GTR000552211;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000
19	18705148	A	C	Haplotype	5706	RCV000006060	34280	CRLF1	NM_004750.4:c.1121T>G	NP_004741.1:p.Leu374Arg	NM_004750.4:c.1121T>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cold-induced sweating syndrome 1;COLD-INDUCED SWEATING SYNDROME 1	12509788,21370513		Adult	<1 / 1 000 000		germline	GeneReviews:NBK52917;Genetic Alliance:Cold-induced+sweating+syndrome+1/8000;Genetic Alliance:Crisponi+Syndrome/2012;MedGen:C1848947;OMIM:272430;Orphanet:157820
19	18710530	C	T	Haplotype	5706	RCV000006060	20745	CRLF1	NM_004750.4:c.242G>A	NP_004741.1:p.Arg81His	NM_004750.4:c.242G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Cold-induced sweating syndrome 1;COLD-INDUCED SWEATING SYNDROME 1	12509788,21370513		Adult	<1 / 1 000 000		germline	GeneReviews:NBK52917;Genetic Alliance:Cold-induced+sweating+syndrome+1/8000;Genetic Alliance:Crisponi+Syndrome/2012;MedGen:C1848947;OMIM:272430;Orphanet:157820
19	36333331	T	A	Haplotype	6872	RCV000007275	38439	NPHS1	NM_004646.3:c.2456A>T	NP_004637.1:p.Asp819Val	NM_004646.3:c.2456A>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Finnish congenital nephrotic syndrome;NEPHROTIC SYNDROME, TYPE 1	10652016	Autosomal recessive inheritance	Infancy			germline	Genetic Alliance:Congenital+Nephrotic+Syndrome+Finnish+Type/1861;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0403399;OMIM:256300;OMIM:602716.0001;OMIM:602716.0002;OMIM:602716.0003;OMIM:602716.0004;OMIM:602716.0005;OMIM:602716.0006;OMIM:602716.0007;OMIM:602716.0008;OMIM:602716.0009;OMIM:602716.0010;Office of Rare Diseases:1500;Orphanet:839;SNOMED CT:197601003
19	36339044	C	T	Haplotype	6872	RCV000007275	21911	NPHS1	NM_004646.3:c.1339G>A	NP_004637.1:p.Glu447Lys	NM_004646.3:c.1339G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Finnish congenital nephrotic syndrome;NEPHROTIC SYNDROME, TYPE 1	10652016	Autosomal recessive inheritance	Infancy			germline	Genetic Alliance:Congenital+Nephrotic+Syndrome+Finnish+Type/1861;Genetic Testing Registry (GTR):GTR000552033;MedGen:C0403399;OMIM:256300;OMIM:602716.0001;OMIM:602716.0002;OMIM:602716.0003;OMIM:602716.0004;OMIM:602716.0005;OMIM:602716.0006;OMIM:602716.0007;OMIM:602716.0008;OMIM:602716.0009;OMIM:602716.0010;Office of Rare Diseases:1500;Orphanet:839;SNOMED CT:197601003
19	38979992	AAG	A	Haplotype	29876	RCV000022757	38831	RYR1	NM_000540.2:c.5726_5727delAG	NP_000531.2:p.Glu1909Glyfs	NM_000540.2:c.5726_5727delAG:frameshift variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	20301467,20839240,22009146,23788249,27854360		Antenatal			germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598
19	38994959	C	T	Haplotype	12985	RCV000013857	28024	RYR1	NM_000540.2:c.8026C>T	NP_000531.2:p.Arg2676Trp	NM_000540.2:c.8026C>T:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Malignant hyperthermia, susceptibility to, 1;MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	14732627,14870754,16163667,16917943,20301325,23788249,25356965,27854360	Autosomal dominant inheritance	All ages			germline	GeneReviews:NBK1146;Genetic Testing Registry (GTR):GTR000246332;Genetic Testing Registry (GTR):GTR000501319;Genetic Testing Registry (GTR):GTR000501425;Genetic Testing Registry (GTR):GTR000506307;Genetic Testing Registry (GTR):GTR000506308;Genetic Testing Registry (GTR):GTR000506311;Genetic Testing Registry (GTR):GTR000506312;Genetic Testing Registry (GTR):GTR000506313;Genetic Testing Registry (GTR):GTR000506314;Genetic Testing Registry (GTR):GTR000508750;Genetic Testing Registry (GTR):GTR000520991;MedGen:CN031421;OMIM:145600;Office of Rare Diseases:3363;Orphanet:423
19	38995998	C	G	Haplotype	12985	RCV000013857	38459	RYR1	NM_000540.2:c.8360C>G	NP_000531.2:p.Thr2787Ser	NM_000540.2:c.8360C>G:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Malignant hyperthermia, susceptibility to, 1;MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	14732627,14870754,16163667,16917943,20301325,23788249,25356965,27854360	Autosomal dominant inheritance	All ages			germline	GeneReviews:NBK1146;Genetic Testing Registry (GTR):GTR000246332;Genetic Testing Registry (GTR):GTR000501319;Genetic Testing Registry (GTR):GTR000501425;Genetic Testing Registry (GTR):GTR000506307;Genetic Testing Registry (GTR):GTR000506308;Genetic Testing Registry (GTR):GTR000506311;Genetic Testing Registry (GTR):GTR000506312;Genetic Testing Registry (GTR):GTR000506313;Genetic Testing Registry (GTR):GTR000506314;Genetic Testing Registry (GTR):GTR000508750;Genetic Testing Registry (GTR):GTR000520991;MedGen:CN031421;OMIM:145600;Office of Rare Diseases:3363;Orphanet:423
19	39002893	T	C	Haplotype	29876	RCV000022757	51078	RYR1	NM_000540.2:c.9242T>C	NP_000531.2:p.Met3081Thr	NM_000540.2:c.9242T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	20301467,20839240,22009146,23788249,27854360		Antenatal			germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598
19	42364887	G	T	Haplotype	6319	RCV000033188	21358	RPS19	NM_001022.3:c.43G>T	NP_001013.1:p.Val15Phe	NM_001022.3:c.43G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Diamond-Blackfan anemia 1;DIAMOND-BLACKFAN ANEMIA 1	12586610,20301769	Autosomal dominant inheritance	Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK7047;Genetic Alliance:Diamond-Blackfan+anemia+1/8226;Genetic Testing Registry (GTR):GTR000320768;Genetic Testing Registry (GTR):GTR000510425;Genetic Testing Registry (GTR):GTR000520412;Genetic Testing Registry (GTR):GTR000525856;MedGen:C2676137;OMIM:105650;Orphanet:124
19	42365273	C	T	Haplotype	6319	RCV000033188	38387	RPS19	NM_001022.3:c.164C>T	NP_001013.1:p.Thr55Met	NM_001022.3:c.164C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Diamond-Blackfan anemia 1;DIAMOND-BLACKFAN ANEMIA 1	12586610,20301769	Autosomal dominant inheritance	Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK7047;Genetic Alliance:Diamond-Blackfan+anemia+1/8226;Genetic Testing Registry (GTR):GTR000320768;Genetic Testing Registry (GTR):GTR000510425;Genetic Testing Registry (GTR):GTR000520412;Genetic Testing Registry (GTR):GTR000525856;MedGen:C2676137;OMIM:105650;Orphanet:124
19	45411034	G	A	Haplotype	17867	RCV000019453	32888	APOE	NM_000041.3:c.61G>A	NP_000032.1:p.Glu21Lys	NM_000041.3:c.61G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hypercholesterolemia and hypertriglyceridemia, type III;HYPERCHOLESTEROLEMIA AND HYPERTRIGLYCERIDEMIA, TYPE III	1713245					germline	MedGen:C4015875
19	45411064	G	A	Haplotype	17860	RCV000019443	32899	APOE	NM_000041.3:c.91G>A	NP_000032.1:p.Glu31Lys	NM_000041.3:c.91G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA	1361196,1674745,22962670					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45411064	G	A	Haplotype	17867	RCV000019453	32899	APOE	NM_000041.3:c.91G>A	NP_000032.1:p.Glu31Lys	NM_000041.3:c.91G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hypercholesterolemia and hypertriglyceridemia, type III;HYPERCHOLESTEROLEMIA AND HYPERTRIGLYCERIDEMIA, TYPE III	1713245					germline	MedGen:C4015875
19	45411110	T	C	Haplotype	17870	RCV000019456	32909	APOE	NM_000041.3:c.137T>C	NP_000032.1:p.Leu46Pro	NM_000041.3:c.137T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	APOE4(-)-FREIBURG;APOE4(-)-FREIBURG	21500874					germline	OMIM:107741.0023
19	45411858	C	G	Haplotype	17872	RCV000019458	32911	APOE	NM_000041.3:c.305C>G	NP_000032.1:p.Pro102Arg	NM_000041.3:c.305C>G:missense variant	association	association	no assertion criteria provided	no assertion criteria provided	OMIM	APOE4 VARIANT;APOE4 VARIANT	18583979,21500874,2341812,3585172					germline	OMIM:107741.0025;OMIM:107741.0028
19	45411902	G	A	Haplotype	17873	RCV000019459	32912	APOE	NM_000041.3:c.349G>A	NP_000032.1:p.Ala117Thr	NM_000041.3:c.349G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	APOE3 VARIANT;APOE3 VARIANT	18583979,6327682					germline	OMIM:107741.0026
19	45411941	T	C	Haplotype	17855	RCV000019438	32903	APOE	NM_000041.3:c.388T>C	NP_000032.1:p.Cys130Arg	NM_000041.3:c.388T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT	1730728,21500874,22962670,25333069,2539388,6860421					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45411941	T	C	Haplotype	17869	RCV000019455	32903	APOE	NM_000041.3:c.388T>C	NP_000032.1:p.Cys130Arg	NM_000041.3:c.388T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4	21500874,22962670,8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45411941	T	C	Haplotype	17870	RCV000019456	32903	APOE	NM_000041.3:c.388T>C	NP_000032.1:p.Cys130Arg	NM_000041.3:c.388T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	APOE4(-)-FREIBURG;APOE4(-)-FREIBURG	21500874					germline	OMIM:107741.0023
19	45411941	T	C	Haplotype	17872	RCV000019458	32903	APOE	NM_000041.3:c.388T>C	NP_000032.1:p.Cys130Arg	NM_000041.3:c.388T>C:missense variant	association	association	no assertion criteria provided	no assertion criteria provided	OMIM	APOE4 VARIANT;APOE4 VARIANT	18583979,21500874,2341812,3585172					germline	OMIM:107741.0025;OMIM:107741.0028
19	45411987	G	A	Haplotype	17856	RCV000019439	32895	APOE	NM_000041.3:c.434G>A	NP_000032.1:p.Gly145Asp	NM_000041.3:c.434G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Apolipoproteinemia E1;APOLIPOPROTEINEMIA E1	6323533					germline	
19	45412031	C	T	Haplotype	17855	RCV000019438	38488	APOE	NM_000041.3:c.478C>T	NP_000032.1:p.Arg160Cys	NM_000041.3:c.478C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT	1730728,21500874,22962670,25333069,2539388,6860421					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45412040	C	T	Haplotype	17860	RCV000019443	32890	APOE	NM_000041.3:c.487C>T	NP_000032.1:p.Arg163Cys	NM_000041.3:c.487C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA	1361196,1674745,22962670					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45412061	G	C	Haplotype	17873	RCV000019459	38495	APOE	NM_000041.3:c.508G>C	NP_000032.1:p.Ala170Pro	NM_000041.3:c.508G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	APOE3 VARIANT;APOE3 VARIANT	18583979,6327682					germline	OMIM:107741.0026
19	45412079	C	T	Haplotype	17856	RCV000019439	32887	APOE	NM_000041.3:c.526C>T	NP_000032.1:p.Arg176Cys	NM_000041.3:c.526C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Apolipoproteinemia E1;APOLIPOPROTEINEMIA E1	6323533					germline	
19	45412079	C	T	Haplotype	17866	RCV000019452	32887	APOE	NM_000041.3:c.526C>T	NP_000032.1:p.Arg176Cys	NM_000041.3:c.526C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III	22962670,8664327					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45412079	C	T	Haplotype	17868	RCV000019454	32887	APOE	NM_000041.3:c.526C>T	NP_000032.1:p.Arg176Cys	NM_000041.3:c.526C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2	22962670,8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45412278	G	A	Haplotype	17866	RCV000019452	38490	APOE	NM_000041.3:c.725G>A	NP_000032.1:p.Arg242Gln	NM_000041.3:c.725G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III	22962670,8664327					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45412314	T	A	Haplotype	17868	RCV000019454	38491	APOE	NM_000041.3:c.761T>A	NP_000032.1:p.Val254Glu	NM_000041.3:c.761T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2	22962670,8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45412337	G	A	Haplotype	17854	RCV000019435	32893	APOE	NM_000041.3:c.784G>A	NP_000032.1:p.Glu262Lys	NM_000041.3:c.784G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE7	22962670,2470732,2738044,7586659					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45412340	G	A	Haplotype	17854	RCV000019435	38487	APOE	NM_000041.3:c.787G>A	NP_000032.1:p.Glu263Lys	NM_000041.3:c.787G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE7	22962670,2470732,2738044,7586659					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	45412358	C	G	Haplotype	17869	RCV000019455	38492	APOE	NM_000041.3:c.805C>G	NP_000032.1:p.Arg269Gly	NM_000041.3:c.805C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4	21500874,22962670,8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005
19	47258781	C	A	Phase unknown	224674	RCV000226653	226485	FKRP	NM_024301.4:c.74C>A	NP_077277.1:p.Ser25Ter	NM_024301.4:c.74C>A:nonsense	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Center for Genetic Medicine Research,Children's National Medical Center	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	27854218	Autosomal recessive inheritance	Adolescent	1-9 / 100 000		unknown	Genetic Alliance:Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754;Genetic Testing Registry (GTR):GTR000501782;Genetic Testing Registry (GTR):GTR000502397;Genetic Testing Registry (GTR):GTR000502450;Genetic Testing Registry (GTR):GTR000506307;Genetic Testing Registry (GTR):GTR000506308;Genetic Testing Registry (GTR):GTR000506321;Genetic Testing Registry (GTR):GTR000506322;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520475;Genetic Testing Registry (GTR):GTR000520476;MedGen:C1846672;OMIM:606596.0004;OMIM:606596.0005;OMIM:606596.0006;OMIM:606596.0011;OMIM:606596.0012;OMIM:606596.0013;OMIM:606596.0014;OMIM:606596.0015;OMIM:606596.0016;OMIM:607155;Orphanet:34515
19	47258781	CGT	C	Phase unknown	224674	RCV000226653	226486	FKRP	NM_024301.4:c.76_77delTG	NP_077277.1:p.Trp26Alafs	NM_024301.4:c.76_77delTG:frameshift variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Center for Genetic Medicine Research,Children's National Medical Center	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	27854218	Autosomal recessive inheritance	Adolescent	1-9 / 100 000		unknown	Genetic Alliance:Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754;Genetic Testing Registry (GTR):GTR000501782;Genetic Testing Registry (GTR):GTR000502397;Genetic Testing Registry (GTR):GTR000502450;Genetic Testing Registry (GTR):GTR000506307;Genetic Testing Registry (GTR):GTR000506308;Genetic Testing Registry (GTR):GTR000506321;Genetic Testing Registry (GTR):GTR000506322;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520475;Genetic Testing Registry (GTR):GTR000520476;MedGen:C1846672;OMIM:606596.0004;OMIM:606596.0005;OMIM:606596.0006;OMIM:606596.0011;OMIM:606596.0012;OMIM:606596.0013;OMIM:606596.0014;OMIM:606596.0015;OMIM:606596.0016;OMIM:607155;Orphanet:34515
19	47259533	C	A	Phase unknown	224674	RCV000226653	19260	FKRP	NM_024301.4:c.826C>A	NP_077277.1:p.Leu276Ile	NM_024301.4:c.826C>A:missense variant	Likely pathogenic	Likely pathogenic	criteria provided, single submitter	criteria provided, single submitter	Center for Genetic Medicine Research,Children's National Medical Center	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	27854218	Autosomal recessive inheritance	Adolescent	1-9 / 100 000		unknown	Genetic Alliance:Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754;Genetic Testing Registry (GTR):GTR000501782;Genetic Testing Registry (GTR):GTR000502397;Genetic Testing Registry (GTR):GTR000502450;Genetic Testing Registry (GTR):GTR000506307;Genetic Testing Registry (GTR):GTR000506308;Genetic Testing Registry (GTR):GTR000506321;Genetic Testing Registry (GTR):GTR000506322;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520475;Genetic Testing Registry (GTR):GTR000520476;MedGen:C1846672;OMIM:606596.0004;OMIM:606596.0005;OMIM:606596.0006;OMIM:606596.0011;OMIM:606596.0012;OMIM:606596.0013;OMIM:606596.0014;OMIM:606596.0015;OMIM:606596.0016;OMIM:607155;Orphanet:34515
19	49468583	C	T	Haplotype	427576	RCV000017941	31516	FTL	NM_000146.3:c.-182C>T		NM_000146.3:c.-182C>T:5 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hyperferritinemia cataract syndrome;HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	23421845,9226182		All ages	<1 / 1 000 000		germline	Genetic Alliance:Hyperferritinemia+cataract+syndrome/3553;Genetics Home Reference:hyperferritinemia-cataract-syndrome;MedGen:C1833213;OMIM:134790.0001;OMIM:134790.0002;OMIM:134790.0003;OMIM:134790.0004;OMIM:134790.0005;OMIM:134790.0006;OMIM:134790.0007;OMIM:134790.0008;OMIM:134790.0009;OMIM:134790.0011;OMIM:134790.0012;OMIM:134790.0017;OMIM:134790.0020;OMIM:600886;Office of Rare Diseases:2806;Orphanet:163
19	49468587	T	G	Haplotype	427576	RCV000017941	260732	FTL	NM_000146.3:c.-178T>G		NM_000146.3:c.-178T>G:5 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Hyperferritinemia cataract syndrome;HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	23421845,9226182		All ages	<1 / 1 000 000		germline	Genetic Alliance:Hyperferritinemia+cataract+syndrome/3553;Genetics Home Reference:hyperferritinemia-cataract-syndrome;MedGen:C1833213;OMIM:134790.0001;OMIM:134790.0002;OMIM:134790.0003;OMIM:134790.0004;OMIM:134790.0005;OMIM:134790.0006;OMIM:134790.0007;OMIM:134790.0008;OMIM:134790.0009;OMIM:134790.0011;OMIM:134790.0012;OMIM:134790.0017;OMIM:134790.0020;OMIM:600886;Office of Rare Diseases:2806;Orphanet:163
19	49519883	A	G	Haplotype	14414	RCV000015495	38465	LHB	NM_000894.2:c.104T>C	NP_000885.1:p.Ile35Thr	NM_000894.2:c.104T>C:missense variant	Benign	Benign	no assertion criteria provided	no assertion criteria provided	OMIM	LUTEINIZING HORMONE POLYMORPHISM;LUTEINIZING HORMONE POLYMORPHISM	10199775,10323405,10739843,12620433,1727817,7714098,7904610,8784083					germline	OMIM:152780.0002
19	49519905	A	G	Haplotype	14414	RCV000015495	29453	LHB	NM_000894.2:c.82T>C	NP_000885.1:p.Trp28Arg	NM_000894.2:c.82T>C:missense variant	Benign	Benign	no assertion criteria provided	no assertion criteria provided	OMIM	LUTEINIZING HORMONE POLYMORPHISM;LUTEINIZING HORMONE POLYMORPHISM	10199775,10323405,10739843,12620433,1727817,7714098,7904610,8784083					germline	OMIM:152780.0002
20	4680251	A	G	Haplotype	13399	RCV000014336	28436	PRNP	NM_000311.4:c.385A>G	NP_000302.1:p.Met129Val	NM_000311.4:c.385A>G:missense variant;NM_001271561.1:c.*74A>G:3 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Jakob-Creutzfeldt disease;CREUTZFELDT-JAKOB DISEASE	10581230,12205650,1353341,1353342,1469441,16227536,1671440,1671983,1684756,19038218,20298421,20301407,7709737,9751723		Adult			germline	GeneReviews:NBK1229;Genetic Alliance:Creutzfeldt-Jakob+Disease/2006;MedGen:C0022336;OMIM:123400;Office of Rare Diseases:6956;Orphanet:204;Orphanet:282166;Orphanet:454700;SNOMED CT:792004
20	4680251	A	G	Haplotype	13399	RCV000014337	28436	PRNP	NM_000311.4:c.385A>G	NP_000302.1:p.Met129Val	NM_000311.4:c.385A>G:missense variant;NM_001271561.1:c.*74A>G:3 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Fatal familial insomnia	10581230,12205650,1353341,1353342,1469441,16227536,1671440,1671983,1684756,19038218,20301407,7709737,9751723		Adult	<1 / 1 000 000		germline	GeneReviews:NBK1229;Genetic Alliance:Fatal+Familial+Insomnia/2793;MedGen:C0206042;OMIM:600072;Orphanet:466;SNOMED CT:83157008
20	4680398	G	A	Haplotype	13399	RCV000014336	28438	PRNP	NM_000311.4:c.532G>A	NP_000302.1:p.Asp178Asn	NM_000311.4:c.532G>A:missense variant;NM_001271561.1:c.*221G>A:3 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Jakob-Creutzfeldt disease;CREUTZFELDT-JAKOB DISEASE	10581230,12205650,1353341,1353342,1469441,16227536,1671440,1671983,1684756,19038218,20298421,20301407,7709737,9751723		Adult			germline	GeneReviews:NBK1229;Genetic Alliance:Creutzfeldt-Jakob+Disease/2006;MedGen:C0022336;OMIM:123400;Office of Rare Diseases:6956;Orphanet:204;Orphanet:282166;Orphanet:454700;SNOMED CT:792004
20	4680398	G	A	Haplotype	13399	RCV000014337	28438	PRNP	NM_000311.4:c.532G>A	NP_000302.1:p.Asp178Asn	NM_000311.4:c.532G>A:missense variant;NM_001271561.1:c.*221G>A:3 prime UTR variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Fatal familial insomnia	10581230,12205650,1353341,1353342,1469441,16227536,1671440,1671983,1684756,19038218,20301407,7709737,9751723		Adult	<1 / 1 000 000		germline	GeneReviews:NBK1229;Genetic Alliance:Fatal+Familial+Insomnia/2793;MedGen:C0206042;OMIM:600072;Orphanet:466;SNOMED CT:83157008
20	10393439	C	A	Haplotype	5308	RCV000005632	38435	MKKS	NM_170784.2:c.724G>T	NP_740754.1:p.Ala242Ser	NM_170784.2:c.724G>T:missense variant;NR_072977.1:n.364-3988G>T:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	McKusick Kaufman syndrome;MCKUSICK-KAUFMAN SYNDROME	10802661,16104012,20301675		Childhood			germline	GeneReviews:NBK1502;Genetic Alliance:McKusick+Kaufman+syndrome/4529;MedGen:C0948368;OMIM:236700;Office of Rare Diseases:3427;Orphanet:2473
20	10393913	G	A	Haplotype	5308	RCV000005632	20347	MKKS	NM_170784.2:c.250C>T	NP_740754.1:p.His84Tyr	NM_170784.2:c.250C>T:missense variant;NR_072977.1:n.364-4462C>T:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	McKusick Kaufman syndrome;MCKUSICK-KAUFMAN SYNDROME	10802661,16104012,20301675		Childhood			germline	GeneReviews:NBK1502;Genetic Alliance:McKusick+Kaufman+syndrome/4529;MedGen:C0948368;OMIM:236700;Office of Rare Diseases:3427;Orphanet:2473
20	39742755	A	G	Haplotype	16773	RCV000018261	31812	PLCG1-AS1	NM_003286.3:c.1598A>G	NP_003277.1:p.Asp533Gly	NM_003286.3:c.1598A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	DNA topoisomerase I, camptothecin-resistant;DNA TOPOISOMERASE I, CAMPTOTHECIN-RESISTANT	1849260					germline	MedGen:C4016020
20	43255143	G	C	Haplotype	1981	RCV000002058	38420	ADA	NM_000022.3:c.316C>G	NP_001308979.1:p.Thr9=	NM_000022.3:c.316C>G:missense variant;NM_001322050.1:c.27C>G:synonymous variant;NR_136160.1:n.467C>G:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency;SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	3304460,9361033					germline	MedGen:C0392607
20	43255169	T	C	Haplotype	1981	RCV000002058	17020	ADA	NM_000022.3:c.290A>G	NP_000013.2:p.Tyr97Cys	NM_000022.3:c.290A>G:missense variant;NR_136160.1:n.441A>G:non-coding transcript variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency;SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	3304460,9361033					germline	MedGen:C0392607
20	62044831	G	T	Haplotype	369808	RCV000408720	390693	KCNQ2	NM_172107.3:c.1735C>A	NP_742105.1:p.Leu579Met	NM_172107.3:c.1735C>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Early infantile epileptic encephalopathy 7	20437616,25818041		Infancy	<1 / 1 000 000		germline	GeneReviews:NBK32534;Genetic Alliance:Epileptic+encephalopathy%2C+early+infantile%2C+7/8345;MedGen:C3150986;OMIM:613720;Orphanet:439218
20	62044832	C	T	Haplotype	369808	RCV000408720	390692	KCNQ2	NM_172107.3:c.1734G>A	NP_742105.1:p.Met578Ile	NM_172107.3:c.1734G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Early infantile epileptic encephalopathy 7	20437616,25818041		Infancy	<1 / 1 000 000		germline	GeneReviews:NBK32534;Genetic Alliance:Epileptic+encephalopathy%2C+early+infantile%2C+7/8345;MedGen:C3150986;OMIM:613720;Orphanet:439218
21	37833740	A	T	Haplotype	375673	RCV000417144	19890	CLDN14	NM_012130.3:c.254T>A	NP_036262.1:p.Val85Asp	NM_001146077.1:c.254T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	Laboratory of Molecular Genetics,National Institutes of Health	Perrault Syndrome;Deafness;Primary ovarian insufficiency;Perrault Syndrome						germline	Illumina Clinical Services Laboratory,Illumina:37522;MedGen:CN239459
21	47551895	G	A	Haplotype	29642	RCV000022490	38596	COL6A2	NM_001849.3:c.2489G>A	NP_001840.3:p.Arg830Gln	NM_001849.3:c.2489G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE;BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE	18852439,19949035					germline	OMIM:120240.0011;OMIM:120240.0017;OMIM:120240.0018;OMIM:120240.0019
21	47551933	C	T	Haplotype	29642	RCV000022490	38597	COL6A2	NM_001849.3:c.2527C>T	NP_001840.3:p.Arg843Trp	NM_001849.3:c.2527C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE;BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE	18852439,19949035					germline	OMIM:120240.0011;OMIM:120240.0017;OMIM:120240.0018;OMIM:120240.0019
22	24109650	C	G	Haplotype	180222	RCV000157071	178410	CHCHD10	NM_213720.2:c.172G>C	NP_998885.1:p.Gly58Arg	NM_213720.2:c.172G>C:missense variant;NR_125755.1:n.217G>C:non-coding transcript variant;NR_125756.1:n.139+371G>C:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Myopathy, isolated mitochondrial, autosomal dominant;MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT (1 family)	25193783,9324076		Childhood	<1 / 1 000 000		germline	MedGen:C4015513;OMIM:616209;Orphanet:457050
22	24109650	C	G	Haplotype	204293	RCV000192234	178410	CHCHD10	NM_213720.2:c.172G>C	NP_998885.1:p.Gly58Arg	NM_213720.2:c.172G>C:missense variant;NR_125755.1:n.217G>C:non-coding transcript variant;NR_125756.1:n.139+371G>C:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Myopathy, isolated mitochondrial, autosomal dominant;Myopathy, isolated mitochondrial, autosomal dominant	2519378		Childhood	<1 / 1 000 000		germline	MedGen:C4015513;OMIM:616209;Orphanet:457050
22	24109779	G	C	Haplotype	204293	RCV000192234	200690	CHCHD10	NM_213720.2:c.43C>G	NP_998885.1:p.Arg15Gly	NM_213720.2:c.43C>G:missense variant;NR_125755.1:n.140-52C>G:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	GeneReviews	Myopathy, isolated mitochondrial, autosomal dominant;Myopathy, isolated mitochondrial, autosomal dominant	2519378		Childhood	<1 / 1 000 000		germline	MedGen:C4015513;OMIM:616209;Orphanet:457050
22	24109779	G	T	Haplotype	180222	RCV000157071	178409	CHCHD10	NM_213720.2:c.43C>A	NP_998885.1:p.Arg15Ser	NM_213720.2:c.43C>A:missense variant;NR_125755.1:n.140-52C>A:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Myopathy, isolated mitochondrial, autosomal dominant;MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT (1 family)	25193783,9324076		Childhood	<1 / 1 000 000		germline	MedGen:C4015513;OMIM:616209;Orphanet:457050
22	25625439	C	A	Haplotype	217348	RCV000203383	214001	CRYBB2	NM_000496.2:c.343C>A	NP_000487.1:p.Pro115Thr	NM_000496.2:c.343C>A:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Eye Genetics Research Group,Children's Medical Research Institute	Congenital cataract	26694549					de novo	Human Phenotype Ontology:HP:0000519;Human Phenotype Ontology:HP:0001108;Human Phenotype Ontology:HP:0007679;Human Phenotype Ontology:HP:0007726;Human Phenotype Ontology:HP:0007788;MedGen:C1842324
22	25625451	G	A	Haplotype	217348	RCV000203383	214002	CRYBB2	NM_000496.2:c.355G>A	NP_000487.1:p.Gly119Arg	NM_000496.2:c.355G>A:missense variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Eye Genetics Research Group,Children's Medical Research Institute	Congenital cataract	26694549					de novo	Human Phenotype Ontology:HP:0000519;Human Phenotype Ontology:HP:0001108;Human Phenotype Ontology:HP:0007679;Human Phenotype Ontology:HP:0007726;Human Phenotype Ontology:HP:0007788;MedGen:C1842324
22	36661906	A	G	Haplotype	6080	RCV000006453	21119	APOL1	NM_145343.2:c.1072A>G	NP_663318.1:p.Ser358Gly	NM_145343.2:c.1072A>G:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Focal segmental glomerulosclerosis 4, susceptibility to;FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO	20647424,24206458		Childhood			germline	Genetic Alliance:Focal+segmental+glomerulosclerosis+4%2C+susceptibility+to/8438;MedGen:C2675525;OMIM:612551;Orphanet:84271
22	36662034	T	G	Haplotype	6080	RCV000006453	76004	APOL1	NM_145343.2:c.1200T>G	NP_663318.1:p.Ile400Met	NM_145343.2:c.1200T>G:missense variant	risk factor	risk factor	no assertion criteria provided	no assertion criteria provided	OMIM	Focal segmental glomerulosclerosis 4, susceptibility to;FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO	20647424,24206458		Childhood			germline	Genetic Alliance:Focal+segmental+glomerulosclerosis+4%2C+susceptibility+to/8438;MedGen:C2675525;OMIM:612551;Orphanet:84271
22	40757623	G	C	Haplotype	208488	RCV000190501	205025	ADSL	NM_000026.3:c.994G>C	NP_000017.1:p.Asp332His	NM_000026.3:c.994G>C:missense variant;NR_134256.1:n.1053G>C:non-coding transcript variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Adenylosuccinate lyase deficiency;Adenylosuccinate lyase deficiency	10090474,23519317	Autosomal recessive inheritance	Childhood	<1 / 1 000 000		germline	Genetic Alliance:Adenylosuccinase+Deficiency/230;Genetic Testing Registry (GTR):GTR000500613;Genetic Testing Registry (GTR):GTR000500614;Genetic Testing Registry (GTR):GTR000506349;Genetic Testing Registry (GTR):GTR000514881;Genetic Testing Registry (GTR):GTR000515526;Genetic Testing Registry (GTR):GTR000520979;Genetic Testing Registry (GTR):GTR000520995;Genetic Testing Registry (GTR):GTR000520996;Genetic Testing Registry (GTR):GTR000529343;Genetic Testing Registry (GTR):GTR000551668;MedGen:C0268126;OMIM:103050;Office of Rare Diseases:550;Orphanet:46;SNOMED CT:15285008
22	40760969	G	A	Haplotype	208488	RCV000190501	17501	ADSL	NM_000026.3:c.1277G>A	NP_000017.1:p.Arg426His	NM_000026.3:c.1277G>A:missense variant;NM_001123378.1:c.1191+600G>A:intron variant;NR_134256.1:n.1367G>A:non-coding transcript variant	Likely pathogenic	Likely pathogenic	no assertion criteria provided	no assertion criteria provided	Mendelics Analise Genomica	Adenylosuccinate lyase deficiency;Adenylosuccinate lyase deficiency	10090474,23519317	Autosomal recessive inheritance	Childhood	<1 / 1 000 000		germline	Genetic Alliance:Adenylosuccinase+Deficiency/230;Genetic Testing Registry (GTR):GTR000500613;Genetic Testing Registry (GTR):GTR000500614;Genetic Testing Registry (GTR):GTR000506349;Genetic Testing Registry (GTR):GTR000514881;Genetic Testing Registry (GTR):GTR000515526;Genetic Testing Registry (GTR):GTR000520979;Genetic Testing Registry (GTR):GTR000520995;Genetic Testing Registry (GTR):GTR000520996;Genetic Testing Registry (GTR):GTR000529343;Genetic Testing Registry (GTR):GTR000551668;MedGen:C0268126;OMIM:103050;Office of Rare Diseases:550;Orphanet:46;SNOMED CT:15285008
X	13768812	TCTCAAACACTTGGG	T	Haplotype	11542	RCV000012298	76962	OFD1	NM_003611.2:c.936-550_936-537delACACTTGGGCTCAA		NM_003611.2:c.936-550_936-537delACACTTGGGCTCAA:intron variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Oral-facial-digital syndrome;OROFACIODIGITAL SYNDROME I	15221448,20301367	X-linked inheritance	Infancy	1-9 / 1 000 000;Estimates range from 1:250,000 to 1:50,000.		germline	GeneReviews:NBK1188;Genetic Alliance:Orofaciodigital+syndromes/5428;Genetic Testing Registry (GTR):GTR000322591;Genetic Testing Registry (GTR):GTR000500143;Genetic Testing Registry (GTR):GTR000500190;Genetic Testing Registry (GTR):GTR000501489;Genetic Testing Registry (GTR):GTR000501490;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000514882;Genetic Testing Registry (GTR):GTR000519097;Genetic Testing Registry (GTR):GTR000520051;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000528542;Genetic Testing Registry (GTR):GTR000552165;MedGen:C1510460;OMIM:311200;Office of Rare Diseases:4121;Orphanet:2750;SNOMED CT:52868006
X	22112123	T	C	Haplotype	10818	RCV000011565	25857	PHEX	NM_000444.5:c.755T>C	NP_000435.3:p.Phe252Ser	NM_000444.5:c.755T>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial X-linked hypophosphatemic vitamin D refractory rickets;HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	22319799,7550339,9106524		Childhood			germline	GeneReviews:NBK83985;Genetic Alliance:Familial+Hypophosphatemic+Rickets/2752;MedGen:C0733682;OMIM:307800;Office of Rare Diseases:6735;Orphanet:89936;SNOMED CT:82236004
X	22112127	G	A	Haplotype	10818	RCV000011565	38453	PHEX	NM_000444.5:c.759G>A	NP_000435.3:p.Met253Ile	NM_000444.5:c.759G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Familial X-linked hypophosphatemic vitamin D refractory rickets;HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	22319799,7550339,9106524		Childhood			germline	GeneReviews:NBK83985;Genetic Alliance:Familial+Hypophosphatemic+Rickets/2752;MedGen:C0733682;OMIM:307800;Office of Rare Diseases:6735;Orphanet:89936;SNOMED CT:82236004
X	100658834	G	A	Haplotype	10723	RCV000011470	38452	RPL36A-HNRNPH2	NM_000169.2:c.334C>T	NP_000160.1:p.Arg112Cys	NM_000169.2:c.334C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Fabry disease;FABRY DISEASE	12735292,1315715,16980809,20301469,20505683,20610207,21934708,23788249,23860966,25173338,25355838,25356965,27854360	Autosomal recessive inheritance;X-linked inheritance;X-linked recessive inheritance	Childhood	1-9 / 1 000 000	Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function	germline	GeneReviews:NBK1292;Genetic Alliance:Fabry+Disease/2690;Genetic Testing Registry (GTR):GTR000246735;Genetic Testing Registry (GTR):GTR000260631;Genetic Testing Registry (GTR):GTR000311196;Genetic Testing Registry (GTR):GTR000325415;Genetic Testing Registry (GTR):GTR000326183;Genetic Testing Registry (GTR):GTR000327665;Genetic Testing Registry (GTR):GTR000330580;Genetic Testing Registry (GTR):GTR000337467;Genetic Testing Registry (GTR):GTR000500007;Genetic Testing Registry (GTR):GTR000500441;Genetic Testing Registry (GTR):GTR000502877;Genetic Testing Registry (GTR):GTR000502896;Genetic Testing Registry (GTR):GTR000502949;Genetic Testing Registry (GTR):GTR000502955;Genetic Testing Registry (GTR):GTR000503037;Genetic Testing Registry (GTR):GTR000503042;Genetic Testing Registry (GTR):GTR000503199;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000505068;Genetic Testing Registry (GTR):GTR000507480;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000512526;Genetic Testing Registry (GTR):GTR000514924;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519384;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520414;Genetic Testing Registry (GTR):GTR000520447;Genetic Testing Registry (GTR):GTR000522329;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528500;Genetic Testing Registry (GTR):GTR000528516;Genetic Testing Registry (GTR):GTR000528528;Genetic Testing Registry (GTR):GTR000528536;Genetic Testing Registry (GTR):GTR000551442;Genetic Testing Registry (GTR):GTR000552214;Genetics Home Reference:fabry-disease;MedGen:C0002986;OMIM:301500;Office of Rare Diseases:6400;Orphanet:324;SNOMED CT:16652001
X	100658972	C	G	Haplotype	10723	RCV000011470	25762	RPL36A-HNRNPH2	NM_000169.2:c.196G>C	NP_000160.1:p.Glu66Gln	NM_000169.2:c.196G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Fabry disease;FABRY DISEASE	12735292,1315715,16980809,20301469,20505683,20610207,21934708,23788249,23860966,25173338,25355838,25356965,27854360	Autosomal recessive inheritance;X-linked inheritance;X-linked recessive inheritance	Childhood	1-9 / 1 000 000	Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function	germline	GeneReviews:NBK1292;Genetic Alliance:Fabry+Disease/2690;Genetic Testing Registry (GTR):GTR000246735;Genetic Testing Registry (GTR):GTR000260631;Genetic Testing Registry (GTR):GTR000311196;Genetic Testing Registry (GTR):GTR000325415;Genetic Testing Registry (GTR):GTR000326183;Genetic Testing Registry (GTR):GTR000327665;Genetic Testing Registry (GTR):GTR000330580;Genetic Testing Registry (GTR):GTR000337467;Genetic Testing Registry (GTR):GTR000500007;Genetic Testing Registry (GTR):GTR000500441;Genetic Testing Registry (GTR):GTR000502877;Genetic Testing Registry (GTR):GTR000502896;Genetic Testing Registry (GTR):GTR000502949;Genetic Testing Registry (GTR):GTR000502955;Genetic Testing Registry (GTR):GTR000503037;Genetic Testing Registry (GTR):GTR000503042;Genetic Testing Registry (GTR):GTR000503199;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000505068;Genetic Testing Registry (GTR):GTR000507480;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000512526;Genetic Testing Registry (GTR):GTR000514924;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519384;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520414;Genetic Testing Registry (GTR):GTR000520447;Genetic Testing Registry (GTR):GTR000522329;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528500;Genetic Testing Registry (GTR):GTR000528516;Genetic Testing Registry (GTR):GTR000528528;Genetic Testing Registry (GTR):GTR000528536;Genetic Testing Registry (GTR):GTR000551442;Genetic Testing Registry (GTR):GTR000552214;Genetics Home Reference:fabry-disease;MedGen:C0002986;OMIM:301500;Office of Rare Diseases:6400;Orphanet:324;SNOMED CT:16652001
X	107823943	G	T	Haplotype	10464	RCV000011210	35671	COL4A5	NM_033380.2:c.866G>T	NP_203699.1:p.Gly289Val	NM_000495.4:c.866G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Alport syndrome, X-linked recessive;ALPORT SYNDROME, X-LINKED	20301386,22166944,7706490,9195222		Childhood	1-9 / 100 000		germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome/335;MedGen:C1567742;OMIM:301050;Orphanet:63;Orphanet:88917
X	107929326	C	T	Haplotype	10464	RCV000011210	38451	COL4A5	NM_033380.2:c.4282C>T	NP_203699.1:p.Arg1428Cys	NM_000495.4:c.4264C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Alport syndrome, X-linked recessive;ALPORT SYNDROME, X-LINKED	20301386,22166944,7706490,9195222		Childhood	1-9 / 100 000		germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome/335;MedGen:C1567742;OMIM:301050;Orphanet:63;Orphanet:88917
X	135738552	T	A	Haplotype	11158	RCV000011908	26197	CD40LG	NM_000074.2:c.384T>A	NP_000065.1:p.Ser128Arg	NM_000074.2:c.384T>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Immunodeficiency with hyper IgM type 1;IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	20301576,7678782					germline	GeneReviews:NBK1402;Genetic Alliance:Immunodeficiency+with+hyper+IgM+type+1/3776;MedGen:C0398689;OMIM:308230;Office of Rare Diseases:73
X	135738554	A	G	Haplotype	11158	RCV000011908	38454	CD40LG	NM_000074.2:c.386A>G	NP_000065.1:p.Glu129Gly	NM_000074.2:c.386A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Immunodeficiency with hyper IgM type 1;IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	20301576,7678782					germline	GeneReviews:NBK1402;Genetic Alliance:Immunodeficiency+with+hyper+IgM+type+1/3776;MedGen:C0398689;OMIM:308230;Office of Rare Diseases:73
X	148564464	C	G	Haplotype	10502	RCV000011248	25541	IDS	NM_000202.7:c.1466G>C	NP_000193.1:p.Gly489Ala	NM_000202.7:c.1466G>C:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Mucopolysaccharidosis, MPS-II;MUCOPOLYSACCHARIDOSIS, TYPE II	12794697,20301451,21863056,25071396	X-linked recessive inheritance	Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;Genetic Testing Registry (GTR):GTR000317503;Genetic Testing Registry (GTR):GTR000502138;Genetic Testing Registry (GTR):GTR000502487;Genetic Testing Registry (GTR):GTR000502489;Genetic Testing Registry (GTR):GTR000502916;Genetic Testing Registry (GTR):GTR000506477;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000520051;Genetic Testing Registry (GTR):GTR000521892;Genetic Testing Registry (GTR):GTR000522252;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000551442;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009
X	148564466	C	A	Haplotype	10502	RCV000011248	38394	IDS	NM_000202.7:c.1464G>T	NP_000193.1:p.Met488Ile	NM_000202.7:c.1464G>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Mucopolysaccharidosis, MPS-II;MUCOPOLYSACCHARIDOSIS, TYPE II	12794697,20301451,21863056,25071396	X-linked recessive inheritance	Childhood	1-9 / 1 000 000		germline	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;Genetic Testing Registry (GTR):GTR000317503;Genetic Testing Registry (GTR):GTR000502138;Genetic Testing Registry (GTR):GTR000502487;Genetic Testing Registry (GTR):GTR000502489;Genetic Testing Registry (GTR):GTR000502916;Genetic Testing Registry (GTR):GTR000506477;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000520051;Genetic Testing Registry (GTR):GTR000521892;Genetic Testing Registry (GTR):GTR000522252;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000551442;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009
X	148564527	C	T	Haplotype	221203	RCV000204179	25537	IDS	NM_000202.7:c.1403G>A	NP_000193.1:p.Arg468Gln	NM_000202.7:c.1403G>A:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	Mucopolysaccharidosis, MPS-II	18414213,20301451,21863056,25071396	X-linked recessive inheritance	Childhood	1-9 / 1 000 000		maternal	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;Genetic Testing Registry (GTR):GTR000317503;Genetic Testing Registry (GTR):GTR000502138;Genetic Testing Registry (GTR):GTR000502487;Genetic Testing Registry (GTR):GTR000502489;Genetic Testing Registry (GTR):GTR000502916;Genetic Testing Registry (GTR):GTR000506477;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000520051;Genetic Testing Registry (GTR):GTR000521892;Genetic Testing Registry (GTR):GTR000522252;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000551442;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009
X	148564536	T	A	Haplotype	221203	RCV000204179	222899	IDS	NM_000202.7:c.1394A>T	NP_000193.1:p.Gln465Leu	NM_000202.7:c.1394A>T:missense variant	Pathogenic	Pathogenic	criteria provided, single submitter	criteria provided, single submitter	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	Mucopolysaccharidosis, MPS-II	18414213,20301451,21863056,25071396	X-linked recessive inheritance	Childhood	1-9 / 1 000 000		maternal	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;Genetic Testing Registry (GTR):GTR000317503;Genetic Testing Registry (GTR):GTR000502138;Genetic Testing Registry (GTR):GTR000502487;Genetic Testing Registry (GTR):GTR000502489;Genetic Testing Registry (GTR):GTR000502916;Genetic Testing Registry (GTR):GTR000506477;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000520051;Genetic Testing Registry (GTR):GTR000521892;Genetic Testing Registry (GTR):GTR000522252;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000551442;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009
X	153762605	G	A	Haplotype	10392	RCV000011127	25430	G6PD	NM_000402.4:c.682C>T	NP_000393.4:p.Arg228Cys	NM_001042351.2:c.592C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Chronic granuloma and hemolytic anemia;CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	1353664,4125296					germline	MedGen:C4016535
X	153762653	G	A	Haplotype	10392	RCV000011127	38393	G6PD	NM_000402.4:c.634C>T	NP_000393.4:p.Arg212Trp	NM_001042351.2:c.544C>T:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Chronic granuloma and hemolytic anemia;CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	1353664,4125296					germline	MedGen:C4016535
X	153762655	T	A	Haplotype	10382	RCV000011109	25421	G6PD	NM_000402.4:c.632A>T	NP_000393.4:p.Asp211Val	NM_001042351.2:c.542A>T:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD SANTAMARIA;G6PD SANTAMARIA	1978554,1999409,6433630,8956035					germline	OMIM:305900.0023
X	153763492	T	C	Haplotype	10361	RCV000011075	25399	G6PD	NM_000402.4:c.466A>G	NP_000393.4:p.Asn156Asp	NM_001042351.2:c.376A>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Glucose 6 phosphate dehydrogenase deficiency;G6PD A-	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703	X-linked recessive inheritance				germline	Genetic Alliance:Glucose+6+Phosphate+Dehydrogenase+Deficiency/3096;Genetic Testing Registry (GTR):GTR000500957;Genetic Testing Registry (GTR):GTR000503100;Genetic Testing Registry (GTR):GTR000503114;Genetic Testing Registry (GTR):GTR000520114;Genetics Home Reference:glucose-6-phosphate-dehydrogenase-deficiency;MedGen:C0017758;Office of Rare Diseases:6520
X	153763492	T	C	Haplotype	10361	RCV000011076	25399	G6PD	NM_000402.4:c.466A>G	NP_000393.4:p.Asn156Asp	NM_001042351.2:c.376A>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD BETICA	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703					germline	OMIM:305900.0002
X	153763492	T	C	Haplotype	10361	RCV000011077	25399	G6PD	NM_000402.4:c.466A>G	NP_000393.4:p.Asn156Asp	NM_001042351.2:c.376A>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD CASTILLA	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703					germline	OMIM:305900.0002
X	153763492	T	C	Haplotype	10361	RCV000011078	25399	G6PD	NM_000402.4:c.466A>G	NP_000393.4:p.Asn156Asp	NM_001042351.2:c.376A>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD DISTRITO FEDERAL	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703					germline	OMIM:305900.0002
X	153763492	T	C	Haplotype	10361	RCV000011079	25399	G6PD	NM_000402.4:c.466A>G	NP_000393.4:p.Asn156Asp	NM_001042351.2:c.376A>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD TEPIC	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703					germline	OMIM:305900.0002
X	153763492	T	C	Haplotype	10382	RCV000011109	25399	G6PD	NM_000402.4:c.466A>G	NP_000393.4:p.Asn156Asp	NM_001042351.2:c.376A>G:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD SANTAMARIA;G6PD SANTAMARIA	1978554,1999409,6433630,8956035					germline	OMIM:305900.0023
X	153763551	G	C	Haplotype	10392	RCV000011127	25431	G6PD	NM_000402.4:c.407C>G	NP_000393.4:p.Ser136Cys	NM_001042351.2:c.317C>G:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Chronic granuloma and hemolytic anemia;CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	1353664,4125296					germline	MedGen:C4016535
X	153764217	C	T	Haplotype	10361	RCV000011075	25400	G6PD	NM_000402.4:c.292G>A	NP_000393.4:p.Val98Met	NM_001042351.2:c.202G>A:missense variant	Pathogenic	Pathogenic	no assertion criteria provided	no assertion criteria provided	OMIM	Glucose 6 phosphate dehydrogenase deficiency;G6PD A-	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703	X-linked recessive inheritance				germline	Genetic Alliance:Glucose+6+Phosphate+Dehydrogenase+Deficiency/3096;Genetic Testing Registry (GTR):GTR000500957;Genetic Testing Registry (GTR):GTR000503100;Genetic Testing Registry (GTR):GTR000503114;Genetic Testing Registry (GTR):GTR000520114;Genetics Home Reference:glucose-6-phosphate-dehydrogenase-deficiency;MedGen:C0017758;Office of Rare Diseases:6520
X	153764217	C	T	Haplotype	10361	RCV000011076	25400	G6PD	NM_000402.4:c.292G>A	NP_000393.4:p.Val98Met	NM_001042351.2:c.202G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD BETICA	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703					germline	OMIM:305900.0002
X	153764217	C	T	Haplotype	10361	RCV000011077	25400	G6PD	NM_000402.4:c.292G>A	NP_000393.4:p.Val98Met	NM_001042351.2:c.202G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD CASTILLA	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703					germline	OMIM:305900.0002
X	153764217	C	T	Haplotype	10361	RCV000011078	25400	G6PD	NM_000402.4:c.292G>A	NP_000393.4:p.Val98Met	NM_001042351.2:c.202G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD DISTRITO FEDERAL	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703					germline	OMIM:305900.0002
X	153764217	C	T	Haplotype	10361	RCV000011079	25400	G6PD	NM_000402.4:c.292G>A	NP_000393.4:p.Val98Met	NM_001042351.2:c.202G>A:missense variant	other	other	no assertion criteria provided	no assertion criteria provided	OMIM	G6PD TEPIC	10734064,1303173,1978554,2253938,2503817,2572288,2836867,2912886,3393536,4388132,5448,5492291,669721,7106752,7291768,903703					germline	OMIM:305900.0002
